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ABSTRACT 
Heart development is a complex process which is regulated by molecular 
mechanisms still largely unknown. Disruptions in these processes cause 
congenital heart defect, that affects over 1 out of every 100 live births and 
is responsible for most antenatal losses. In the last few decades, several 
mutations have been shown to cause isolated as well as syndromic 
congenital heart defects and the genetic contribution to this pathology now 
is being recognized as important not only for the rare familial cases but 
also in regard to the much more complex multifactorial varieties of the 
disease. 
The work summarized in this thesis was mainly an effort to clarify the role 
of mutations of a particular gene, MYH6, in congenital heart disease. 
Recently, this gene was identified as responsible for a Mendelian variety 
of atrial septal defect. 
The other main subject of this thesis is the mutational analysis work done 
in order to identify a new gene, besides TBX5 and SALL4, for Holt-Cram 
Syndrome, a developmental disorder characterized for the coexistence of 
congenital heart defects with upper limb abnormalities. Four candidate 
genes within the most likely chromosomal interval have been screened 
and excluded as responsible genes. 
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Chapter 1 INTRODUCTION 
1.1 The heart 
1.1.1 Evolutionary aspects 
Through evolution, hearts arose as devices to pump fluids through the 
body circulation and have varied greatly according to the size, biology and 
environment of the different organisms. 
The first recognizable pattern of cardiac evolution begins with the 
contractile tubular organs found in the urochordates, like the modem 
ascidians. In order to provide some evolutionary perspective of the heart, 
the morphology and development of the heart-like systems in this 
organism as well as in Drosophila melanogaster will be discussed. 
1.1.1.1 The heart in the ascidians 
These rudimentary organs do not contain chambers, valves or antero-
posterior polarity and show the ability to reverse peristaltic direction. The 
vessel is formed by a single layer of myoepithelial cells with no endothelial 
lining and surrounded by a pericardial coelom (Simoes-Costa et al. 2005). 
7 
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The development of the ascidian pump has been studied in Cion a 
in testinalis. Two blastomeres expressing mesoderm posterior (MESP) a 
helix-loop-helix transcription factor, divide during gastrulation giving origin 
to two paired bilateral populations of cells expressing orthologues of genes 
involved in vertebrate cardiogenesis like Nkx, Gata and Hand. These 
cardiac rudiments migrate ventroanteriorly fusing along the ventral midline 
and forming the pump field in a similar way as the vertebrate primary heart 
field is constructed (Figure 1.1A) (Davidson and Levine 2003). 
8 
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Figure 1.1: A, Localization and fate of the cardiac progenitor cells along the primitive line and 
their migration route to the cranial lateral plate mesoderm. B, Segmentation of the cardiac 
crescent according to the cardiac tissue they give rise to. C, The lineal cardiac tube before 
looping. D, The looped cardiac tube (see text) . Figure taken from "Human embryology and 
developmental biology" , by Bruce M. Carlson. 3rd ed. Mosby. Philadelphia (2004). 
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1.1.1.2 Drosophila melanogaster 
The Drosophila heart or dorsal vessel is an elongated sac-like organ, 
located inside the dorsal pericardial cavity. The wall of the vessel is 
formed by two cell layers. The luminal layer consists of contractile 
myocardial cells. The filtering and secretory cells of the external layer are 
called nephrocytes and provide lining to the pericardial cavity. During 
relaxation the hemolymph enters the heart through several laterally placed 
ostia which are closed during contraction. This autonomous contraction 
wave is originated caudally and moves anteriorly. The hemolymph is 
expelled through the aorta which drains into the head of the animal 
(Bodmer 1999). 
1.1.1.2.1 Development of the dorsal vessel in Drosophila 
During the first part of stage 12 of development, the mesoderm tissue in 
the Drosophila embryo is divided in discrete masses of cells, the primordia 
of the somatic and visceral musculature, the fat body and the dorsal 
vessel. The cluster of cells that give rise to the dorsal vessel migrate 
dorsally beside the overlying ectoderm at stage 13, forming two rows of 
cells showing different features. The dorsal row cells form a straight line, 
assuming a cuboidal shape. These cells are the cardioblasts that form the 
contractile portions of the dorsal vessel. The cells of the lateral row 
10 
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conserve their spherical shape and irregular arrangement, giving rise to 
the pericardial cells or nephrocytes (Campos-Ortega 1985). At stage 17 
the row of cardioblasts of each side migrate centrally meeting and fusing 
to the contralateral. The resultant double row of cardioblasts forms a 
tubular structure with a central lumen. 
Tinman (Tin), a Drosophila orthologue of the vertebrate family of 
homeobox transcription factors NK, has been shown to regulate the 
specification of the dorsal mesoderm (Azpiazu and Frasch 1993). This 
gene is initially expressed ubiquitously in the mesoderm cells under the 
control of the helix-loop-helix transcription factor twist (Yin et al. 1997). Its 
expression is limited subsequently to a section of the dorsal trunk 
mesoderm, maintained by induction of the overlaying endoderm by means 
of secretion of Oecapentaplegic (Opp) a member of the BMP family or 
transcription factors (Lockwood and Bodmer 2002). By stage 11 the 
expression of tinman is observed in dorsal clusters of mesodermal cells 
induced by neighbouring ectodermal and endodermal cells secreting 
wingless, a member of the Wnt protein family (Park et al. 1996). Both 
cardioblasts and nephrocytes derive from these cell clusters expressing 
tinman (Alvarez et al. 2003). In the absence of tin man expression or Opp 
or Wnt signals, the dorsal vessel does not develop (Frasch 1995). 
Pannier, a GAT A transcription factor is a transcriptional target of Tinman in 
the heart forming region where they are coexpressed. Through physical 
interaction the two factors function synergistically in the regulation of 
11 
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cardiac gene expression (Gajewski et al. 2001). During stage 11, pannier 
is induced by ectodermal Dpp signalling (Herranz and Morata 2001). The 
role of pannier in Drosophila heart development has been tested with 
mutants and ectopic expression experiments (Klinedinst and Bodmer 
2003). Mesodermal pannier expression is in turn required to maintain 
adequate levels of tinman expression (Gajewski et al. 1999). 
1.1.2 Heart development in vertebrates 
Being designed for efficient and durable delivery of oxygen and nutrients 
to all tissues, the / circulation must begin to function very early in 
/ 
development, and grow to meet the demands of the embryo. 
As discussed above, heart development follows an evolutionarily 
conserved programme which is initiated by specific molecular signals and 
directed by tissue-specific transcription factors. This process controls the 
differentiation of mesodermal stem cells into cardiomyocytes and the 
subsequent expression of genes coding contractile proteins. 
The complexity of the molecular determinants of heart development is 
highlighted by the sheer number of zebrafish mutants (Yelon 2001), null 
mouse mutants and human heritable conditions with altered heart 
morphogenesis (see below). 
12 
Molecular Genetics of Congenital Heart Disease and Holt-Cram Syndrome 
1.1.2.1 The cardiac progenitor cells 
The first recognizable heart forming cells (around 50 in the mouse) (Tam 
et al. 1997) are found in the early gastrulating embryo as a linear cluster of 
epiblast cells along the anterior part of the primitive streak (Garcia-
Martinez and Schoenwolf 1993). Derivatives of these cells contribute to 
form endocardium, myocardium and parietal pericardium. (Fishman and 
Chien 1997). The Cbp/p300-interacting transcriptional transactivator 
CITED2 (MSG1) has been shown to be a marker of these cells (Schlange 
et al. 2000a). Within this linear cluster, myocardial (Yatskievych et al. 
1997) and heart segment specification already exist. The anterior-most 
cells will form the outflow tract while the posterior ones will contribute to 
the atria and inflow tract (Garcia-Martinez and Schoenwolf 1993). During 
gastrulation these cells, amongst others, invaginate through the primitive 
streak, between the epiblast and the definitive endoderm to form part of 
the lateral plate mesoderm (Rosenquist 1970) (Figure 1.1A). The 
transformation of the progenitor cells from the epiblast into mesoderm is 
thought to be initiated before gastrulation due to induction by the subjacent 
hypoblast through T G F ~ ~ superfamily molecules like Nodal or Vg1 (Cheng 
et al. 2003) and FGF signalling which seems to be important for. the 
transition of their epithelial pattern in the epiblast to the mesenchymal one 
through repression on the cell-adhesion molecule E-cadherin via activation 
of the transcription factor snail (Ciruna and Rossant 2001). 
13 
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The cardiac progenitor cells give origin to two different mesodermal cell 
lineages. The first constitutes the primary heart field whereas the second 
forms both the anterior and secondary heart fields (Meilhac et al. 2004). 
Just after gastrulation, (15-16 days of development in humans, 7 dpc in 
mouse), the newly specified precardiac mesoderm cells of the first lineage 
migrate to form the cardiac crescent, a mesodermal structure in a 
horseshoe shape open caudally, located in the cranial regions of the 
embryo and containing diagonal bilateral and symmetric heart fields which 
joint medially and cranially (Schultheiss 1999). The migration route of 
these cells occurs according to their original position in the primitive 
streak. Those derived from the cranial part of the primitive streak migrate 
mainly cranially, close to the midline and occupy the anterior-most, fused 
pole of the crescent. Cells derived from the caudal end of the streak move 
cranially and laterally, in order to form two caudal ends of the crescent 
(Garcia-Martinez and Schoenwolf 1993) (Figure 1.1 B). 
This migration event seems to require the expression of FgfB (Sun et al. 
1999) and the basic helix-loop-helix proteins mesoderm posterior 1 and 2 
(Mesp1, and Mesp2) (Kitajima et al. 2000). 
1.1.2.2 The primary heart fields and the cardiac crescent 
During the migration of the cardiac forming cells to form the cardiac 
crescent, they are contained in the local lateral plate mesoderm on the left 
14 
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and right side and constitute the primary heart fields. The contribution of 
the heart fields to subsequent antero-posterior structures is unequal. The 
right heart field has a greater contribution to the cranial end of the heart 
tube whereas the left field contributes more to the caudal end (Stalsberg 
1969) (Figure 1.18). 
When the lateral plate mesoderm divides in two epithelial layers, a dorsal 
one, called the somatic mesoderm and a ventral one, the splacnic 
mesoderm, the heart progenitors are segregated to the second (Linask et 
al. 1997) and express the calcium-dependent adhesion molecule N-
cadherin (Takeichi 1991). The space left between the two mesodermal 
sheets constitutes the intra embryonic coelom which at the level of the 
cardiac crescent is called pericardial coelom, primordium of the pericardial 
cavity (Figure 1.2A). A number of vesicles between myocardium 
primordium cells begin to appear in the near vicinity of the pharyngeal 
endoderm. These vesicles eventually fuse to form the lumen of the two 
paired endocardial tubes and the N-cadherin negative cells lining the 
tubes constitute the endocardial primordium (Larsen 2001). The 
developing myocardium secretes an acellular and viscous matrix which is 
deposited between the myocardial and endocardial primordia, called the 
cardiac jelly (Carlson 2004) (Figure 1.28). 
15 
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Primitiwgut 
2-somite embryo 
( ~ 2 0 0 days) 
7 -somite embryo 
( ~ 2 2 2 days) 
( ~ 2 1 1 days) 
1 o-somite embryo 
( ~ 2 2 + + days) 
Figure 1.2: Diagram of transversal sections at four stages of development to show the structure 
of the heart forming structures and surrounding structures (see text) . Figure taken from "Human 
embryology and developmental biology", by Bruce M. Carlson. 3rd ed. Mosby. Philadelphia 
(2004) . 
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These morphological events in the cardiac crescent appear to be 
controlled by a number of inductions produced by the surrounding 
structures. The adjacent foregut endoderm secretes bone morphogenetic 
proteins (BMPs) producing an activity gradient increasing from the midline 
to the lateral edges of the crescent probably shaped by secretion of BMP 
inhibitors like Noggin and Chordin by the neighbouring axial mesoderm 
(Schlange et al. 2000b). The role of the BMPs in the crescent is to specify 
and maintain the myocardial lineage (Schultheiss et al. 1997) through 
positive regulation of the expression of FgfB, required for cardiac induction 
(Alsan and Schultheiss 2002), and the Smad family (Liberatore et al. 
2002). Smads in turn, interact with the basic-leucine-zipper activating 
trancription factor 2 (Atf2) (Monzen et al. 1999), which can be activated 
through phosphorylation by the protein kinase kinase Tak1 (Monzen et al. 
2001). 
Indian hedgehog (/hh) and Sonic hedgehog (Shh) are also expressed by 
the pharyngeal endoderm below the crescent where their products along 
their receptor smoothened seem to function as permissive factors in 
cardiogenesis whereas their Inhibitor receptor patched (Pte) appears to 
have the opposite effect (Zhang et al. 2001). 
Another kind of signalling molecules secreted by the endoderm adjacent to 
the myocardium primordium are Wnt inhibitors of the Dickkopf and Frizzled 
families (Schneider and Mercola 2001). SpeCifically, Crescent, one of the 
latter, binds to Wnt-1, Wnt-3, Wnt-S. All three molecules are present in the 
17 
Molecular Genetics of Congenital Heart Disease and Holt-Oram Syndrome 
neural ectoderm and expressed in the lateral plate mesoderm, acting 
through the canonical Wnt (via p-catenin) pathway, which is thought to 
negatively regulate specification of cardiac mesoderm (Marvin et al. 2001). 
Conversely, Wnt molecules acting through the non-canonical (PKC-
dependent) pathway like Wnt-11, expressed in the posterior edge of the 
heart field, are powerful cardiac inducers (Koyanagi et al. 200S). The 
establishment of the lateral limits of the crescent is thought to be mediated 
by Notch signalling. The expression of one of its ligands, Serrate, is 
repressed in cardiogenic cells while differentiating, whereas is activated In 
the surrounding, non-cardiogenic mesoderm (Rones et al. 2000). 
In response to the inductive stimuli produced by the neighbouring 
endoderm (BMPs, Fgf factors, Wnt inhibitors like Dkk and Crescent and 
Hedghog proteins), peripheral (Notch and Serrate) and central inhibitory 
influences (BMPs antagonist like Chordin and Noggin) by the notochord 
and posterior by the neural plate ( ~ - c a t e n i n n pathway Wnt proteins), the 
cardiac crescent activates a number of myocardial transcriptional 
regulators in the myocardium primordium, like Nkx2.S, Gata 4-6, myocyte 
transcription factors (Mef2b, Mef2c), heart and neural crest derivatives 
expressed 1 and 2 (Hand1, Hand2), T-Box Sand 20 (TbxS, Tbx20), serum 
response factor (SRF), Myocardin, besides genes encoding patterning 
molecules like the slow twitch cardiac muscle calcium transport ATPase 
(Atp2a2), phospholamban (PIn) and retinaldehyde dehydrogenase type 2 
(RALDH2) (Brand 2003; Harvey 2002). 
18 
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The expression of Gata6 on the crescent is restricted to the cells that are 
furthermost from the midline which, later in development, give origin to the 
heart conduction system (Davis et al. 2001). 
Nkx2.5 is one of the first genes to be expressed in the cardiac fields, 
specifically in the cells with ventricular fate (Redkar et al. 2001) and it 
continues to be expressed in cardiac tissue throughout life (Komuro and 
Izumo 1993). Nkx2.5 is known to modulate the expression of other cardiac 
specific genes like eHand (Biben 1997a), Mef2c, N-myc, Msx2, myosin 
light chain 2V (Mlc2v) (Tanaka et al. 1999), atrial natriuretic factor 
precursor (Nppa) (Durocher et al. 1996), a-cardiac alpha (Chen et al. 
1996), cardiac ankyrin repeat protein (Carp) (Zou et al. 1997), Iroquois 
homeobox gene 4 (Irx4) (Bruneau et al. 2000) endothelin-converting 
enzyme-1 (ECE1) (Funke-Kaiser et al. 2003), connexin-40 (Cx40) 
(Heathcote et al. 2005), type II iodothyronine deiodinase (0102) (Dentice 
et al. 2003), GATA4, TBX5 (Riazi et al. 2005; Sun et al. 2004), pro-
collagen type I alpha 2 (pro-coI1a1) (Ponticos et al. 2004), a cardiac-
specific isoform of the RNA helicase Mov1011 (Csm) (Ueyama et al. 2003). 
The list is growing fast and much more downstream targets of NKX2.5 are 
likely to be found in the future. 
1.1.2.3 The anterior and secondary heart fields 
The cardiac precursor cells from the second lineage are first identified as a 
second, Ffg8 and Fgf10 expressing crescent, continuous with and 
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medially located to the crescent of the primary heart field (Kelly et al. 
2001). These cells give rise to a population of mesodermal cells located in 
the pharyngeal mesoderm that can be distinguished by their expression of 
the LIM homeodomain transcription factor Islet-1 (Cai et al. 2003), as well 
as Nkx2.5, Gata4 and Mef2c (Dodou et al. 2004; Waldo et al. 2001). 
The anterior heart field comprises a subpopulation of pharyngeal 
mesodermal cells of the Islet-1 positive linage that express the forkhead 
transcription factor Foxh1 (von Both et al. 2004) and migrate through the 
splachnic mesoderm and the dorsal mesocardium in order to populate the 
prospective proximal outflow tract and the right ventricle during cardiac 
looping (Kelly et al. 2001; Mjaatvedt et al. 2001; Zaffran et al. 2004). 
The secondary heart field is formed by another subpopulation of 
precardiac pharyngeal mesoderm cells that express Tbx1 and migrate to 
the heart tube to contribute to the formation of the distal outflow tract 
(Waldo et al. 2001; Xu et al. 2004) as well as the atria and the inflow tract 
(Brown et al. 2004). 
1.1.2.4 The heart tube 
Around the 22nd day of human development (8 dpc in the mouse), both 
cardiac primordia, each one formed by a medial endocardial tube, flanked 
laterally by a layer of cardiac jelly, myocardium primordium and the 
pericardial coelom are brought together in the midline driven by the lateral 
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and ventral folding of the embryo and fuse, creating a single, central heart 
tube (Carlson 2004) (Figure 1.1 C and 1.2D ). 
This migration event depends on a cranio-caudal concentration gradient of 
fibronectin in the extracellular matrix between mesoderm and endoderm 
(Lin ask and Lash 1986) and a conserved structural and functional integrity 
of the foregut endoderm. The failure in central migration and fusion by the 
cardiac primordia produces two separate developing hearts, a condition 
called cardia bifida (Harvey 2002). The zebrafish mutants casanova 
(sox32) (Alexander et al. 1999), faust (GATAS) (Reiter et al. 1999) and the 
G-protein-coupled receptor for sphingosine-1-phosphate miles apart 
(Kupperman et al. 2000) and the mutant mouse embryos for GATA4 
(Narita et al. 1997), Foxp4 (Li et al. 2004), Mesp1 (Saga et al. 1999) and 
furin (Roebroek et al. 1998) display defects of the foregut endoderm and 
cardia bifida. Interestingly, Foxp4 mutants develop two complete, separate 
hearts with proper looping and chamber formation, showing that fusion of 
the bilateral cardiac primordia is not required for cell or chamber 
specification in the heart (Li et al. 2004). 
Outside the endocardial lining, the next layer of the heart tube is 
constituted by the cardiac jelly, followed by a layer of myocardial cells 
which remains attached dorsally to the pericardial mesoderm covering the 
foregut through the dorsal mesocardium, important as a migration route for 
the cells of the anterior and secondary heart fields (see above). The tube 
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is suspended inside the pericardial coelom by its connection to the arterial 
and venous vessels and the dorsal mesocardium (Figure 1.3). 
The endocardial tubes do not fuse at their caudal end but continue 
posteriorly as the venous inflow tract of the heart whereas their cranial end 
generates arterial arches that surround the pharynx (Carlson 2004). 
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Figure 1.3: Diagram of transversal sections at four stages of development to show the 
heart and outflow tract (see text) . Figure taken from "Human embryology and 
developmental biology", by Bruce M. Carlson. 3rd ed. Mosby. Philadelphia (2004). 
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1.1.2.4.1 Cranio-caudal patterning in the cardiac tube 
Virtually all the retinoic acid (RA) in the embryo is synthesized by the 
retinaldehyde dehydrogenase type 2 (RAlDH2). Expression of the 
RALDH2 gene is limited to the sinuatrial regions during the cardiac 
crescent and tube stages. The resultant graded concentration of RA is 
thought to be important in the establishment of the cranio-caudal 
patterning seen in these structures. Indeed, high concentrations of 
exogenous RA in the embryo are deleterious to heart development only if 
the exposure occurs in the cardiac crescent stage, causing "atrialization" 
of the whole organ (Simoes-Costa et al. 2005), whereas mice with 
mutations in RAlDH2 show unlooped hearts lacking sinuatrial tissue 
(Niederreither et al. 1996) and fail to display the normal cranial to caudal 
increasing heart tube gradient of TBX5 (Bruneau et al. 1999). SERCA2 is 
present mainly in the caudal inflow end, and phospholamban, present 
mainly in the cranial, outflow end (Moorman et al. 2000). These proteins 
regulate cytoplasmic calcium concentration and seem to be responsible 
for the highest rate of contraction in the caudal part of the tube. 
1.1.2.5 Cardiac looping 
The embryo displays a symmetrical configuration until gastrulation, when 
the symmetry is broken by the unidirectional movement of cilia from cells 
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around the primitive node (Nonaka et al. 1998). These posteriorly tilted 
cilia that move in clockwise direction (Nonaka et al. 2005) are thought to 
generate a leftward flow of yolk sac fluid (nodal flow) driving yet 
unidentified molecules to the left part of the embryo, where they could be 
responsible for the predominantly left lateral plate mesoderm expression 
of Nodal at the early somite stage, which in tum activates the expression 
of Lefty1 (along the left side of the primitive streak), Lefty2, and the bicoid-
type homeobox Pitx2 in the same side (Nonaka et al. 2002), initiating a 
cascade of events that eventually produces the asymmetric 
morphogenesis seen in the adult organism. The nodal flow has been 
reversed experimentally in cultured mouse embryos. This resulted in a 
situs reversal with altered expression of several left-right determinants 
(Nonaka et al. 2002). 
Heart looping represents the first macroscopically visual manifestation of 
left-right asymmetry in the vertebrate embryo. The heart tube develops In 
the closed pericardial cavity and in order to grow in length as well as 
width, it undergoes, between the 23rd and 28th day in humans, a rightward 
looping that ultimately places the primordia of the cardiac chambers in 
their definitive positions. The dorsal mesocardium, which initially tethers 
the developing cardiac tube, is disrupted, releasing most of it. As the 
looping progresses, the bulbus cordis (outflow tract, primordium of the 
conotruncus) is displaced caudally, ventrally and to the right. The 
prospective ventricle is displaced to the left and the primordium of the atria 
is displaced cranially and posteriorly (Figure 1.10 and 1.3). The ventral 
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surface of the tube is placed as the outer surface of the loop while the 
dorsal surface of the tube becomes the inner surface of the loop. When 
the heart chambers form, they begin to develop as evaginations of the 
outer surface of the looped heart, undergoing a process called ballooning. 
The molecular mechanisms responsible of cardiac looping are not well 
understood. As embryonic hearts explanted in culture retain the ability to 
loop (Manning and McLachlan 1990), this phenomenon can not be 
explained solely by a constrained longitudinal growth. Marked differences 
in mitosis or apoptosis between regions of the looping heart tube have not 
been observed (Stalsberg 1970) and disruption of actin filaments (Itasaki 
et al. 1991) or microtubules (Icardo and Ojeda 1984) which directs cell 
shape do not prevent cardiac looping. 
Cardiac looping appears to be controlled at least in part by the same 
pathway controlling laterality in other structures of the early embryo. The 
axial signalling system that determines the direction of cardiac looping 
also affects the position of the lungs, liver, spleen and gut. Interpretation of 
left-right signals is mediated in part by the transcription factor Ptx2, which 
is expressed along the left side of developing organs, including the early 
heart tube. Mouse models of left-right defects demonstrate absent, 
bilaterally symmetrical, or reversed Nodal and Ptx2 expression. In 
humans, mirror-image reversal of left-right asymmetry is often associated 
with normal organogenesis, but a discordance of cardiac, pulmonary and 
visceral asymmetry (heterotaxy syndrome) reflects a lack of coordinated 
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left-right signalling and is universally associated with defects in 
organogenesis. The common association of human cardiac alignment 
defects with abnormalities in left-right asymmetry points to intersecting 
pathways that regulate the direction and process of cardiac looping, and 
highlights the clinical significance of this area of study (Capdevila et al. 
2000). 
Very early in heart development, left-right differential gene expression can 
be detected. Transcriptional coactivator CITED2 expression is transiently 
stronger in the right heart field in the chick (Schlange et al. 2000a). 
Other asymmetrically expressed genes during gastrulation and neurulation 
include activin receptor lIa (ACVR2A), sonic hedgehog, the the 
transcription factor Foxa2 (Levin et at 1995), wnt-8c, patched, the activin 
binding protein gene follistatin and the snail-related transcription factor 
gene SnR-1 (Isaac et al. 1997; Levin 1997). Additionally, some 
extracellular matrix molecules like hLAMP and fJectin (both expressed 
mainly on the left) and JB3 (expressed mainly on the right) are though to 
be important for looping as treatment with antibodies against f1ectin-can---
randomize the direction of it (Linask et al. 2002). 
Aberrant looping is observed in the Nodal hypomorph mouse (Lowe et al. 
2001) and when this gene Is ectopically expressed in the right side of the 
embryo (Levin et al. 1995). 
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During looping, expression of Hand1 occurs mainly on the left part of both 
atrial (Biben 1997a) and ventricular primordial and antisense translational 
inhibition of both Hand1 and Hand2 in chick embryos prevents normal 
looping (Srivastava et al. 1995). 
In zebrafish, a Tbx20 antisense morpholino impairs looping, and a straight 
cardiac tube is formed (Szeto et al. 2002). In these morphants, expression 
of Tbx5 is upregulated whereas over expression of Tbx20 downregulates 
Tbx5. It is thought that these two proteins compete for the same binding 
sites on promoters of specific cardiac expressed genes like ANF 
(Plageman and Yutzey 2004). Moreover the zebrafish Tbx5 mutant 
heartstrings show unfolded hearts (Garrity et al. 2002). 
In zebrafish cardiac looping is not the first macroscopic event breaking the 
symmetry of the early embryo. Instead, during cardiac "jogging" the caudal 
end of the heart tube is displaced in most embryos to the left side and then 
returns to the midline to start looping to the opposite side. Cardiac jogging 
always precedes looping and always occurs to the opposite side, even in 
mutants where looping is randomized. In a mutant screening in zebrafish, 
(Chen et al. 1997a), it was found that mutants showing altered looping 
morphogenesis display perturbations of the normally asymmetric BMP4 
expression, remaining symmetric or randomized. Those retaining BMP4 
symmetry show failure to "jog" whereas those with right-predominance of 
the BMP4 pattem show reversion of the direction of jogging and looping. 
Experimental upregulation and downregulation of BMP4 impairs 
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directional jogging or looping, suggesting that the expression pattern of 
BMP4 could participate in the interpretation of laterality signals (Chen et 
al. 1997b). 
1.1.2.6 Development of the venous inflow to the atria 
By day 24th• the venous flow reaches the primitive atrium through two 
symmetric horns of the single and medial sinus venosus. Each horn in turn 
receives venous return through a common cardinal vein (draining the 
anterior and posterior cardinal veins), an umbilical vein (carrying 
oxygenated blood from the placenta) and a vitelline vein (draining the liver 
and other developing viscera). In the next days the venous system 
undergoes extensive reorganization. The three caudal tributaries of the left 
horn (posterior cardinal, umbilical and vitelline left veins) undergo 
involution, while the remains of the left horn and left common cardinal vein 
stop growing, and constitute later the coronary sinus and the oblique vein 
of the left atrium respectively. The right cardinal vein atrophies while the 
left umbilical and vitelline veins fuse to form the inferior vena cava and 
anterior cardinal vein gives rise to the superior vena cava (Larsen 2001). 
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The pulmonary vein sprouts from the primitive atrium at the beginning of 
the fourth week of development. as a strand of endothelium that runs 
through the dorsal mesocardium and makes connection with the vascular 
plexus surrounding the developing lung buds. The trunk of the pulmonary 
vein divides in left and right branches to each developing lung, which in 
tum bifurcate to produce a total of four pulmonary veins (Webb et al. 2001) 
(Figure 1.3). 
1.1.2.7 Ballooning and specification of chamber myocardium 
Anatomic identity of the cardiac cavities becomes to appear only soon 
after cardiac looping. However, the cell fate of the cardiac fibres of the 
chambers is genetically programmed since much earlier stages of 
development. The heart tube is divided along the anterior-posterior axis 
Into precursors of the aortic sac, conotruncus pulmonary and systemic 
ventricles, and atria. Each one differs in its gene expression and functional 
patterns (Srivastava and Olson 2000). 
The myocardial tissue that forms the primordia of the cardiac chambers is 
located after looping In the outer curvature of the cardiac tube. These 
segments experience a change called ballooning, which consists in the 
outpouching and thickening of the wall of the tube. Gene expression of this 
myocardial tissue as well as functional analysis suggest that this active or 
"working" myocardium generates most of the contractile effort and 
electrical connectivity of the organ at this stage. 
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A common feature of the more differentiated working myocardium is the 
development of trabeculae, which form the spongiform, irregular surface 
tissue lining the lumen of the ballooned segments of the cardiac loop, 
characteristic of the adult ventricles. Anf, Hand1, Cited1, Chisel, Irx1, Irx3, 
Irx5 Cx40 and Cx43 are expressed in the trabeculated areas of the outer 
curvature (Christoffels et al. 2000a; Christoffels et al. 2000b). 
Between the endocardium layer and the prospective trabeculated layer of 
myocardium the cardiac jelly persists, though some areas of direct contact 
between the two layers exist. The development on the trabeculated tissue 
is induced by the subjacent endocardium by means of Neuregulin-1 
molecules that diffuse through the jelly and reach the membrane tyrosine 
kinase co-receptors Erbb2 and Erbb4 of the myocardium (Lee et al. 1995). 
The functional interactions of these receptors with CD44 (Bourguignon et 
al. 2001), a membrane receptor for the glycosaminoglycans present in the 
jelly is thought to be important for the process, as trabeculae are absent in 
mice with mutations in the hialuronan synthetase-2 gene (Has2) 
(Camenisch et al. 2000). 
Defects in ventricular trabeculation have also been observed in mice 
lacking angiogenic factors, such as vascular endothelial growth factor 
(VEGF) (Carmeliet et al. 1996) and angiopoietin-1 (Suri et al. 1996), that 
are expressed in the endocardium. In Nkx2.S and Tbx5 null mouse 
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embryos the heart retains a tubular appearance, failing to loop and to 
express working myocardium markers (see above) 
1.1.2.8 Development of the atria 
After looping has occurred, the primordium of both atria is constituted by 
the cranially displaced caudal limb of the cardiac loop. The outer wall of 
this segment of the loop expands and thickens (in a process known as 
"ballooning") producing a single and medial chamber, the primitive atrium. 
This atrial component of the looped heart tube contributes in variable 
degree to the definitive atrial chambers (see below) and in both sites the 
cranio-Iateral wall of the tube balloons to form both auricles, surrounding 
the developing outflow tract from either side (Moorman et al. 2003). 
By the 31 st day of development, the prospective superior and inferior 
venae cavae as well as the primordium of the coronary sinus empty Into 
the right hom and the remaining left hom of the sinus venosus, which in 
turn drains into the primitive atrium through a long and narrow orifice 
located in the right posterior wall of the chamber (Carlson 2004). 
The wall of the right hom of the sinus venosus is then incorporated to the 
right and posterior wall of the primitive atrium by an intussusception 
process, displacing the right part of the primitive atria wall ventrally and to 
the right and pulling the venae cavae and the coronary sinus, so each one 
drains at this stage through its own ostium. Two tissue flaps form at either 
32 
Molecular Genetics of Congenital Heart Disease and Holt-Oram Syndrome 
side of the three ostia, the left and right venous valves, and join cranially, 
to form the septum spurium. Later in development, the left valve is 
incorporated to the septum secundum, while the right valve forms the 
(Eustachian) valve of the inferior vena cava and the (Thebesian) valve of 
the coronary sinus (Larsen 2001). 
The displaced part of the prospective right atrium forms the right or 
triangular auricle which has a broad connection with the atrium. The 
trabeculae in the auricle consist of pectinate muscles, which extend all 
around the parietal atrioventricular junction. The border between its 
trabeculated surface and the smooth wall of the rest of the chamber is 
indicated by the terminal crest which runs from its roof to the caudal 
atrioventricular junction and constitutes a preferential route for the 
electrical impulse between the sinuatrial and atrioventricular nodes. The 
left (tubular) auricle, which is formed by the same process in the opposite 
side, has a much narrower communication with the atrium and the 
trabeculated surface is limited to the auricle. 
The differences in morphology between the two auricles are important 
because they can identify the morphologically right and left atria, 
regardless of their spatial arrangement in a malformed heart. This is 
because their primordia do not participate in cardiac looping and therefore 
they derive from separate left and right structures, in contrast to the 
ventricles, whose primordia are initially located in a cranio-caudal 
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sequence and receive contributions from both left and right elements 
(Campione et al. 2001). 
Displaced myocardium from the primitive atrioventricular canal is an 
important source of atrial tissue. By the 10th week of development, the 
caudal-most part of the atria, the smooth wall of the vestibule of both 
atrioventricular valves (Kim et al. 2001) is derived from remodelled 
myocardium displaced during the rightward movement of the 
atrioventricular canal. 
Cells from the anterior and secondary heart fields that migrate during and 
after cardiac looping through the remaining dorsal mesocardium also 
contribute to the formation of the primary atrium (Meilhac et al. 2004). 
During and after atrial septation the developing pulmonary vein that drains 
through a single ostium located in the cranial posterior wall of the 
prospective left atrium undergoes an intussuception process similar to that 
described for sinus venosus, incorporating the wall of the vessel to the 
roof of the chamber. The absorption reaches the first and second 
branching points of the pulmonary vein, so that ultimately four independent 
pulmonary veins communicate with the heart (Kelly et al. 2001). 
These four sources of atrial tissue can be recognized as four different 
transcriptional domains. The auricles can be identified as a derivative of 
the pro-atrial segment of the cardiac tube because of their expression of 
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ANF in the fetal stages. MLC2V is expressed in the atrioventricular canal 
and sinus venosus derived tissues. Pitx2 specifically marks the interatrial 
septa, pulmonary vein derivatives as well as contributions of the left atrial 
auricle and left part of the atrioventricular canal (Franco et al. 2000) 
(Figure 1.4). 
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Figure 1.4: Diagram of the posterior aspect of the heart from just before looping to the four 
chamber stage showing the development of the venous inflow (see text) . Figure taken from 
"Human embryology and developmental biology", by Bruce M. Carlson. 3rd ed. Mosby. 
Philadelphia (2004). 
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1.1.2.9 Septation of the atria 
The division of the primitive atrium in a left and right atria is a complex 
process carried out in several stages approximately between the 33rd and 
43rd days of development. Firstly a muscular septum develops in a 
crescent shape, emerging from the posterior and cranial walls of the 
primitive atrium. This laminar structure expands ventrally and caudally, 
leaving a rounded space, the ostium primum, as a transient 
communication point between the developing left and right atria that 
eventually closes near the end of the 6th week (Figure 1.5). 
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Figure 1.5: Diagram of coronal sections of the developing heart, showing the changes in the 
luminal morphology og the chambers, septa and valves (see text). Figure taken from "Human 
embryology and developmental biology", by Bruce M. Carlson . 3rd ed. Mosby. Philadelphia 
(2004) . 
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The free edge of the expanding septum primum is covered by a cap 
formed by mesenchymal tissue, the cranial spur of the atrial spine. This 
relatively undifferentiated tissue has an extracardiac origin, entering the 
heart by the posterior mesocardium and penetrating the atrium to form the 
right rim of the pulmonary orifice and to be placed on top of the inferior 
endocardial cushion, producing its spur. When the spur and the body of 
the atrial spine fuse with the superior endocardial cushion, the ostium 
primum is obliterated. After the fusion, the atrial spine mesenchymal tissue 
becomes myocardium, except for the central portion, which condenses 
and persist as the fibrous tendon of Todaro (Webb et al. 1998). 
The muscular tissue that form the septum primum· expresses the left 
markers CK-B (Wessels et al. 2000) and Pitx2 (Campione et al. 2001). 
Before the closure of the ostium primum is completed, a number of small 
perforations in the dorsal septum primum are formed by apoptosis, which 
eventually become confluent to constitute a bigger orifice, the ostium 
secundum, so the shunt between both developing atria is not interrupted. 
While the left venous valve regresses, another infolding of the dorsal wall 
of the primitive atrium, the septum secundum, develops in a similar way as 
the septum primum, growing ventrally and caudally as a crescent and 
leaving a space that becomes a caudal and dorsal orifice, the foramen 
ovale. Thus, the dorsal and cranial rims of this orifice are formed by the 
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septum secundum, whereas the ventral and caudal rims are a contribution 
of the myocardialized atrial spine. 
In humans, the septum secundum is difficult to identify during embryonic 
development, becoming evident during the second trimester (Lamers and 
Moorman 2002). The atrial septa forms part of the mediastinal component 
of the atrial tissue, along with that derived from the pulmonary vein. 
During development, there is a pressure gradient between right and the 
.. 
... left atria (in that direction) that allows the flow of blood between the two 
chambers through the foramen ovale, displacing the septum primum to the 
left and passing though the septum secundum. This is the flap valve of the 
oval foramen. 
Normally, during and shortly after birth, when the flow through the 
umbilical vessels stops and the pulmonary circulation expands, the 
pressure gradient is inverted and the septum primum is tightly applied 
. against the septum secundum, obliterating the atrial shunt. 
1.1.2.10 Development of the ventricles 
The ventricles derive from the cranial and intermediate limbs of the looped 
heart tube. During looping, the cranial limb of the loop, the primordium of 
the conotruncus, receives migrating cells from the cardiac crest and the 
anterior and secondary heart fields. As described above, after looping, the 
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inner and outer curvatures carry out different and sequential roles in 
development (Figure 1.3). 
The apical portions of the two ventricles balloon from the outer curvature 
of the intermediate limb of the cardiac loop. The inlet portion of the limb 
gives rise to the apical part of the left ventricle, whereas the right ventricle 
originates from outlet portion, according to the position of the respective 
primordia in the heart tube (Lamers and Moorman 2002). The myocardium 
formed by these ballooning events can be distinguished by their 
expression of working myocardium markers. 
While the ballooning of the ventricles start, they are located in sequence, 
with the primitive atrium connected directly and exclusively with the left 
ventricle through the developing atrioventricular canal, the left ventricle in 
tum empties in the right ventricle through the interventricular foramen, 
surrounded by the primary ring which can be specifically identified by its 
expression of markers like the G1 N epitope (Lamers et al. 1992) and the 
right ventricle drains in the outflow tract. The outflow tract is entirely 
supported by the right ventricle (see Figure 1.6). 
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The wall of the developing right atrium is initially continuous with the wall 
of the outflow tract through the inner curvature. In order to allow the 
aligment of the atrioventricular canal to both developing ventricles, the 
ventricular segment of the inner curvature must undergo an extensive 
remodelling, mostly accomplished by the expansion of the atrioventricular 
canal and the displacement of tissue from its right side to the vestibule of 
the tricuspid valve (Kim et al. 2001). 
Several studies in model organisms have begun to reveal the genetic 
basis of ventricular development (Lyons 1996). The helix-loop-helix 
(bHLH) transcription factors dHAND/HAND2 and eHAND/HAND1 are 
expressed predominantly in the primitive right and left ventricular 
segments, respectively, during mouse heart development (Srivastava et 
al. 1995; Srivastava et al. 1997). Deletion of dHAND in mice results in 
hypoplasia of the right ventricular segment. eHAND has also been 
implicated in left ventricular development, although early placental defects 
of eHAND mutant mice precluded a detailed analysis of its role in the heart 
(Firulli 1998). 
Mice lacking Nkx2.5 also show lethal defects in ventricular morphogenesis 
and fail to express eHAND in the heart, suggesting that eHAND may act 
downstream of Nkx2.5 to control left ventricular development (Biben 
1997b). The ventricular-specific homeobox gene Irx4 is dependent on 
dHAND and Nkx2.5 for expression, and is sufficient, when missexpressed 
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in the atria, to activate ventricle-specific gene expression (8ao et al. 1999; 
Bruneau et al. 2000). 
In the zebrafish, which has a single ventricle, only one HAND gene 
(dHANO) has been identified, mutation of which abolishes the ventricular 
segment of the heart (Yelon et al. 2000). Mice lacking the transcription 
factor MEF2C, which is normally expressed throughout the atrial and 
ventricular chambers, also show hypoplasia of the right and left ventricles, 
resulting in their early demise in embryogenesis (Lin et al. 1997). 
1.1.2.11 Septation of the ventricles 
The septation of the ventricles is the last step to separate the aortic and 
pulmonary outflow from the heart cavities, in addition to separate the 
bicuspid and tricuspid valves, and thereby, in and outflow. The septum has 
two main components, a membranous part and a muscular part. The 
muscular component comes from the ventricular wall itself and it grows 
towards the fused endocardial cushions to finally meet the membranous 
part. The latter is formed by the union of the fused endocardial cushions 
with the fused truncoconal ridges (Anderson et al. 2003a). Because of the 
complexity of its development, the membranous part is where most of the 
VSD arise. See figure 1.5. 
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1.1.2.12 Formation and Septation of the outflow tract 
The symmetric division of the outflow tract into the systemic and 
pulmonary outlets starts during the fifth week of normal embryonic 
development. The outflow tract can be first identified as a purely muscular 
structure, which connects the embryonic right ventricle with the aortic sac. 
Later in development, the endocardial jelly inside the tract concentrates to 
form pairs of cushions facing each other (Anderson et al. 2003b). The 
cushions form continuous structures running through the length of the 
outflow tract (ridges), which spiral round one another and solidify. 
Afterwards, there is an invasion of mesenchymal cells from the neural 
crest, which enter in a distal to proximal manner and induce the 
downwards growth and fusion of the ridges to form the aortico-pulmonary 
septum (Lamers and Moorman 2002). 
Partition of the truncus arteriosus will also contribute to the formation of 
the aortic and pulmonary semilunar valves. 
1.1.2.13 Development of the valves 
During development, division of the cardiac tube in cavities is achieved by 
means of regional swellings of extracellular matrix, called cardiac cushions 
that mark the location of the valves. Reciprocal signalling between the 
endocardial and myocardial cell layers in the cushion region, mediated in 
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part by TGF-* family members, induces a transformation of endocardial 
cells into mesenchymal cells (Brown et al. 1999). These migrate into the 
cushions and differentiate into the fibrous tissue of the valves; they are 
also involved in septation of the common atrioventricular canal into right-
and left-sided orifices. Studies using gene targeting in mice has revealed 
novel roles for the NF-ATc and Smad6 transcription factors in the 
formation of cardiac valves. Mice lacking NF-ATc, a downstream mediator 
of signalling by the calcium-dependent protein phosphatase calcineurin, 
exhibit fatal defects in valve formation, reflecting a potential role for 
calcineurin in transduction of signals in valve development (de la Pompa 
et al. 1998; Ranger et al. 1998). Galvin et al. showed that Smad6, which is 
implicated in the activation of gene expression in response to TGF-f 
signalling, is also expressed specifically in cardiac valve primordia, but 
disruption of Smad6 leads to abnormal valves (Galvin et al. 2000) . 
. 1.2 The myosins 
The myosins are a family of proteins with members present in a wide 
range of organisms, from yeast to plants and humans. They have in 
common the ability to produce movement through interaction with actin 
and hydrolysis of ATP (Mermall et al. 1998). In general, they display a 
modular structure comprising a motor domain, a neck domain that can 
bind light chains or calmodulin and a tail domain that allow the protein to 
form complexes with other myosin molecules, for example the thick 
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Figure 1.6: A. Diagram showing a coronal (A) and sagital (8) sections (corresponding to 
dashed line in A) of the heart just before septation. 1) Inferior atrioventricular 
endocardial cushion; 2) Superior atrioventricular endocardial cushion; 3) Parietal outflow 
tract ridge; 4) Septal outflow tract ridge; 5) Spur of the atrial spine on the edge of septum 
primum; 6) Non-balloned portion of atrial heart tube; 7) Primary ring . The atrial 
appendages (blue) and ventricles (red), are ballooned from the outer curvature and non-
ballooned portions of the primitive heart tube (purple) later contribute to septation. AS: 
atrial spine, PAS: septum primum; PIF: ostium primum; RA: right atrial appendage; LA: 
left atrial appendage; LV: developing left ventricle; RV: developing right ventricle. The 
circles show transversal sections of the atrioventricular canal (AVC) and outflow tract 
(OFT) showing the orientation of the endocardial cushion and ridges. Figure taken from : 
Moorman AFM, Lamers WH: Cardiac septation: a late contribution of the embryonic 
primary myocardium to heart morphogenesis. Circ Res. 2002;91 :93-103. 
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filament of the sarcomere, in order to be in position to interact with actin 
(Sellers 2000). 
Myosins are phylogeneticaly classified in at least 18 classes according to 
their structure. In humans members of 11 classes have been found: " II, 
III, V, VI, VII, IX, X, XV, XVI, XVIII (Berg et al. 2001). It has been shown 
that mutations in these genes can cause human disease (see table 1.1). 
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Table 1.1: Human diseases caused by mutations in myosin genes 
Class Symbol Chrom. Fenotype Reference 
I MY01A 12 Neurosensory Deafness (Donaudy et al. 2003) 
II MYH2 17 Inclusion Body Myopathy (Martinsson et a!. 2000) 
MYH6 14 Atrial Septal Defect (Ching et a!. 2005) 
Hypertrophic Cardiomyopathy (Niimura et a!. 2002) 
MYH7 14 Hypertrophic Cardiomyopathy (Anan et al. 1994) 
Laing Distal Myopathy (Meredith et al. 2004) 
MYHB 17 Camey Complex (Veugelers et al. 2004) 
MYH9 22 May-Hegglin Anomaly (Seri et al. 2000) 
Sebastian Syndrome 
Fetchner Syndrome 
Neurosensory Deafness (Lalwanl et al. 2000) 
MYH14 19 Neurosensory Deafness (Donaudy et al. 2004) 
III MY03A 10 Neurosensory Deafness (Walsh et al. 2002) 
V MY05A 15 Griscelli Syndrome (Pastural et al. 1997) 
VI MY06 6 Neurosensory Deafness (Melchlonda et al. 2001) 
VII MY07A 11 Usher Syndrome (Weil et al. 1995) 
Neurosensory Deafness (Uu et al. 1997) 
XV MY015A 17 Neurosensory Deafness (Wang et al. 1998) 
MLC MYL3 3 Hypertrophic Cardiomyopathy (Poetter et al. 1996) 
MYL2 9 Hypertrophic Cardiomyopathy 
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1.2.1 Class II myosins 
Myosins of class II were the first ones to be described. Because of that 
they are called "conventional myosins". These myosins form hexameric 
complexes: two heavy chains of molecular weight ranging from 100,000 
Da to 250,000 Da and two pairs of light chains between 15,000 Da and 
20,000 Da (Korn 2000). 
The amino-terminal end or "head" of the class II myosin heavy chain 
contains the motor domain, adjacent to the "neck" that features two IQ 
domains. The carboxyl end of the molecule consist of a long coiled-coil 
tract which homodimerizes with another myosin heavy chain forming the 
"rod", giving the typical two-headed structure of this complexes which 
allows them to form filaments (Hodge et al. 1992; Rayment et al. 1993b). 
According to the phylogenetic sequence of the motor domain, class II 
myosins can be classified in four different categories: 1) sarcomeric 
myosins from striated skeletal and cardiac muscles, 2) vertebrate smooth 
and non-muscle myosins, 3) myosins from protozoans and other lower 
eukaryotes and 4) myosins from fungi (Sellers 2000). 
The motor domain is constituted of four subdomains: 1) An amino-terminal 
subdomain, displaying a SH3-like motif.; 2) The upper 50 kDA subdomain 
which shows in its surface the so called "hypertrophic cardiomyopathy 
(HCM) loop" because missense mutations changing amino acid residues 
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located in it can cause the disease (Geisterfer-Lowrance et al. 1990); 3) 
The lower 50 kDa subdomain and 4) The converter region from which a 
long a helix emerges to form the neck region which has two IQ domains. 
The essential light chain binds to the closest to the converter region 
whereas the regulatory light chain binds to the second. 
These submotifs are linked by flexible tracts that allow certain mobility 
between them. They are two protease sensitive parts of the myosin motor 
domain whose structure using crystallography as not been resolved, 
probably because of their flexible nature (Mornet et al. 1981): 1) Loop 1, 
close to the ATP binding site and 2) Loop 2, in the actin binding site. 
These two regions are hypervariable amongst class II myosins and 
interestingly they are also subject of alternative splicing (Itoh and Adelstein 
1995). 
The upper and lower 50 kDa subdomains form most of the actin binding 
site. As a three-dimensional structure, these two subdomains are 
separated by a cleft which closes slightly when binding ATP and closes 
even more when binding actin molecules (Houdusse et a!. 1999). 
The ATP binding site is an open pocket in which three conserved 
sequence elements can be recognized: the Switch 1 (residues 233-237), 
Switch 2 (Asp 454) and P-Ioop (residues 181-187) (Minehardt et a!. 2002). 
Their functions are not yet clear. The cavity is formed mainly by seven ~ ~
strands (Rayment et al. 1993b). 
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1.2.2 Cardiac Myosin Heavy Chains 
Cardiac myosins are the main cytoskeletal component and force generator 
molecules of the heart. Myosin complexes in the ventricles are designated 
V1, V2 and V3. V1 is formed by two a-cardiac myosin heavy chains (a-
MHC), V3 by two (3-cardiac myosin heavy chains ((3-MHC) and V2 by one 
of each type (Morkin 2000). 
The ventricular content of myosin complexes varies according to the 
speed of contraction. Fast-contracting ventricles like those of small 
rodents contain mainly of V1, those of intermediate speed (for example 
rabbit or guinea pig) are mostly formed by V3 and lower amounts of V1 and 
V2 whereas slow ventricles (human and bovine) contain less than 10% of 
V1 (Swynghedauw 1986). 
The amino acid sequences of mouse a- and ~ - M H C C are 93% (Krenz et al. 
2003) similar, whereas the similarity between their human counterparts is 
92%. 
It has been shown that the rabbit V1 myosin complex has a 2-3 fold faster 
actin filament sliding velocity compared with V3 but generates only about 
50% the isometric force (Palmiter et al. 1999). It is thought that these 
functional differences between a- and ~ - M H C C are due to structural 
differences in the Loop 1, located between residues 213 and 223 and the 
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Loop 2 regions, between positions 624 and 646 (Rayment et al. 1993a). 
Loop 1 appears to modulate velocity through ADP release while Loop 2 
regulates the actin dependent ATP hydrolysis rate (Murphy and Spudich 
2000). 
The genes encoding the human a-MHC and j3-MHC are MYH6 and MHY7 
respectively. They share a remarkable sequence similarity and are located 
next to each other head to tail in the long arm of chromosome 14 (14q12), 
being MYH6 centromeric to MYH7. They are separated by 4.5 kb of 
intergenic sequence and each one contains 39 exons and spans 
approximately 26 kb of genomic sequence. 
The genomic organization of these genes is similar to that found in every 
placental mammal studied so far (Ensembl Genome Browser, EMBL-
WTSI) suggesting that both genes were originated by· a duplication in 
tandem occurred at least before the divergence of eutherians and 
metatherians, some 125 million years ago (Luo et al. 2003). 
1.2.2.1 Control of the Expression of MYH6 
The expression of cardiac myosin heavy chain begins between 7.5 and 8 
days after fertilization at the heart tube stage along with atrial and 
ventricular myosin light chains and skeletal and cardiac a-actins (Lyons et 
al. 1990). As the formation of the cavities progresses, by the 10th day of 
development, the expression of J3-MHC is limited to ventricular 
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cardiomyocytes. At the same time, the levels of a-MHC in these cells 
decrease while its expression remains high in atrial cells. The a-MHC : 13-
MHC ratio in ventricular cells is reverted briefly shortly after birth probably 
due to a surge of the blood levels of thyroid hormone (Lompre et al. 1984). 
In the human adult I3-MHC is the main ventricular myosin whereas a-MHC 
is predominantly expressed in the atria (Kurabayashi et al. 1988). 
The intergenic sequence between MYH7 and MYH6 contains a promoter 
that drives the expression of MYH6 and an antisense transcript that 
modulates the expression on MYH7. Comparisons of the human and rat 
MYH6 promoters show that a portion of sequence between positions -340 
and +20 might be sufficient for expression (Molkentin et al. 1996). 
Within this segment, several binding targets for transcription factors and 
modulators have been described. Most of them have been characterized 
in rodents and later either for experiment or alignment their human 
counterparts identified (see Figure 1.7). In the human sequence, from 
downstream to upstream from the transcriptional start, after the TATA box, 
are found: a proximal CArG site that binds serum response factor (SRF) 
(Molkentin et al. 1996), two contiguous thyroid hormone response 
elements (TRE) (Izumo and Mahdavi 1988). a distal CArG site binding 
SRF (Molkentin et al. 1996), a site that binds an A-rich binding factor 
(Molkentin and Markham 1994), an M-CAT site for transcriptional 
enhancer factor 1(TEF-1) (Farrance et al. 1992), two GATA binding sites 
for GATA-4 (Molkentin et al. 1994), two sites for Ku, a protein from a DNA 
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binding family of unclear function (Sucharov et al. 2004), a site for 
myocyte-specific enhancer-binding factor-2 (MEF-2) (Molkentin and 
Markham 1993), and finally, two sites for Ying Yang 1 (YV1), an 
ubiquitously expressed transcriptional modulator (Mariner et al. 2005). 
Three E-box sites were described in rodents but not found in humans 
(Molkentin et al. 1996; Navankasattusas et al. 1994). Alignments of the 
promoter region of the genes encoding a-MHC in different species show 
several sites of localized conservation besides those mentioned above 
that are highly likely to be associated in the future with yet undiscovered 
transcription modulators (see Figure 1.7). 
The MYH6 cis-regulatory sequences are not limited to the conventional 
promoter. A purine-rich negative regulatory element (PNR) has been 
characterized in the first intron of the gene (Gupta et al. 1998). It appears 
to contain two Ets sites that bind PURa and PURj3 proteins (see Figure 
1.7) (Gupta et al. 2003). 
Due to the observation that in normal conditions as well as in pathologic 
states the level of a-MHC mRNA is not directly related to the levels of 
protein (i. e. the a-MHC content represents approximately 7.2% of total 
MHC protein and 35% of the MHC mRNA in healthy subjects), it is 
believed that the expression of this gene is also subject to translational 
regulation (Miyata et al. 2000). This regulation seems to be carried out at 
least in part by creatine kinase BB isoform (Vracar-Grabar and Russell 
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2004), an enzyme that binds selectively to the 3'UTR of the a-MHC 
mRNA, localizes in the Z-band of the sarcomere, and is expressed in the 
embryonic heart and in the adult cardiac tissue in response to ischaemia, 
hypertrophy and heart fairlure, (Ingwall 2002; Ritchie 1996) known causes 
of a-MHC downregulation. 
Indeed, as well as being regulated by transcription modulators, 
physiological, pathological and environmental stimuli can modify the 
expression of MYH6. Increased plasma levels of thyroid hormone can up 
regulate the mRNA levels of a-MHC in the ventricles at any stage of adult 
life whereas hypothyroidism (where (3-MHC can be up regulated) has the 
opposite effect (Morkin et al. 1983) (Figure 1.7). 
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Figure 1.7: Conserved cis-regulatory elements upstream of the 
transcriptional start of MYH6. 
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The increment in the tension of the heart cavities walls due to pressure or 
volume overload can also produce up regulation of ~ - M H C C and down 
regulation of a-MHC (Imamura et al. 1991). Nevertheless, when these 
conditions are recreated in rodent models, once the stimulus stops, the 
levels of a-MHC protein are recovered rapidly while the high levels of ~ ~
MHC persist for weeks, suggesting that the overload triggered signals 
regulate both genes independently (Gupta and Gupta 1997). 
These differential and in some instances antithetical expression profiles of 
the MYH6 and MYH7 genes are thought to be controlled mainly by the 
regulatory sequence located between both genes which works as a bi-
directional promoter, formed by two clusters of transcription modulators 
binding sites. The one which is closer to the transcriptional start of MHY6 
drives the expression of a-MHC while the one nearest to MYH7 drives the 
expression of an antisense transcript originating 2kb downstream of the 
MYH7 gene and is transcribed along its entire length from the opposite 
strand. This transcript is believed to prevent the processing of the ~ - M H C C
pre-mRNA and could be important to regulate rapid changes in the 
expression of cardiac MHC (Haddad et al. 2003). 
1.2.2.2 Disease Causing Mutations in MYH6 and MYH7 
Because of their sequence similarity and close vicinity, MYH6 and MYH7 
are potentially prone to n o n - h o ~ o l o g o u s s recombination events. The 
outcome of such an event has been reported in a family with hypertrophic 
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cardiomyopathy (Tanigawa et al. 1990). The resultant hybrid MYH61MYH7 
gene has a 5' portion identical to MYH6 that ends around exon 27 where it 
continues with a 3' segment identical to MYH7 until the end of the gene. 
This hybrid is located between two complete copies of MYH6 and MYH7 
and it was thought to be the cause of the phenotype in that family. A 
missense mutation in the normal copy of MYH7 on the same chromosome 
(Arg4532Cys) was discovered later in that family as well as in other 
hypertrophic cardiomyopathy families without the hybrid gene (Watkins et 
al. 1992), therefore concluding that the rearrangement probably does not 
have a functional significance. 
Since then, it has been estimated that nearly half of hypertrophic 
cardiomyopathy cases are caused by missense mutations in MYH7 
(Watkins et al. 1992) and mutations of the same gene producing dilated 
cardiomyopathy (Kamisago et al. 2000), Laing distal myopathy (Meredith 
et al. 2004) and myosin storage myopathy (Tajsharghi et al. 2003) have 
been also described. 
In humans, only two disease causing mutations of MYH6 have been 
found. Arg795Gln has been related to hypertrophic cardiomyopathy of the 
elderly (age of onset 74). This mutation replaces a hydrophilic glutamine 
for a basic arginine in a position located in the first 10 domain, possibly 
disrupting the interaction with the essential myosin light chain (Niimura et 
al. 2002). lle820Asn was found in a large family with autosomal dominant 
atrial septal defect and is located in the second 10 domain, where has 
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been shown to prevent the interaction with the regulatory light chain 
(Ching et al. 2005). 
1.2.2.3 Animal Models of Mutations in MYH6 
Homozygous transgenic mice for null Myh6 alleles die in utero at 11-12.5 
days post-fertilization displaying gross heart defects while the 
heterozygotes, though appearing externally normal, show a decrease in 
the length and disruption of the cardiac sarcomere pattern with wide Z-
bands and shortening of the A-band. The ventricles show significant 
reductions in contractility and relaxation parameters and multifocal fibrosis. 
These changes however had incomplete penetrance (5/8) probably due to 
genetiC or epigenetic variability or to still unknown compensatory 
mechanisms (Jones et al. 1996). 
Another murine model of MYH6 mutation was constructed with a 
modification identical to one of the mutations observed in human MYH7 
(Arg403Gln) in cases of hypertrophic cardiomyopathy. The homozygous a-
MHCArg403Gln/Arg403Gln mice die by a fulminant dilated cardiomyopathy at the 
8th of postnatal life due to myocyte loss, showing ventricular multifocal 
transmural necrosis and secondary calcification. The sarcomere structure 
was normal apart from some focal myofibrillar disarray. Heterozygous a-
MHCArg403Gln/+ mice develop myocardial histologic abnormalities similar to 
those found in cases of familial hypertrophic cardiomyopathy (Fatkin et al. 
1999). 
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During a screening for Zebrafish mutations affecting cardiac chamber 
formation, Berdougo et al. (Berdougo et al. 2003) described the locus 
weak atrium which later was found to encode the Zebrafish atrial myosin 
heavy chain. weak atrium mutants show atrial contractility defects, the 
atrial chamber becomes dilated, a characteristic blood pool caudal to the 
atria develops and the atrial sarcomere shows disorganization of 
myofilaments. These mutants do not exhibit abnormalities outside the 
heart and can become fertile adults probably because the weak atrium 
protein product is not expressed in the ventricles. 
1.3 Congenital heart defects 
1.3.1 Aetiology 
The aetiology of congenital heart defects remains unknown in most cases. 
Approximately a quarter of cases of CHD occur as part of a complex with 
malformations in other organs in the form of an aSSOCiation, Mendelian 
syndrome or a chromosomal abnormality (Ferencz 1993; Ferencz et al. 
1989). The remaining three quarters of cases occur as isolated 
malformations, mainly sporadically. Both environmental and genetiC 
factors seem likely to be implicated in these cases (Nora 1993). 
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1.3.2 Identified environmental factors 
In newborns from mothers infected by rubella during pregnancy the risk of 
CHD is 35% (Burn 2002), the more common being persistent ductus 
arteriosus, pulmonary arterial stenosis and septal defects (Emmanouilides 
eta1.1964; Rowe 1963). 
Maternal diabetes has long been known to increase the incidence of CHD 
to 4%, approximately five times the incidence in the general population. 
Ventricular septal defect, coarctation of aorta and complete transposition 
were found in more than 50% of the cases (Rowland et al. 1973). Different 
degrees of the left isomerism sequence have been also reported (Splitt et 
al. 1999). 
Early diagnosis and dietary restrictions during childhood have allowed 
female patients with phenylketonuria to reach reproductive age. Unless a 
previously abandoned phenyalanine-free diet is reintroduced before 
conception, the risk of CHD for the unborn child increases to between 25% 
and 50% (Burn 2002; Walter 1995), especially tetralogy of Fallot (Lenke 
and Levy 1980). 
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It has been estimated that fetal alcohol syndrome affects 1 % to 3% of 
newborns (Mengel et a!. 2006), approximately 30% to 40% of them 
additionally show a CHD, typically ventricular or atrial septal defect and 
tetralogy of Fallot (Moss 1992). 
Maternal consumption of the anticonvulsant drugs like valproates and 
hydantoin has been related to CHD. Fetal hydantoin syndrome occurs in 
10% of exposed pregnancies (Holmes et a!. 2001) and a fraction of them 
suffers a form of CHD, but no specific lesion seem to predominate 
(D'Souza et a!. 1991; Lin 1990). 
Lithium exposure during gestation has been linked to Ebstein's 
malformation (Weinstein and Goldfield 1975), whereas according to other 
reports the incidence of a particular CHD does not prevail (Kallen 1987). 
The incidence of CHD in monozygotic twins is considerably higher than in 
dizygotic twins or products of single pregnancies (Bum and Corney 1984), 
reaching 2.3% in some estimates (Karatza et a!. 2002), without 
considering those cases where twin-twin transfusion syndrome occurs. For 
monochorionic-diamniotic monozygotic twins the risk of a CHD has been 
calculated as 7%, and 57% for monochorionic-monoamniotic twins 
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(Manning and Archer 2006). ventricular septal defects and right isomerism 
being the more common anomalies. 
Products of pregnancies conceived by in vitro fertilization show a fourfold 
incidence increase of CHD in both singletons and twins (Koivurova et al. 
2002). 
Usually accounting for 5% to 10% of CHD, patent ductus arteriousus is 
the more common CHD in children born at high altitudes like Mexico City 
or the Peruvian Andes where the incidence of this defect is 30 times the 
observed at sea level (Fyler 1980; Penaloza et a!. 1964), possibly due to 
decreased levels of blood oxygen. The same mechanism is likely to 
influence the high incidence of the same defect in premature infants 
(Ellison et al. 1983). 
1.3.3 Atrial Septal Defects 
Atrial septal defects are amongst the most common congenital cardiac 
defects. The mildest forms of the disease can be sub-clinical during many 
years. However, blood circulation consequences develop along time. The 
higher blood pressure from the left atrium causes blood to pass to the right 
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atrium, which leads to pulmonary hypertension. Over the years, this 
increases the pressure on the right ventricle, the right atrium and 
ultimately causes reversal of flow in the interatrial communication, mixing 
both oxygenated and non-oxygenated blood, which is translated into 
cyanosis in the patient. On the other end of the spectrum of septal defects 
is the premature closure of the foramen ovale during development. When 
this occurs prenatally, the blood flow passes completely from the right 
atrium to the right ventricle, causing considerable hypertrophy of the right 
side of the heart. In contrast, the left side is hypoplastic due to the 
substantial decrease of blood flow. Individuals suffering this condition 
typically die during the first days of life. 
A persisting communication between the two atria (shunt) can be caused 
by a range of events during early development. The most common 
varieties of this malformation are due to hypoplastic growth of the septum 
secundum or lack of resorption of tissue around the foramen secundum. 
On the other hand, a lack of union between the leading edge of the 
septum primum and the endocardial cushions can give raise to a lower 
less common defect. If the malformation involves the endocardial 
cushions, the atrioventricular valves can be affected, making the clinical 
outcome more severe. The presence of a common atrium is one of the 
most serious conditions of this kind, and it is produced by lack of septation 
of the atria. 
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1.3.4 Tricuspid atresia 
This defect consists in the complete occlusion of the opening between the 
right and left ventricle. The direct consequence of this would be death by 
lack of blood oxygenation, as the blood can not get access to the lungs. 
However, the patients can survive during months or years thanks to the 
existence of secondary defects or shunts. In order to allow the blood to 
reach the lungs from the right atrium, an interatrial defect must exist so the 
blood can pass to the left atrium and then to the left ventricle. Secondly, 
one or more secondary shunts must permit blood to circulate to the 
pulmonary arterial system, either by an interventricular septal defect or 
from the aorta through a patent ductus arteriosus. From the lungs, the 
blood goes back to the left atrium and could be recycled through the lungs 
before reaching the systemic circulation. 
1.3.5 Ventricular septal defect 
VSD is the most common septal defect. The membranous part of the 
interventricular septum is a weak spot due to the convergence of several 
embryonic tissues at this level. Consequently, in 70% of the cases the 
VSD lies in this area. In the initial stages of the disease, the higher left 
ventricular pressure leads to a left to right shunt without cyanosis. 
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However, right ventricular hypertrophy can develop, causing pulmonary 
hypertension and a reversal of the shunt. Notably, in the majority of cases 
the defect closes spontaneously before age of ten. 
1.3.6 Persistent truncus arteriosus 
During normal embryonic development, the outflow tract is divided in order 
to generate the pulmonary trunk and the aorta. However, In some 
individuals the truncoconal ridges do not fuse to form the septae that 
should divide the tract, and thus there is a persistence of a large single 
outflow tract overriding the ventricular septum. This outflow vessel 
receives the blood flow from both ventricles and it is almost always 
accompanied by a ventricular septal defect. This condition is clinically 
translated into severe cyanosis and death during the first year of life, if not 
corrected. 
1.3.7 Transposition of the Great Vessels 
This condition is the most common cause of cyanosis in the newborns. 
When the truncoconal ridges fail to spiral when dividing the outflow tract, 
two independent circulatory systems are created, with the right ventricle 
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emptying venous blood into the aorta and the general circulation, and the 
left ventricle pumping highly oxygenated blood to the lungs through the 
pulmonary artery. This malformation is compatible with life only when 
associated with ASD, VSD and patent ductus arteriosus. 
1.3.8 Tetralogy of Fallot, Aortic and Pulmonary Stenosis 
Aortic and pulmonary stenosis may be caused by asymmetric partitioning 
of the outflow tract. Complete occlusion of one of the vessels is called 
aortic or pulmonary atresia. 
One example of asymmetric fusion of truncoconal ridges is the Tetralogy 
of Fallot (TOF), which is the most common cause of cyanosis in infants. 
TOF consists in pulmonary stenosis, a large aorta, right ventricular 
hypertrophy and membranous interventricular septal defect. Poorly 
oxygenated blood is pumped through the enlarged aorta to the circulatory 
system and causes cyanosis from birth. Clubbing of the fingers is also a 
common feature due to chronic hypoxemia. The prognosis is poor, with a 
survival rate of 50% if not corrected within the first two years of life. 
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1.3.9 Patent Ductus Arteriosus 
During normal postnatal development, the ductus arteriosus is 
spontaneously closed, separating the aortic arch from the pulmonary 
artery. If this structure persists, a slow progressive disease occurs. The 
condition is silent at birth, but over the years, the high aortic pressure 
causes blood to flow towards the pulmonary circulation through the patent 
ductus leading to pulmonary hypertension, and eventually, heart failure. 
Lower-body cyanosis can appear due to an inversion of the blood 
circulation through the ductus. There is a higher incidence of patent ductus 
arteriosus in pregnancies complicated by rubella infection or hypoxia. 
1.3.10 Coarctation of the Aorta 
The embryogenesis of the coarctation of the aorta is not well known yet. 
Several factors could lead to the same malformation, for example, there is 
a higher incidence of coarctation of the aorta in Down and Turner's 
syndrome patients. This anomaly consists of a narrowing of the 
descending aorta, which could be upstream or downstream from the 
ductus arteriosus. Usually, the ductus arteriosus remains open in the 
preductal type, and the blood reaches the descending aorta through it. 
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However, there is also flow of venous blood through the ductus, which 
causes cyanosis of the lower trunk and limbs. 
The most common form (95% of cases) is the postductual coarctation. As 
the arterial circulation of the upper and lower part of the body is separated 
by the narrowing, collateral circulatory channels between small arteries 
are developed to communicate both systems. As a consequence, the 
small arteries carry an abnormally large blood flow, which clinically 
translates as notches in the ribs by radiographic analysis and higher blood 
pressure in the arms than in the legs. 
1.4 Recurrence risk in siblings and offspring of CHD 
patients. 
A previous antecedent of a CHD case in the family was the single largest 
determinant in the CHD cases cohort of the large Baltimore-Washington 
study (Boughman 1993; Boughman et al. 1987). Even though this pOints 
to an important genetic component in the aetiology of CHD, several 
studies have reported a very different empirical offspring recurrence risk of 
the disease in general and specific lesions (Czeizel et al. 1982; Emanuel 
et al. 1983; Whittemore et al. 1982). This disparity was probably due to 
selection bias. When the bias is corrected the recurrence risk for offspring 
is 4.1 % which is significantly higher than the recurrence risk for siblings 
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(2.1 %; p=O.021) (Burn et al. 1998). During the same study, when the data 
for individual defects were used in computer inheritance pattern modelling, 
atrioventricular septal defect appeared to be a single gene disorder, 
tetralogy of Fallot as an oligogenic defect and transposition as an entirely 
sporadic entity. The ratio of affected offspring from affected mothers 
versus those from affected fathers was 2.23. This phenomenon could be 
due to selective imprinting of the allele from the father and dependence of 
the maternal allele for normal function. 
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Chapter 2 MATERIALS AND 
METHODS 
2.1 Bacteriological techniques 
2.1.1 Preparation of calcium chloride competent cells 
An isolated, single colony was picked using a sterile toothpick from a plate 
previously incubated for 16-20 hours at 37°C. Material from the colony 
was transferred into 5 ml of LB medium and incubated in rotation 
overnight. Two ml were taken from the overnight culture and used to 
inoculate 100 ml of plain LB medium which in tum is incubated in rotation 
from 90-120 minutes, until optical density reaches OD6oo=0.6. 
When the desired 00 was achieved, the cultured was harvested by 
centrifugation at 3500rpm for 15 minutes at 4°C, the resultant pellet re-
suspended in 50ml of ice cold 50mM Cael2 and 10% glycerol, snap frozen 
with liquid nitrogen and stored in 1 00 ~ I I aliquots at -80°C. 
2.1.2 Preparation of electrocompetent cells 
Overnight cultures in 400ml of LB were centrifuged at 4000g for 10 
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minutes. The resultant pellet was re-suspended in 200ml of ice cold sterile 
distilled water. The suspension was centrifuged again at 4000g for 10 
minutes and the new pellet re-suspended with 100ml of ice cold sterile 
distilled water and the process repeated with 10ml of ice cold 10% glycerol 
and finally with 1 ml of 10% glycerol. The suspension was distributed in 
5 0 ~ 1 1 aliquots and these frozen in liquid nitrogen and stored at -ao°c. 
2.1.3 Transformation of calcium chloride competent cells 
Aliquots of CaCI2 competent cells were thawed on ice and a solution of 
DNA at the appropriate concentration was applied and mixed using a 
chilled pipette tip. The mix was incubated for 30 minutes on ice and then 
transferred to a 42°C water bath and incubated there for 90 seconds. The 
tube was transferred again to ice, to be incubated for 2 minutes and then 
applied to a loosely capped tube with 5ml of SOC medium where the 
reaction was incubated for 60 minutes in a shaker incubator at 150 rpm. 
The culture was harvested in a tabletop centrifuge at 8000rpm and the 
pellet re-suspended in 2 0 0 ~ 1 1 of LB medium. 100 J.JI of the suspension was 
applied to LB-agar plates with the appropriate selective reagent. These 
plates were incubated overnight at 3rC. 
2.1.4 Transformation of electrocompetent cells 
A 50IJI aliquot of electrocompetent cells was thawed on ice and a solution 
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of DNA applied and mixed. The mixture was then transferred to a pre-
chilled electroporation cuvette (Eurogentec) and incubated in ice for 30 
minutes more. Next, the cuvette was dried externally and located in a 
GenePulser (Biorad), where the electroporation takes place. The following 
GenePulser parameters were used: capacitance, 25jJFD; capacitance 
extender, 125jJFD; resistance 2000; and voltage 2500V. After 
electroporation, the mix was applied to a tube with 750jJi of SOC medium 
and put in shaker incubator for 60 minutes at 37°C. The suspension was 
then spread in LB-agar Petri dishes at variable volumes. 
2.1.5 Preparation of selective media 
LB-broth and LB-agar were supplemented with antibiotics as a selection 
measure. In the case or the agar the substance was added to the molten 
medium just before was poured and allowed to set in Petri dishes. The 
final concentration of each agent on the media was: ampicillin 100mgll, 
kanamycin 2Smgll. 
2.1.6 Preparation of glycerol stocks 
Glycerol stocks were prepared adding 3001J1 of 80% glycerol solution to 
500jJi of overnight broth culture. The mix was snap frozen in liquid nitrogen 
and stored at -80°C. 
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2.2 Nucleic acid amplification (Polymerase chain 
reaction) 
2.2.1 RNA extraction 
Animal tissue was obtained from 11.5 dpc mouse embryos, dissecting 
limbs and hearts and flash freezing them in liquid nitrogen. RNA was 
extracted following the protocol for Purescript Total RNA Purification Kit 
(Gentra). All the glass and plastic ware used were treated with DEPe 
(diethyl pyrocarbonate) water to avoid RNase activity. In brief, 5 to 10 mg 
of fresh animal tissue were collected In Eppendorf tubes containing 3001J1 
of lysis solution, and homogenized with an RNase-free plastic pestle. 100 
IJI DNA-protein precipitation solution were added to the lysate and mixed 
by inverting the tubes. After 5 minutes on ice, the solution was centrifuged 
for 3 min to separate the RNA from DNA and proteins, which precipitate in 
a pellet. The supernatant was transferred to a fresh tube and 300 IJI of 
100% Isopropanol were added to precipitate the RNA. After inverting 
several times, the RNA was pelleted by centrifugation for 3 min at full 
speed, washed in 70% ethanol, dried and resuspended in sterile distilled 
water treated with DEPe. 
2.2.2 Reverse transcription 
In order to produce cDNA for downstream experiments, total RNA was 
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reversed transcribed using the 1 st strand Synthesis Kit from ABgene. In 
brief, after heat denaturation at 72°C, 1 ~ g g of RNA is mixed with oligo-dT, 
reverse transcriptase (blend of AMV and MMuLV), 5X buffer, 5nm dNTPs 
and RNase inhibitor. The solution was incubated at 45-50°C for 90 
minutes, followed by 10 minutes at 75°C for enzyme inactivation. RT 
reactions were set up without adding reverse transcriptase, to use as 
negative controls. 
2.2.3 Primer design 
Design of oligonucleotides to be use as PCR primers was assisted by the 
web interfaces of the Primer3 program at the Whitehead Institute for 
Biomedical Research (Rozen 2000) and NetPrimer (Premier Biosoft 
International). 
2.2.4 peR reactions 
PCR reactions were performed in volumes of 20 and 50 ~ I , , according to 
the amount of product required in the downstream application. All the 
reactions were carried out in independent 2 0 0 ~ 1 1 tubes or 96 well plates 
and several different thermal cyclers. The typical recipe is showed below: 
Forward primer 1 O p m o l / ~ I I
20 ~ I I reaction 
1 ~ I I
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Reverse primer 1 O p m o l / ~ . J I I 1 ~ I I 2.5 ~ I I
dNTPs 2mM 2 ~ I I 5.0 ~ I I
10x peR reaction buffer * 2 ~ I I 5.0 ~ I I
Taq polymerase 5 U / ~ 1 1 0.1 ~ I I 0.5 ~ I I
Sterile distilled water 11.9 ~ I I 30.5 ~ I I
DNA [ 5 0 n g / ~ ' ] ] 2 1 .. 11 5 ~ I I
*100 mM Tris-HCI, pH 8.3 at 25°C; 500 mM KCI: 15 mM MgCI2: 0.01 % 
gelatin 
2.3 DNA manipulation techniques 
2.3.1 Agarose gel electrophoresis 
Standard 1 % (w/v) agarose gel was made by melting 0.5g of agarose in a 
total volume of 50ml 1X TAE (40mM Tris-Acetate, 10mM EDTA) and 
adding 0.5J,lg/ml Ethidium bromide. Gel loading buffer (30% glycerol, 
0.025% (w/v) Bromophenol Blue, 0.025% (w/v) Xylene Cyanol) was added 
to DNA samples before loading onto agarose gels. 
2.3.2 Gel extraction 
DNA was extracted from agarose gels using the Gel extraction kit supplied 
by QIAGEN according to the manufacturer's instructions. Briefly, the 
76 
Molecular Genetics of Congenital Heart Disease and Holt-Cram Syndrome 
bands containing DNA were carefully excised from the gel with a sterile 
scalpel, mixed with 3 volumes of a buffer containing guanidine thiocyanate 
and heated at 50 0 e until the gel slice was dissolved. The mixture was 
applied to a QIAquick silica column and centrifuged. Salts were washed 
away by applying a buffer containing ethanol to the column and 
centrifuging. Residual ethanol was eliminated by an additional 
centrifugation step. The DNA was eluted from the column applying sterile 
distilled water, letting stand for 5 min and centrifuging at maximum speed. 
2.3.3 Digestion of DNA 
Basic digests were carried out using the corresponding restriction 
enzymes, according to the restriction map of the DNA template. All the 
reactions were performed according manufacturer's instructions. 
2.3.4 Ligation 
Direct ligation of peR products were performed using the pGEM-T easy 
system kit (Promega), according to the manufacturer's instructions. In 
brief, the reactions are set up adding T4 DNA ligase (3U/J,JI), T-easy vector 
(50ng), 2X ligation buffer, the peR product, and sterile distilled water to 
the desired volume. The ligation mixture is then incubated overnight at 
4°C. 
77 
Molecular Genetics of Congenital Heart Disease and Holt-Cram Syndrome 
ligation of DNA fragments produced by restriction digest was performed 
using T4 DNA ligase (Invitrogen). Reactions were set up adding 5X ligase 
buffer, insert:vector at a 3: 1 molar ratio, T 4 DNA ligase 0.1 to 1 units and 
sterile distilled water to the desired volume. Incubation was carried out 
overnight at 14°C. 
2.3.5 Plasmid DNA isolation 
Bacterial cultures were grown overnight and harvested by centrifugation at 
3000Xg for 1 minute. Plasmid DNA was isolated by using a QIAprep Spin 
Miniprep Kit (Qiagen) according to manufacturer's instructions. 
2.3.6 Measurement of DNA concentration 
A 1/10 dilution of the original miniprep was measured in a GeneQuant 
RNA/DNA calculator (Pharmacia Biotech), using UV wavelength of 260nm, 
following the manufacturer's instructions. 
2.3.7 Nucleic acid precipitation 
For plasmid or genomic DNA, 0.7 volumes of isopropanol, or 3 volumes of 
100% ethanol with 0.1 volumes of 3M sodium acetate pH=5.2 were added 
to the DNA solution and mixed thoroughly. For the Isopropanol 
precipitation the mixture was centrifuged at 12000Xg for 15 minutes at 
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room temperature, whereas for the ethanol precipitation the DNA/ethanol 
solution was centrifuged for 10 minutes at 12000Xg to recover the DNA. 
After carefully removing the supernatant, the DNA pellet was washed with 
70% ethanol and centrifuged for 2 minutes at 12000g. The supernatant 
was removed and the excess liquid was evaporated at room temperature. 
The DNA pellet was dissolved in the desired volume of TE buffer or sterile 
distilled water. 
For primer purification, 15 IJI 3M Na acetate (pH 5.6) and 1.5 loll 1 M MgCl2 
were added to 150 loll 1001JM primer and mixed. Afterwards, 500 loll of cold 
100% ethanol were added, the mixture was chilled on ice for 15 to 20 
minutes and centrifuged for 15 to 20 min. This was followed by an 80% 
ethanol wash and 5 minutes spin. After removing the supernatant, the 
pellet was air dried and resuspended in 1201J1 of sterile distilled water, for 
a final concentration of 1001JM. 
2.3.8 End-labelling of DNA oligonucleotides 
32p yATP was used to end-label oligonucleotides in the following manner. 
Approximately 50 pmol of each oligonucleotide were diltuted in 2 ~ 1 1 of 
sterile distilled water. The mixture was heat denaturated by incubating it at 
65° for 3 minutes to remove secondary structure in the oligonucleotide. 
The tube was then placed immediately on ice. Afterwards, 1 ~ I I of 10x 
phosphonucleotide kinase buffer (GIBeO), 1 ~ 1 1 of 32p yATP (AMERSHAM) 
and 1 ~ 1 1 of T4 phosphonucleotide kinase (GIBeO) were added, and the 
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mixture was incubated for one hour at 37°C. The radioactively-labelled 
PCR products were visualized using a Phosphorlmager (Molecular 
Dynamics). 
2.4 Microsatellite typing 
2.4.1 Sample preparation 
The loading buffer for microsatellite gels was prepared mixing 5 0 0 ~ 1 1 of 
0.5M EDTA and 9.5ml of formamide (SIGMA). Approximately 5 mg of 
bromophenol blue and xylene cyanol powder were added to the solution to 
colour it. 
3 ~ 1 1 of each radioactively labeled PCR product were mixed with 7 ~ 1 1 of 
loading buffer, and 4 ~ 1 1 of this solution were loaded on each well on the 8% 
denaturing polyacrylamide gels, prepared as below. 
2.4.2 Radioactive microsatellite gels 
The mobility of PCR products was assessed in 8% denaturing 
polyacrylamide gels. The gels were prepared by mixing 80ml of 40% 
acrylamide solution with 168g of urea and 80 ml of 5X TBE and incubated 
at 65°C until completely dissolved. Enough sterile distilled water was 
added to obtain to 400ml of an 8% solution. To polymerise the gel, 6 4 0 ~ 1 1
of 10% APS and 8 0 ~ 1 1 TEMED were added to 80ml of this solution. 
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The gels were run at 55W for 3 hours at room temperature, using a Life 
Technologies S2 gel electrophoresis system and a BioRad Power Pac 
3000. On completion, the gels were dried on a BioRad gel dryer with 
vacuum pump and examined using a Molecular Dynamics 
Phosphorimager. 
2.5 Northern blot 
2.5.1 Radiolabeling of probe 
Approximately 25 ng of template DNA were mixed with random hexamer 
primers, heated for 2 min and placed on ice for 1 min. The solution was 
spun down at 4°C and returned to ice. 5 0 ~ . J 1 1 reactions were set up adding 
1J.l1 5 mM dNTPs, 10 J.l1 5X buffer, 10 mCi/ml [«_32p]dCTP, 5 units of 
Klenow fragment of E. coli DNA polymerase I and sterile distilled water. 
The mixture was incubated for 1 hour at room temperature, and the 
radiolabeled probe was used immediately. 
2.5.2 Hybridization 
RNA was run on a denaturating agarose gel (1.25g agarose, 87ml sterile 
distilled water, 10mL MOPS/EDTA and 5.1mL formaldehyde). The RNA 
was transferred to a nylon membrane and hybridized, essentially as 
described in the Molecular Cloning Manual (Sambrook 2001). 
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2.6 Informatic analysis 
2.6.1 BLAST 
The Basic Local Alignment Search Tool (BLAST) is one of the algorithms 
available from the NCBI (National Centre for Biotechnology Information) 
website. The BLAST program allows us to compare nucleotide and 
peptide query sequences against the public databases, in a local manner. 
The resulting information is valuable for identification of homologue genes 
or proteins, evolutionary conservation and classification into families. 
2.6.2 GLUE 
The Genetic Linkage User Environment (GLUE) is a free software based 
at the UTBIO (Laboratory for Interdisciplinary Technologies in 
Bioinformatics) website (formerly at HGMP, Human Genome Mapping 
Project Resource Centre). GLUE is a graphic interface to programs used 
for linkage and statistical genetics. Packages currently supported by 
GLUE are Linkage, Genehunter, Merlin, Unphased, and Transmit. The 
linkage format pedigree files generated in this study were uploaded to the 
HGMP file space to be processed. 
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Chapter 3 MUTATIONAL ANALYSIS OF 
MYH6 IN SPORADIC CASES OF 
CONGENITAL HEART DISEASE 
3.1 Introduction 
Twin studies have provided a way to estimate the genetic component in 
the aetiology of complex diseases by comparing the concordance between 
monozygotic (that share both their entire genome and prenatal exposures) 
and dizygotic twins (sharing half their genes and gestational environment). 
A high concordance of a complex disease in monozygotic twins is 
generally accepted as an argument in favour of a strong genetic 
component. 
As the twinning process itself can cause CHD, the low concordance of the 
disease in monozygotic twins can lead to underestimation of the genetic 
contribution in its aetiology. 
Mendelian forms of common complex disease may be explained as 
follows: a) the Mendelian form represents another disease with no causal 
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relation with the sporadic form but they are clinically indistinguishable; b) 
most of the individuals in the Mendelian family carry or are exposed to 
most of the susceptibility conditions so in the affected individuals the 
Mendelian segregation of the remaining susceptibility allele causes the 
disease; c) the familial aggregation of cases occurred by chance and does 
not represent a Mendelian form of the disease. 
In some cases, a gene responsible for a Mendelian form of a complex 
disease also behaves as a susceptibility locus for the sporadic form, as in 
Hirschsprung disease, caused by mutations of RET (Carrasquillo et al. 
2002). However there are examples of the opposite situation, where the 
gene mutated in familial cases have no observable contribution for the 
more common, sporadic form of the disease as in the case of mutations of 
BReA 1 and breast cancer (Pharoah et al. 2002). 
Mutations of several genes are known to produce Mendelian form of non-
syndromic CHD in humans (Table 3.1). Germ-line mutations on several 
genes have been shown to cause either syndromic or Mendelian isolated 
congenital heart disease in humans. A single germ-lime mutation of MYH6 
(1820N) has been shown to be responsible for a familial form of secundum 
atrial-septal defect (Ching et aJ. 2005). 
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Table.1 Mutations In Mendelian CHD 
GENE PHENOTYPE REFERENCE 
BMPR2 Pulmonary hypertension,CHD (Roberts et al. 2004) 
CFC1 double-outlet right ventricle, (Bamford et a!. 2000) transposition great arteries 
DTNA Non-compaction with CHD (Ichida et a!. 2001) 
ELN Supravalvular aortic stenosis (Curran et al. 1993) 
GATA4 ASD (Garg et al. 2003) 
GJA1 Hypoplasic left heart syndrome (Dasgupta et al. 2001) 
JAG1 Tetralogy of Fallot (Eldadah et al. 2001) 
NKX2.5 ASD plus conduction defects, (Schott et a!. 1998) Tetralogy of Fallot 
TAZ Non-compaction (Bleyl et al. 1997) 
ZFPM2 Tetralogyof Fallot (Pizzuti et al. 2003) 
MYH6 ASD (Ching et a!. 2005) 
THRP2 Transposition great arteries (Muncke et al. 2003) 
CAVC, OILV, DORV, D-TGA, 
ZIC3 HLHS, Ive, L-TGA, PA, PAPVR, (Ware et al. 2004) 
PS, SVC, TAPVR 
CRELD1 AVSD (Robinson et al. 2003) 
NKX2.6 Common arterial trunk (Heathcote et al. 2005) 
LDB3 Left ventricular non-compaction (Vatta et al. 2003) 
T8X5* ASD,AVSD (Reamon-Buettner and Borlak 2004) 
HEY2* AVSD (Reamon-Buettner and Borlak 2006) 
CITED2 ASD, VSD, Tetralogy of Fallot (Sperling et al. 2005) 
ventricular inversion with 
ventricular septal defect, inversion 
ACVR28 and transposition of the great (Kosaki et al. 1999) vessels, pulmonary stenosis, total 
anomalous pulmonary venous 
return 
TBX1 TAIAA (Gong et al. 2001) 
eAve = complete atrioventricular canal; OIL V = double Inlet left ventricle; DORV = double outlet 
right ventricle; 0-TGA = O-transpositlon of the great arteries; HLHS = hypoplastic left heart 
syndrome; Ive = inferior vena cava; L-TGA = L-transposition of the great arteries; PA = pulmonic 
atresia; PAPVR = partial anomalous pulmonary venous return; PS = pulmonic stenosis; sve = 
superior vena cava; TAPVR = total anomalous pulmonary venousretum. 
"Somatic mosaicism 
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3.2 Mutational Analysis using denaturing high 
performance liquid chromatography 
Liquid chromatography is an analytical method used for the separation 
and quantification of the components of a heterogeneous solution through 
binding to a solid phase (matrix) and selective elution. Denaturing high 
performance liquid chromatography (dHPLC) is a variant of this procedure 
that, by means of an ion pairing (tri-ethyl ammonium acetate, TEM) and a 
hydrophobic eluant reagent (acetonitrile ACN), allows the separation of 
DNA or RNA molecules that differ in size or base composition when 
passed through a column in solution. 
The chromatography columns used in dHPLC are made of a solid matrix 
formed by C18 alkylated polystyrene-divinylbenzene 3J.Jm beads, creating 
a strongly non-polar phase. A continuous flow of liquid pass through the 
column during the whole process. At the time of the injection of the DNA 
solution (generally a non-purified PCR product), the flow through consists 
of a mix of 50% "Buffer A" (TEM 0.1 M) and 50% "Buffer Bn (TEAA 0.1 M, 
25% ACN). 
The positive ammonium ion of the TEM molecule interacts with the 
phosphate groups of the hydrophilic DNA molecule, whereas its triethyl 
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groups coat the nucleic acid with a hydrophobic outer layer that allows 
interaction with the solid matrix dependent on the length and charge 
density of the DNA fragment. 
The temperatures to be used for dHPLC mutational analysis must be 
carefully determined. This is achieved by testing several temperatures to 
select those that, according to simulation by a subprogram of Navigator 
(Transgenomic), allow all segments of the amplicon to adopt in one of 
them a helical fraction percentage between 40% and 99%, the optimum 
for mutational analysis. 
In order to elute the DNA molecules from the column, the ratio of AlB 
Buffers injected decreases, effectively increasing the concentration of 
ACN while the concentration of TEAA remains constant (gradient stage). 
If a heterozygous variation exists within the amplicon, DNA 
heteroduplexes will form. As more ACN molecules become available in the 
solution the hydrophobic interactions between the DNA molecules and the 
matrix become weaker, heteroduplexes are released from the column 
faster than homoduplexes. 
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3.3 Aims of study 
The aims of this study were: a) To discover de novo mutations of MYH6 
that could explain some of the sporadic CHD cases; b) to identify new 
Mendelian CHD families, not catalogued a such because of low 
penetrance, where the segregation of MYH6 mutations could show a 
Mendelian pattern; c) to find new MYH6 genomic variants that could be 
used in future susceptibility studies. 
3.4 Materials and Methods 
The DNA samples correspond to 144 Australian patent foramen ovale 
patients and 380 British patients with various kinds of non-syndromic 
congental heart disease. 
The genomic sequence of the MYH6 gene was obtained from GeneBank 
at NCBI website (Accesion number: Z20656) and Ensembl Genome 
Browser (Gene ID: ENSG00000197616). These were aligned to the 
sequences of the MYH6 transcript (GeneBank accesi6n: NM_002471, 
Ensembl ID: ENST00000356287) using the web interface of the "BLAST 2 
Sequences" program at NCBI in order to define intron-exon boundaries. 
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To cover the entire coding sequence (39 exons) of the gene, 35 peR 
amplicons were designed. In general, each amplicon spanned the 
complete length of an individual exon plus short segments of flanking 
intronic sequence to either side, to allow the detection of mutations of 
splicing regulatory elements in those locations. In situations where two 
relatively small exons were close enough to each other, a single amplicon 
was designed to cover them both. As the Wave DHPLC system imposes 
limitations on the maximum length of an amplicon, comparatively large 
exons were covered by two overlapping amplicons. 
A pair of oligonucleotides to be used as PCR primers was designed for 
each amplicon (see Table 3.2), using the web interface of the Primer3 
program at the Whitehead Institute for Biomedical Research website and 
requested from commercial suppliers (Sigma-Genosys, Invitrogen). 
The. melting temperature (Tm) for each primer was calculated using the 
formula: 
Tm=63. 72+0.41 (%GC)-600/n 
where %GC is the GC content of the oligonucleotide expressed in 
percentage and n is the length of the primer in base pairs. If the difference 
of Tm of the primers of each pair was smaller than 3°C each pair the 
annealing temperature (Ta) was set 2 to 3°C above their mean Tm. When 
the difference exceeded 3°C a "touchdown" PCR protocol was employed 
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by performing the annealing of the first cycle BOC above the mean Tm and 
reducing the Ta by 0.5°C over the next 15 cycles. The remaining 15 cycles 
were performed using the Ta calculated as above. 
PCR was carried out first using control DNA and 2% agarose gel 
electrophoresis to test the amplification conditions. If a single, strong band 
of the expected size was observed, 50Jjl PCR reactions were then carried 
out in patient DNA samples. 
A final hybridization step was carried out, starting at 95°C and reducing the 
temperature 1.5°C per minute to 25°C in order to favour the formation of 
heteroduplexes. 
The sequence of each individual amplicon was analyzed using the 
Navigator software (Transgenomic) to determine the melting profile of 
each DNA fragment and the select the temperatures at which its different 
melting domains (parts of the molecule that show approximately the same 
secondary structure at speCific conditions) are predicted to adopt a 
percentage of helical forms between 40% and 90%. 
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A peR reaction was performed per patient per amplicon (more than 
eleven thousand in total). Using patient DNA as template, PCR reactions 
were performed, heteroduplexes formed and injected in the dHPLC 
column using the Wave system at the appropriate temperatures. 
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3.5 Results 
A summary of coding variations found in this study is represented in 
Figure 3.1. Within the 494bp amplicon corresponding to a segment of the 
MYH6 promoter only one variant was found. It was observed in patient 
with patent foramen ovale and Ebstein's malformation and consisted in a 
transition G-+A 370 bases upstream the transcriptional start. It is not 
localized in an already known transcription factor binding site but it lies in 
the middle of a 14bp segment that has been conserved through evolution. 
, 
DNA samples from two brothers of the patient were screened for the 
variant, but they were found to be non-carriers (Figure 3.2). 
Two variants were found in the part of the gene that encodes Loop-1, a 
segment of the myosin head involved in ADP release (Murphy and 
Spudich 1998). 1) D208N (aspartate, a charged polar residue for 
asparagine, uncharged polar) was found in 9 patients with different CHDs 
and in two control DNA samples) (Figure 3.3.) and 2) The N211S variant, 
that replaces asparagine (uncharged polar) for serine (same group). It was 
observed in a male patient with aortic valve stenosis for bicuspid aortic 
valve (Figure 3.4). 
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,....--------. 
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78 1 ERLSRIIT RM WMKLYFK1KP 
841 LLKSAETEKE MATMKEEFGR 1KETLEKSEA RRKELEEKMV SLLQEKNDLQ LQVQAEQDNL 
R V 
Figure 3.1: Diagramatic representation of the myosin head. The grey highlighted 
sequence represents conserved segments of the molecule. The nucleotide binding 
pocket regions are indicated by red letters. The blue letters indicate mutations 
found in our cohort (see text) . 
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Figure 3.2: Sequence variant within the promoter amplicon of MYH6. (A) 
dHPLC trace difference in a single sample. The sequence (8) showed a 
transition G-+A in the middle of a 14bp conserved segment (C). Two 
brothers of the patient were screened; one of them has a son with an 
identified heart defect (D), no variant found in them. 
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Figure 3.3: A sequence variant in Exon 7 (A), consisted of a transition G A 
(B) , predicted to produce a D208N (C) protein variant in a residue not 
conserved in an "all myosins" context (0) but conserved when compared 
with the cardiac myosins of other species (E). 
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Figure 3.4: Another sequence variant in Exon 7 besides other two instances 
of the D208N variant (A), consisted of a transition A-+G (8), predicted to 
cause a N211 S (C) protein variant in a residue not conserved in an "all 
myosins" context (D) but conserved when compared with the cardiac 
myosins of other species (E) , 
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A230P (alanine for proline, both nonpolar) was found in a patient with 
atrial septal defect. A Prof prediction of secondary structure locates this 
position in a potential a-helix portion of the nucleotide binding pocket 
(Figure 3.5). Due to its lack of a hydrogen atom on the a-amino group, 
when a proline residue is located in an a-helical segment of a protein, it 
induces an angle in the axis of the helix (Figure3.6). This residue is highly 
conserved in many myosins of many species and is located in the 
nucleotide binding pocket of the molecule. 
H252Q (histidine, charged polar; glutamine uncharged polar) was 
identified in a patient with transposition of great arteries. The healthy 
mother of the patient carries the variant. This residue is not located in a 
conserved segment of the protein (Figure 3.7). 
A nonsense mutation (E501 stop) was found in a patient with tricuspid 
atresia, ventricular septal defect and hypoplastic right ventricle. The 
transcript encoded by the mutated copy of the gene would produce, if 
translated, a truncated protein of 500 residues. However, it seems more 
likely to undergo nonsense mediated decay instead. The same mutation 
was found in the mother and maternal grandfather of the patient, neither of 
whom is affected (Figure 3.8). 
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Figure 3.5: A variant in exon 8 (A), consisted of a transversion G 
predicted to cause a A230P (C) protein. This residue is 
conserved in many myosin molecules (D). 
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Figure 3.6: A Prof prediction of secondary structure of a segment of MYH6 
processed using the sequence of the wild-type (upper panel) protein and the 
A230P variant (lower panel). Black arrows point to the relevant residue. 
According to the prediction, the segment of the variant protein containing 
residue 230 fails to adopt a hel ical conformation present in the wild-type (blue 
arrows). 
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Figure 3.7: A sequence variant in Exon 9 (A), consisted of a transversion 
C ~ G G (8), predicted to cause a H252Q variant (C). This residue is not in a 
conserved position (D) , unlike the flanking residues. 
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Figure 3.8: A sequence variant in exon 14 (A) consisted in a transversion 
G-+ T (8) that predicted an aberrant stop codon at position 501 (E501 Stop). 
The mother and maternal grandfather are healthy carriers of the mutation. 
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A one base pair deletion (Figure 3.9) was found in 12 (various 
phenotypes) of the 380 patients, 31 base pairs upstream the 5' end of 
exon 14, in the putative splicing branch site, modifying its sequence from 
ttctgac to ttcgac (consensus [C/t]n[c/t]t[a/g]a[c/t] or ynytray IUPAC code). 
This variant has been found in four of 192 control subjects screened. 
D588A (aspartate, charged polar for alanine, non-polar) was discovered in 
a patient with atrioventricular septal defect. This residue is located in the 
C-terminal portion of a sequence that harbours the secondary actin 
binding loop. This particular position is non-conserved (Figure 3.10) 
V700M (valine for methionine, both non-polar) was found in a patient with 
a large foramen ovale. Two healthy sons of the patient were screened and 
found negative for the variant. This valine residue is highly conserved 
across many myosins from many species and is located in the middle of 
the fulcrum region of the myosin head (Figure 3.11 ). 
The A895V (alanine for valine, both non-polar) variant was found in a 
patient with aortic coarctation and occurs in a non-conserved residue of 
the region of the molecule between the neck and the tail region (Figure 
3.12). 
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Figure 3.9: A sequence variant in amplicon for exon 14 found in 12 patients 
(A), consisted of a deletion (8) of a thymine nucleotide 31bp upstream the 
5' of exon 14, modifying the putative branch site (arrow) of the intron (C). 
The altered branch lies "within range" (inferior "ynytray" between red 
parenthesis) of the acceptor splicing site of exon 14 (inferior green "ag"). The 
only potential alternative branch site in the intron (superior ynytray), if used, 
would use a cryptic acceptor site (superior green ag), and induce a partial 
intron retention in the mature transcript. 
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Figure 3.10: A sequence variant in exon 15 (A) consisted in a transversion 
A- C (8), that predicted a D588A variant protein (C). Even though this is a 
well conserved segment of the protein, the relevant residue itself is not (0). 
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Figure 3.11 : A sequence variant in exon 18 (A) consisted in a transition 
G-A (8), that predicted a V700M variant protein (C). This residue is 
located in the middle of the "fulcrum" of the myosin head and is extremely 
conserved in myosin molecules of diverse species (D). 
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Figure 3.12: A sequence variant in exon 21 (A) that consisted in a transition (8) 
C-+ T (as the primers used for amplification did not yield a readable sequence, it 
was necessary to clone the PCR product, here just the segment from the variant 
chromosome is shown). The variant is predicted to encode a A895V protein. 
The residue in that position does not show conservation. 
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R111 S (arginine, basic charged polar for serine, uncharged polar) was 
detected in a patient with atrial septal defect. This residue is conserved in 
many myosins of many species and (as all variants described below) is 
located in the myosin tail (Figure 3.13). 
A1366D (alanine, nonpolar for aspartate, charged polar) was discovered in 
a patient with aortic stenosis and dysplastic aortic valve. This position is 
occupied in other myosins by non polar aminoacids (alanine, 
phenylalanine or valine) (Figure 3.14). 
T1379M (threonine, uncharged polar for methionine, nonpolar) was 
detected in a patient with coarctation of the aorta, atrioventricular septal 
defect and multiple ventricular septal defects. The variant is not located in 
a conserved residue (Figure 3.15). 
R1422Q (arginine, basic charged polar for aspartate, acid charged polar) 
was found in a patient with atrioventricular septal defect. This position is 
occupied in other myosin by lysine or arginine (both basic charged 
nonpolar residues) (Figure 3.16). 
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Figure 3.13: A sequence variant in exon 26 (A) that consisted in a transversion 
C- A (8), that predicted a R1116S variant protein (C). This residue is located in 
the tailor the myosin molecule and is highly conserved in various of many 
species (0 ). 
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Figure 3.14: A sequence variant in the exon 29 (A) that consisted in a 
transversion C A (8) , that predicted a variant protein A 13660 (Figure 3.1SC). 
That position is not conserved in other myosins (C). 
110 
-
Molecular Genetics of Congenital Heart Disease and Holt-Oram Syndrome 
A v 
B A GG A C C AA G T A T G A G A C GG A C G C C A TT C A G C GC 
ftJI/ 
c; CCCCCCCCCT CCCCAGGCGA AGAACGCCCT GGCCCATGCA CTGCAGTCGG CCCGGCATGA 
~ ~
A K N A L A HAL Q S A R H 
CTGCGACCTG CTGCGGGAGC AGTACGAGGA GGAGACAGAG GCCAAGGCCG AGCTGCAGCG , 
C D L L R E Q Y E E E TEA K A E L Q R 
iAlA1366D T1379M In 
CGTCCTGTCC AAGdctAACT CGGAGGTGGC CCAGTGGAGG ACCAAGTATG AGROGGACGC 
I 
\I I ~ ~ K ~ ~ N ~ ~ F' II A Q W R T I<' Y 
CATTCAGCGG ACTGAGGAGC TCGAAGAGGC CAAGTGAGCT CCAGATACCC CCTTAACCTG 
~ ~
I Q R TEE LEE A 
Figure 3.15: A sequence variant in the exon 29 (A) that consisted in a transition 
C--+ T (B), that predicted a variant protein T1379M. That position is normally 
occupied in other myosins by alanine, valine or phenylalanine. all three nonpolar 
residues (Figure 3.14C). 
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Figure 3.16: A sequence variant in the exon 30 (A) that consisted in a transition 
C-.A (8), that predicted a variant protein A 1422Q (Figure 3.17C). The residue in 
that position is occupied by arginine or lysine in other myosins (C). 
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A 14430 (alanine, non-polar for aspartate, charged polar) was discovered 
in a patient with atrial septal defect in addition to a transition G- A located 
50 base pairs downstream the 3' end of exon 30 (both inherited from the 
mother) and a transition T -C 13 base pairs downstream the 3' end of the 
same exon (inherited from the father) (Figure 3.17). 
R1865Q (arginine, charged polar for glutamine, uncharged polar) was 
found in a patient with atrial septal defect. This position does not show 
conservation in other myosins (Figure 3.18). 
A mutation of the acceptor splicing site (AG- GG) at the 5' end of exon 38 
was found in a patient with truncus arteriosus (Figure 3.19). 
Several synonymous and non-coding variants were found within the MYH6 
amplicons. A summary can be found in Table 3.3. 
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A E E A V E A V N A K C S S L E K T K H 
IAJ R1422Q 
C ~ C T A C A G G ARTGAGATAe ReGACTTGRT CGTGGRCGTR eAGCCCTCCR ATCCTCCTGC ; 
R L Q N E E D L M V D V E R S N A A A 
Q 
A1443D 
TGCR C CTG GRCAAGAAGC RCAGAAACTT TGACAACGTG GACCATGCGC G G G G G C C G C ~ ~
~ ~ ) 
A ~ L L DKK QRNF DK 
Figure 3.17: A sequence variant in the exon 30 (A) that consisted in a 
transversion C--+A (8), that predicted a variant protein A1443D (C) . The residue 
in that position does not show conservation in other myosins (alignment in 
Figure 3.16C). 
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B G A eA G A GG AA G A C AAAAA G AA CC T G C T G C GG C T A C A GG''- CC T GG T GG A C AA G C T G C AA - C ' T 
1 
. . ~ ~
c: CCCACCCCCA GACAGAGGAA GACAAAAAGA A C C T G C T T ~ ~ GCTACAGGAC CTGGTGGACA 
~ ~
o 
TEE DKK NLL VD 
AGCTGCAACT GAAGGTCAAG GCCTACAAGC GCCAGGCCGA GGAGGCGGTG AGTTCAGAGC 
~ ~
t. ) 
K L Q L K V K A Y K R Q A E E A 
ql 156087 
qUl!ry 
ql 3041706 
ql 127750 
ql 547973 
91 30"17 10 
ql 30-t1711 
ql 5'l7971 
ql H77559 
ql S1796g 
R1865Q 
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1789 E O O I K D D O O R L D I A A Q Q A L L G G K K Q L Q K L l l R V R I L L O I L L A I Q ~ N N I I K O f t P P S I R R I ~ L T T T
1803 I SAVKDLQlRlDAAELLVnKGGlXAlOKlXQRLKJIQSDLlTIS GEAS lRADRKVRlrrr 
717 I vtVKNLS I RLIEvtLNAV1GSKRIISKLEARIRDLE LELlI t KRR 
7Z0 EEOVXOLOVOTRKLKRRLLGG-KRVIAXLITRIRDLITALDEI TRR T ~ ~ K D P R I K l V Q " "
701 I I I I R I I T V X X I ! A A A A A T R R G R R X V ~ Q 1 R V R l L L A ! r r G I S R R C X X 1 L A Q A R R r t R Q T T . I L Q T T
700 EI EIREI E E A A A A A T T E G R R K V O K L O N R V R l L L A E L L G I I R R ~ A r l S l R R Y I R Q r ~ L L I D D ~ ~ f f I I
179B ! DLKOQLQD lENTAV1RLRTQlNVAEAKVSSLl LSLt EOD RTLRR T K ! l I K a a f t t [ I E ~ ~ Q G G
lB35 ! R Q N K I I R L K K 1 ! I I T T O R ~ T l A T L E 1 K l l l 1 0 L L GY.! RLL K ~ K D K K I ~ I L T f t t l r D r p R R
Figure 3.18: A sequence variant in exon 26 (A) that consisted in a transition 
G ~ A A (8), that predicted a R1865Q variant protein (C). This residue is not 
conserved in other myosin molecules (D). 
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A v 
B CCCC ACTGTCCC ACC ACAGG AGGAGCAA GCC AA CACC A. 
M 
c: CCCCACTGTC C C A C C C ~ G G AGGAGCAAGC CAACACCAAC CTGTCCAAGT TCCGCAAGGT 
~ ~
E E Q ANT N L S K F R K 
GCAGCATGAG CTGGATGAGG CAGAGGAGCG GGCGGACATC GCTGAGTCCC AGGTCAACAA 
Q H E L D E A E ERA D I A E S Q V N k 
GCTTCGAGCC AAGAGCCGTG ACATTGGTGC CAAGGTGGGT CCCTCCCCTG GGCTTCACTA 
L R A K S R DIG A KI 
Figure 3.19: A sequence variant in the exon 38 amplicon (A) that consisted in a 
transition (8) A-+G in the acceptor splicing site at the 5' end of exon 38 (C). 
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Exon Variant Cases Exon Variant Cases 
E1 +82 G-A 1 E22 -35 T-C 4 
+36 C-A 1 +4A-G 1 
+38 T-G 1 E23 E981E 5 
6G-C 1 +56 C-T 1 
E2 +96 C-T 3 +143 T-C 3 
E3 -41G-A 1 E24 L1040L 1 
+16 C-T 27 G1059G 1 
E4 A110A 2 E26 -59 G-A 37 
E5-6 L131L 90 -59 G-A 2 
E134E 90 -66 C-T 14 
R143R 5 E27-28 -46 G-A 1 
+63 T-G 1 E29 513375 40 
+14 C-A 1 E30 A1443D 2 
-81C-G 2 +50 G-A 2 
E8 +119 G-A 1 +13 T-C 2 
E9 -34 G-A 12 E31 delGCT AAG +97 6 
E10 L291L 1 +96 G-A 2 
-11 G-A common E32 E31+71 C-T common 
E11-12 L323L 1 +24 C-T 12 
-29 C-A 2 +42 G-A 1 
E13 N445N 22 S1512S 1 
E14 -26 G-A 1 +71 C-T 3 
-69 C-G 1 +74 C-T 3 
E15 -39 T-C common E34 D1660D common 
-78 T-G 1 -86 G-A common 
E538E 1 -17 A-T 4 
E16 +31 C-T common -9 G-A 1 
E17-18 +15 C-A 5 E35 A1753A common 
E19 
Y717Y 4 -22 A-G 832 common 
N663N 3 E37 L1866L 3 
deIGAG+10 1 
+18 T-C common 
Table 3,3: Other sequence variants found during the dHPLC of MYH6 ampllcoos. The first 
column Indicates the relevant amplicon. The second column Indicates the nature of the 
variation. Synonymous variants show the same one-letter code at the left and right of the 
amlnoacid residue number (example A 110A). Numbers preceded by minus (e. -41 G-A) or 
plus (e.+82G-A) symbols Indicate that the variant Is located 41bp upstream the 5' end of 
the relevant exon or 82bp downstream the 3' end of the exon, respectively. For deletions 
(del) (e. deIGAG+10) the sequence of the deleted segment Is shown with Its position. The 
third column represents the number of times the variant was seen In our cohort. 
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3.6 Discussion 
dHPLC is a powerful technique for detection of mutations. The detection 
rates reported vary according to the source, but in general are thought to 
be close to 97%. However, as the procedure is based in the capability of 
heteroduplexes of DNA molecules to bind to the matrix in the column, 
homozygous variation (unable to form heteroduplexes) can not be 
detected unless the samples are mixed in an equimolar proportion with 
control DNA samples, known to have no heterozygosity within the relevant 
amplicon, a highly impractical procedure. 
Most of the coding variations found in our cohort are unique or at least 
rare. This may indicate that homozygous coding mutations are not likely to 
be significant contributors to the disease in our patients, with the exception 
of cases where consanguinity exist. Much more important to consider is 
the existence of compound heterozygous. No patient carrying two of the 
coding variations described above has been found. The search for a 
compound heterozygous subject in the future must include also non-
coding variations. 
In the only known instance of a mutation of MYH6 causing CHD, an 1820N 
variation seen in a large family with atrial septal defect (Ching et al. 2005), 
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the inheritance pattern was clearly autosomal dominant. It is therefore 
surprising that a stop codon and a mutation of a donor splicing site, found 
in affected subjects, were inherited for healthy parents, and in the case of 
the former, is present in an equally healthy grandfather. Incomplete 
penetrance could account for this Situation, nevertheless, as the stop 
codon occurs much "earlier" in the protein than the missense "Mendelian" 
mutation, a dominant negative mechanism for the later could be proposed. 
Dominant negative mutations often occur in parts of the protein capable to 
interact with other molecules. 1820N is located in the myosin regulatory 
light chain binding site of MYH6. 
In an alternative explanation, mutations affecting the function of the 
myosin monomer encoded by the defective allele, leaving intact the 
function of an interacting partner could behave as recessive mutations 
whereas mutations affecting interactions could produce disease In a 
dominant manner. 
The limits between potentially Mendelian mutations and susceptibility 
alleles become blurred when a Mendelian or at least familial form of a 
mostly complex disease is being studied. As we do not have at the 
moment access to more samples from the extended family of the patient 
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with the nonsense mutation is not possible to obtain quantitative 
information about penetrance. The approach in this cause could be to 
track the mutation instead of the phenotype across the family. 
3.6.1 Branch site mutation 
Mutations of the "T" or "A" positions of the branch site consensus "ynytray" 
in certain genes have been shown to cause disease (Kralovicova et al. 
2004). The one base pair deletion observed in 14 of the 380 CHD patients 
and in 4 of 192 control subjects occurs in the "T" position of one of the only 
two segments compatible with the consensus found in the whole intron 
upstream exon 14 of MYH6. The splicing alterations the MYH6 transcript 
would depend on the existence and functionality of alternative potential 
branch sites in the same intron. 
If there is not an alternative branch site in the same intron, the outcome of 
splicing depends on its size. In the case of short introns, there is a 
tendency towards complete intron retention, probably because the branch 
site of the intact intron is more likely to carry out the attack In its own 
splicing donor site (Kuivenhoven et al. 1996), For long introns the 
tendency favours exon skipping, when the branch site of the Intact Intron 
establishes the covalent bond with the phosphate group of the donor site 
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of the mutated intron (Burrows et al. 1998; Khan et al. 2004; Putnam et al. 
1997). 
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Chapter 4 COpy NUMBER ANALYSIS OF 
MYH6 IN PATIENTS WITH CONGENITAL 
HEART DISEASE 
4.1 Introduction 
Copy number variations (deletions, duplications) are a normal feature of 
the genome of healthy individuals (Conrad et al. 2006). It has been 
estimated that two given normal subjects typically show more that 11 copy 
number variation differences in sequences longer than 100kb (Sebat et al. 
2004). Most of these variants seem to behave in a way similar to SNPs. 
They appeared once in evolution and show linkage disequilibrium with 
other surrounding Mendelian elements (Hinds et al. 2006). 
In contrast, some recurring deletion and Insertion events are responsible 
for numerous Mendelian disorders like Charcot-Marie-Tooth disease type 
1A (Nelis et al. 1996) and DiGeorge syndrome (Tezenas Du Montcel et al. 
1996). These recurring deletions are typically produced by non-allelic 
homologous recombination events between sequences longer than 10 kb, 
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50kb to 10Mb apart, located in tandem and with a similarity of 95% or 
higher (Inoue and Lupski 2002). 
Different types of repetitive elements in the genome like Alu and LINES, 
are also known to mediate this kind of rearrangements. Alu elements 
seem to have originated as an accidental retrotrasposition of a 7SL 
transcript (Rowold and Herrera 2000) and are thought to have played a 
role in the divergence of humans and chimpanzees (Sen et al. 2006). It 
has been estimated that Alu recombination-mediated deletions and 
insertions account for 0.3% of human heritable disorders. These 
recombination events can occur intrachromosomally (producing insertions 
and deletions of variable length, often spanning entire genes or several 
exons in a gene) or interchromosomally causing chromosomal structural 
abnormalities (Deininger and Batzer 1999). 
Non-allelic homologous recombination has been documented between the 
MYH6 and MYH7 genes. A 5' MYH6/3' MYH7 hybrid gene flanked by intact 
copies of MYH6 and MYH7 was discovered in a family with hypertrophic 
cardiomyopathy (Tanigawa et al. 1990), although it was established that 
the hybrid was not related to the phenotype (Watkins et al. 1992). The 
recombination event from which the hybrid gene derived, necessarily 
produced in the same meiosis the counterpart rearrangement, a hybrid 
gene 5' MYH7/3' MYH6 without normal flanking copies of MYH6 and MYH7 
(see Figure 4.1), but such rearrangement has not been found. 
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Ln It) 
Q:l.. 
-o 
Figure 4.1: Non-allelic homologous recombination events between the 0 - (MYH6) and 
13- (MYH7) heavy cardiac myosin genes. Their high degree of similarity and close 
proximity makes them susceptible to these kinds of recombination events. Tanigawa, 
Jarcho et al (1990) reported a hybrid gene (*) 5 ' a l l ' ~ ~ flanked by two normal copies of 
o and 13 in a family with hypertrophic cardiomyopathy (black arrow). The other 
rearrangement produced by this recombination event, a 5'13/3'0 hybrid without 
flanking 0 or 13 genes (red arrow) has not been found. 
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4.2 Multiplex Amplifiable Probe Hybridization 
Multiplex Amplifiable Probe Hybridization (MAPH) is a method that allows 
the identification of copy number variations in a complex DNA sample and 
is based in the capability to amplify in a multiplex PCR reaction probes 
specifically bound to genomic DNA fixed to a nylon surface. The probes 
used are short (100 to 600 bp), and are flanked by the same pair of peR 
primer binding sites. The length of every probe is different so they can be 
resolved and quantified by electrophoresis once amplified in the final 
multiplex PCR. The comparison between the amounts of different test and 
control probes recovered from the nylon filter, after stringent washes to 
eliminate not specifically bound probe, is a reflection of the amount of 
targets present in the DNA attached to the membrane (Armour et al. 
2000). 
The aim of the project described in this chapter was to use MAPH to 
answer the question of whether non-allelic homologous recombination 
between MYH6 and MYH7 or repetitive elements recombination-mediated 
deletions could account for the phenotype in some of the patients in our 
CHD cohort. 
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4.3 Materials and Methods 
4.3.1 Design of the MAPH probes 
The sequences of all 39 exons and their neighbouring parts of the 
corresponding introns were submitted to BLAST searches against the 
human genome in order to identify possible cross-hybridization targets, ie 
regions of the genome besides the exon whose sequences was used as a 
BLAST query with strong enough similarity to allow the binding of a probe 
covering the exon. 
As MAPH enables us to easily detect 25% variations in dosage, that is the 
reduction expected in the case of a deletion of an two-copy element per 
haploid genome in a diploid organism, exons with no or one potential 
cross hybridization targets were used to make probes (exons 1, 2, 3, 6, 9, 
10, 13, 16,25,36, 18,27,28,30,32,34,39 and a 408bp fragment of the 
promoter) whereas those with more than one potential cross hybridization 
target were screened using intronic probes flanking the exon (the 
remaining exons) (see Figure 4.2). 
The sequence of the segments used for potential intronic probes were 
submitted to BLAST searches against the human genome in order to 
detect similarity with repetitive elements. 
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Figure 4.2: Scaled diagrams showing the genomic organization of MYH6 and the 
localization and relative size of the 49 MYH6 probes used for MAPH. A) Exons (blue 
boxes and numbers) are labelled according to their order 5' to 3'. Probes (purple and 
red boxes and red numbers) are labelled with respect to their size, except for "new18" 
probe whose size is between 46 and 47 probes (there is no 18 probe). B) Probes 
aligned by size. 
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In addition to 49 MYH6 probes X (ZIC3) and Y (SRY) linked probes were 
designed in order to detect normal variations of gonosomes according to 
sex. Control probes in other autosomes (MEF2C in 5q14, IRX3 in 16q12, 
HEY2 in 6q21) were designed to be able to detect whole-gene deletions of 
MYH6. A non-human probe was designed as a control for non-specific 
binding and was derived from lambda-phage DNA, with a total of 55 
probes (Table 4.1 and Box 4.1 ). 
4.3.2 Preparation of plasmid stocks 
Once all the probes were designed as amplicons (Figure 4.2), primary 30 
cycles, 2 0 ~ 1 1 peR reactions were performed using genomic DNA from a 
control subject as template for each probe plus a zero DNA control. 
Secondary 20 cycles peR reactions with a 0 . 5 ~ 1 1 input from the primary 
peR were carried out (Figure 4.3A). 
Amplification was assessed using 2% agarose gel electrophoresis of 2 ~ 1 1 of 
each secondary peR reactions. DNA from the remaining 1 8 ~ 1 1 was purified 
using ethanol precipitation and treated with the Klenow Fragment of DNA 
polymerase I to remove the template-independent 3' terminal Adenosine 
nucleotide added by Taq polymerase at the end of each polymerisation 
cycle (Figure 4.3B). 
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Table 4.1: Sequence of peR primers used to produce amplicons for the MAPH probes. Sizes of 
the amplicons and full probes, as well as GC content of the amplicons are also shown. Capital 
letters indicate exonic sequence 
Probe Exon Amplicon Full probe Primer 5' Primer 3' 
1 18(5') 89 148 aagaccttagtctggggaggac G T T G T C C A T C A C C ~ c c
2 7(3') 94 153 I tQacccgaQttacccctaacc I gtcttccatactgggctgacc 
3 21(3') 97 156 looccaCQtoattatctcttcao aaaaoagctggcactcctagac 
4 22(3') 100 159 caoctccctctoQcttcao ccaocctOoaoacatctatQo 
5 21(5') 103 162 catQttcaQtgtagtQatQttQQ ataaaagaQagcttcccaatcatoo 
6 9 106 165 ctctQtcccattCQtccccaQ aQcctccctgc!Qgtac!cac 
7 15(3') 109 168 C A A C T G C C G A T A C T G g t ~ ~ cctocctatggagtcatgtge 
8 15(5') 113 172 aatattggcttcctgttttaQgO agQcttccacagtcccatacc 
9 36(5') 116 175 cccctaaagacagaaacaagQ cccaaQQatctcctttc!cc 
10 36(3') 120 179 I gatgtQgaagtttcttctctgg aagtcaaactgactgcagagc 
11 33(3') 123 182 AAGCAAGTCAAGAGCCTCCAG I ggaggaatctggtgg:!gtatc 
12 38(3') 127 186 caottctoaoootcccatagc l o t t a g a g g c a c t t g t g g t t t l J ~ ~
13 39 130 189 loccccctcacacctcttatt aagoacagat 
14 14(5') 134 193 cagtcattgtccctgtcttcag aocagtcagaaagtgggtgtg 
15 11-12(3') 137 196 agaQactctgagQcttgtgg cacctcaottctootgaotoc 
16 10 141 200 cctcccctccacccacctcao loQgoatQocaQocaoottcac 
17 !Hl(5') 144 203 actcccaagggacccaagt aaggctgggcatgaggtt 
19 6 152 211 cagacacccacccagatcc accctaggcatCaQCQtgta 
20 17(5') 155 214 ItgalQaooaaagaagctaggg cat 
21 19(5') 158 217 GGCAGAGgtgQQtatQagg CGA T ACctgaggagggaagtg 
22 31(5') 161 220 agaooccaaaoocaacctc Igacaagg<:tcactcttca...!l.C 
23 1 166 225 taaaooaactooaactttoaao ttaataQtJgcccttawcctcc 
24 7(5') 169 228 IgaootttaaooctoQQattgc I J j J Q l l t t c c t a c t ~ t t c t c c a ~ ~
25 20 176 235 tctaccccttgcctgcag tcccttttcctcctgtctca 
26 35(5') 181 240 loacatcatccacttacctcatcc atagcaaaaggtctgcagtattacc 
27 8(3') 185 244 AACTCCTCCCGCTTTalQag aotoaaaaotcaoacctttgg 
28 4(5') 189 248 Itaaocaacaaataccctaaagc lotacctttctcttaccaaatcc 
29 16 197 256 loooctcctttattttccaac ataJHItllm1tca 
30 19(3') 202 261 atgttga aaa tatc 
31 11-12(5') 207 266 itocagtcacacacctcactcc laaaaot acca3Q1t 
32 29(5') 211 270 aaaaa1cctct Ictotaccccattctctagattc 
33 38(5') 215 274 caocaaaacaoaattcIQaaoo Igggattctcamctcaacc 
34 32 221 280 ca 
35 29(3') 223 282 CAAotoaactccaaataccc 19tataa aaage 
36 24 230 289 tttcatattttccacactttoc Igacacctccatl/JQ<;QC::l,:tc 
37 30(5') 233 292 IcaalQlctcaaaaaaatatagg CTCTACGTCCACCATCAAGTCC 
38 33(5') 241 300 ctccccaataoc CCTTGATCTGGTTGAACTCTAGC 
39 13 245 304 tcacttatcctttccctctcaac G T G G C T G C T T G G T C ~ C A G G
40 23(3') 250 309 CTGTCCAAGTCTAAGGTCAAGC IctlQa attgg 
41 3 255 314 tct 
42 14(3') 263 322 t ItaooatctttccatgaatQllCQ 
ZlC3 274 333 CCCTAGCTACTTGCTGTTTCC GATAGGCTGCCGCATATAACG 
43 26(5') 260 339 tatoattoa taooccatcaataooaatttag 
44 37(5') 287 348 gaacctalQtaaatccaggttgg cctccatcattttactcttctcc 
45 34 293 352 ctoctcacacccactctcc ctagatgtcctgggctct!lC . 
46 2 299 358 tctoactccctoatctotcc ctooagtat 
SRY 305 364 CCATGCACAGAGAGAAATACCC a tctttgtaocc 
IRX3 321 380 ctcctoaatctcacctcttttoc AACAAACCTCACAGCGAATGC 
new18 335 394 acctotcactcccccacc c c c c t t c t c a ( l ! I C 8 Q t t t t ~ ~
47 37(3') 366 425 GotaaottCll<laactttcttcc tQctaIJlcagcaactcacatcc 
MEF2C 374 433 ttcttcggaaacgtatttgacc a a g c u ~ t c a 8 ! W . .
HEY2 391 450 cattttgctgtggtg(ltcttagg lQaaQtcatctacttacCTTT ACCC 
llImbdll 400 459 gagagttaatttCQctcacttCQ aattcacaccaactcatttaaoc 
46 Promoter 408 467 aaaooa aac c c c a c c c t c t o t c t a ( l a ~ c c
49 27&28 461 520 ccctctcttccttcctctgg ct a t o a a ~ ~
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Box 4.1: Sequences of the PCR amplicons used to produce the 55 MAPH probes. 
Capital letters indicates exonic sequence. 
>1) MYH6 Exon 185', 91bp 
aagaccttagtctggggaggacagctggcatccactttaccctaaggctgaccctttccccttccctcctgacacagGGGTGATG 
GACAAC 
>2) MYH6 Exon 7 3', 94bp 
tgacccgagttacccctaaccctcccctccctgtgacgtggtggggacagccacactgagctgggctcccgatggtcagcccagtat 
ggaagac 
>3) MYH6 Exon 213', 97bp 
ggccacgtgattatctcttcagccctctcctcccctcccctagattatagcccatctcacaaccagggactgggagtctaggagIgcca 
gclctttt 
>4) MYH6 Exon 22 3', 100bp 
cagctccctctggcttcagcccaggtctcctcaagactcccagactagagtgttgtcctggtccttggcalggaggtccccatagalgtc 
tccaggctgg 
>5) MYH6 Exon 21 5', 103bp 
catgttcagtgtagtgatgttggaggtgggtgtgcacaagaaggaagtctacgtgcctacgaacttgcttagtagggcccatgattggg 
aagctctcttttat 
>6) MYH6 Exon 9, 106bp 
ctctgtcccattcgtccccagGGGAAA TICA TIAGGATCCACTITGGGGCCACTGGAAAGCTGGCTIC 
TGCAGACATAGAGACCTgtgagtaccagcagggaggct 
>7) MYH6 Exon 153' 109bp 
CAACTGCCGA T ACTGgtaagcaggcagcccctgcactgggccaggggacttctgaagacacaaagggccagggtcct 
gctgcttcaaagcacatgactccataggcagg 
>8) MYH6 Exon 15 5' 113bp 
aatattggcttcctgttttagggtaagaggtaccagcacagcgccccttcagcaggccagcgctactggctccagattccttttcctgtca 
gggtatgggactgtggaagcct 
>9) MYH6 Exon 36 5' 116bp 
cccctaaagacagaaacaaggccttgggtccaggccaggccactgtgctgtaacaccaagccaactctgcagttctgtggatttga 
gggcctgatgggagaaaggagatccttggg 
>10) MYH6 Exon 36 3', 120bp 
gatgtggaagtttcttctctggccccactgccccgccctcacagggctcctctcacctcctccttgagatgctgttggtagatttaacgttctt 
ctcacgctctgcagtcagtttgactt 
>11) MYH6 Exon 333', 123bp 
AAGCAAGTCMGAGCCTCCAGAGCTIGCTGAAGgtacatgggggcgggaggtcccctcaggggactggcct 
ccatgtggcctggagaagcagtggtgtctggatacaggcaccagattcctcc 
>12) MYH6 Exon 38 3', 127bp 
cagttctgagggtcccatagcttacataacctgagaatccactctcctgctcaaaacagccccccactgactggaacttctgcagaga 
tccccagttccatccccctaaaccacaagtgcctctaac 
>13) MYH6 Exon 39, 131bp 
gccccctcacacctcttattctttttgcagCAAAAAA TGCACGATGAGGAGTGACACTGCCTCGGGAACCT 
CACTCTTGCCAACCTGT MT AM TATGAGTGCCAaactctgcctgagcccatctgtcctt 
>14) MYH6 Exon 145', 134bp 
cagtcattgtccctgtcttcaggggaagccctcctccactgccctgacatggaggggacagccataccctgctgggctcggcacagt 
gcacgggcacagccccaatggccactcacacccactttctgactgct 
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Box 4.1 (continued) 
>15) MYH6 Exon 11·123', 137bp 
agagactctgaggcttgtggggeagtggggtgtgttgtgggatggtgagggacagggacgtgggagacgtgggcagacagagagt 
ccaccacaatcccaactcctcaaccccagctgcacteaccagaactgaggtg 
>16) MYH6 Exon 10, 141bp 
cctcccctccacccacctcagACCTGCTGGAGAAGTCCCGGGTGATCTTCCAGCTGAAAGCTGAGAG 
AAACTACCACATCTTCTACCAGA TTCTGTCCAACAAGAAGCCGGAGTTGCTGGgtgaacctgcctg 
ceaccccc 
>17) MYH6 Exon 5-6 5', 144bp 
actcccaagggacccaagtccccttcccccctccacccctagteagctgeaggaggagtagagccagctggagtgaacagggaea 
tgcctggctgccaccactgcctgtcccaggctctccccaccaacctcatgcccagcctt 
>19) MYH6 Exon 6, 152bp 
cagacacccacccagatcctcagccctgaccccattgcttctcctcttttttcttccagA TCGGGAGAACCAGTCCATCCTC 
ATCACgtgagcgagtgccatcctcccacagaagggactgggctgggggcatacacgctgatgcctagggt 
>20) MYH6 Exon 175', 155bp 
tgatgaggaaagaagctagggctacgtagtcgttttttagtgtgtagattccacaaaagcctgaactcacgtcacaaattatgtggcagc 
ccctgtccctttgatgattctggtggagagtgtctggggaccagggtttaagggcctaagggatg 
>21) MYH6 Exon 19 5', 158bp 
GGCAGAGgtgggtatgagggtgccccagagctcatagaacagggggagccaggctgccctgatgggaatgggatctgcaggt 
gaccctggaattctgtgggcagagcagatcactgcagagcatgggtgactctggacacttccctcctcagGT ATCG 
>22) MYH6 Exon 31 5', 161bp 
agaggccaaaggcaacctccttggaggtggaggaggagggctaagcccaggctcgggaccagggacagalcttggacalgcgg 
ctgaggctgggggctggggcactgggaagcaggagggctggggagctaaggctggggggctgaagaglgagccttgtc 
>23) MYH6 Exon 1, 165bp 
taaaggaactggagctttgaggacagA T AGAGAGACTCTGCGGCCCAGgtaagaggaggtttggggtgggatgccct 
gcagcccgtccacagagcccccaccgtgagggacctccttcaccaggagtggggtgcaggtcagttggaggcclaagggctctatt 
aa 
>24) MYH6 Exon 75' 170bp 
gaggtttaaggctgggattgcagggagcatggggcactgagctctcattagaggggtgccagagcaatgaaccatgtcaggcaaat 
cctgctgggtgctgggctctgatggccaggctgggaaggggagcatgtgatgctgagccctgtatggagaacagtaggaatcct 
>25) MYH6 Exon 20, 176bp 
t c t a ~ g G T G T T C T T C A A G G C A G G G C T G C T T G G G C T G C T G G A G G A G A T G C G G G A T T
GAGAGGCTGAGCCGCATCATCACGCGCATGCAGGCCCAAGCCCGGGGCCAGCTCATGCG 
CA TTGAGTTCAAGAAGATAGTGGAACGCAGgtgagacaggaggaaaaggga 
>26) MYH6 Exon 35 5', 181bp 
gacatcatccacttacctcatcccctGttccttaccccactacattcttggtatagctataaacatctctggaatattgtcctggtaaaaagtt 
gtttccatcttccttggaatattgtcatgctcctacgtaaacatgttgctaaagagctccagggtaatactgcagaccttttgctat 
>27) MYH6 Exon 8 3', 185bp 
AACTCCTCCCGCTTTgtgagtgcctttgaccactcccagtggcctcatccagccttgacaagaaaaagggggtgctgttttgc 
cacacccagttgattgtactgtatctggctttgggatatcaacalgcacacgttggtgggaagagagcataggctttggagccaaaggt 
ctgactttccact 
>28) MYH6 Exon 4 5', 190bp 
tgagcaacagataccctaaagcgctgcccgcgggagacagcctcggggtcagcataaggtgtgcacagatctgagagctgccaat 
ctccaggtctgccccaagacccttggaacatagggaelgaagagtgatggtcatgggcacagggtgtccccaggatggtctggggat 
ctggcaagagaaaggtac 
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Box 4.1 (continued) 
>29) MYH6 Exon 16, 197bp 
gggctcctttattttccagctcctgttgattatttctcctctcgctgtttagGGGACAGTGGTAAAAGCAAAGGAGGCMG 
MAAAGGGCTCATCCTTCCAGACGGTGTCGGCTCTCCACCGGgtaagaagggcccaggggtgccag 
gacacctggtggaatggcccagcccagagacttctggctgcaccacctat 
>30) MYH6 Exon 19 3', 202bp 
atgttgagtggagcagagaggagtttaggaggcagaagcctaattctggcttccttatcaaccttatcaagggctgaaacccaggcttc 
attccggtcttgtttgtcaaatttttactcttacttctagaaggcatggggtgatgggtcacctgggagctcatccagggtcttccaccctgg 
atactcccctctgaggctgc 
>31) MYH6 Exon 11·125', 207bp 
tgcagtcacacacctcactccttctccacccttctctccactcctccctcggcttgtctttgccttctcctctttatttgcctccccatctcccatgt 
gtcactcccctgccaccctccctcctccttgttactggagcccctgccagggcccctcttctaccctttcacttcctctgggttcactccttggt 
ccttgctgacttct 
>32) MYH6 Exon 29 5', 211bp 
aagagtcctctgcaagggaaagaccctccagtctaggttctgccctgcagctaagcgtcatttaatgcctcttttcttattcglaaggggat 
ggggtgagcagactgggaaactcctcaaacagtgaggtgccacatcagcccacatggtgaataaggctgggcttggttgaagtact 
acataagaagagaatctagagaatggggcacag 
>33) MYH6 Exon 38 5', 216bp 
cagcaaaacaggattctgaaggggcccagatcgggcagcatgggatttgtctggggcagtggalggccgtgaaggactctgagig 
ctggacatgtttgagaagagtgcaaggcagttgcaggalacccttgggaaggctgttgcaggaalatgcatgaggtatgggtgcctca 
gggacagggagctggaacctcaggttgagaggctgagaatccc 
>34) MYH6 Exon 32, 221bp 
calaggctttgagctttctggccctctgglccccagAGGAAA TCTCGGACCn ACTGAGCAGCT AGGAGMGG 
AGGAAAGAATGTGCATGAGCTGGAGMGGTCCGCAAACAGCTGGAGGTGGAGMGCTGG 
AGCTGCAGTCAGCCCTGGAGGAGGCAGAGgtgagggccgagaactccctgcaccccatccctgttctgccgctg 
tctcccacttctccc 
>35) MYH6 Exon 29 3', 22Sbp 
CAAgtgagctccagatacccccttaacctgactctcagagaggaaggggcgagaggacctggggtggggacaggcaaagtggt 
catgagacggaagtggaagagacaggaggaactcggagggcaacagaagtgcttggaagaaagcctgaactctttgctctgtga 
actctggctggccctgacccacttcctgtgacgggcgagcttttggcccgggttatac 
>36) MYH6 Exon 24, 230bp 
tttcatgttttccacactttgcttattttcttccctccaacagCTGGAGGGA TCCCTAGAGCMGAGMGAAGGTGC 
GCATGGACCTGGAGCGAGCAMGCGGAAACTGGAGGGCGACCTGMGCTGACCCAGGAG 
A G C A T C A T G G A C C T G G A M A T G A T A A A C T G C A G C T G G M G A A A A G C n A A G A A g ~ g a c t g t t
ggtggccaggaggggctaatggaggtgic 
>37) MYH6 Exon 30 5', 234bp 
cggtgtctcaaggagatatagggagggggtggaaggaggtccacccaaggctccagtgttgcccagtagagtcacacacacacc 
ctccaccctcacctgggcagAMGMGCTGGCCCAGCGGCTGCAGGATGCCGAGGAGGCCGTGGA 
GGCTGTTMTGCCMGTGCTCCTCACTGGAGMGACCMGCACCGGCTACAGMTGAGATA 
GAGGACTTGATGGTGGACGTAGAG 
>38) MYH6 Exon 33 5', 241 bp 
cagcactttctccccaatagcaccgtggtgggcatgggglgcagatcccacctccccatctcttctcagctcttcttctctgggcgatagtc 
ctggctgacaccgtgtatcttctcatcctccctctcaaccctgccctgtgccctgtctgcccgccctcgccccaccccttcccagGCCT 
CCCTGGAGCACGAGGAGGGCMGATCCTCCGGGCCCAGCTAGAGTTCMCCAGATCMG 
G 
>39) MYH6 Exon 13, 245bp 
tcacttatcctttccctctcaaccagATGCTGACMGTCGGCCTACCTCATGGGGCTGMCTCAGCTGAC 
CTGCTCMGGGGCTGTGCCACCCTCGGGTGAMGTGGGCAACGAGTATGTCACCMGGG 
GCAGAGCGTGCAGCAGGTGTACTACTCCATCGGGGCTCTGGCCAAGGCAGTGTATGAGAA 
GATGTTCMCTGGATGGTGACGCGCATCMCGCCACCCTGGAGACCAAGCAGCCAC 
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Box 4.1 (continued) 
>40) MYH6 Exon 23 3', 250bp 
CTGTCCAAGTCT AAGGTCAAGCTGGAGCAGCAGGTGGATGA Tgtgagtagtaagaaccatgctcct 
gctctcagagcaagattttgcaggcaacaccaatggcccagaaagtcctgatccctagaattaacttctatggcccctgaagctttt 
ttgctctctgtagttcctcactacagtaggtctctgaatcctttgtgcttgcaggatttctctgttggtttgacttccaatcccactggacttca 
ag 
>41) MYH6 Exon 3, 255bp 
gccctcctgtctctgacccagGGGAAGCACCAAGATGACCGATGCCCAGATGGCTGACTTTGGGG 
CAGCGGCCCAGTACCTCCGCAAGTCAGAGAAGGAGCGTCTAGAGGCCCAGACCCGGC 
CCTTTGACATTCGCACTGAGTGCTTCGTGCCCGATGACAAGGAAGAGTTTGTCAAAGCC 
AAGA TTTTGTCCCGGGAGGGAGGCAAGGTCA TTGCTGAAACCGAGAA TGGGAAGgtgagt 
agggcatggcgccg 
>42) MYH6 Exon 14 3', 263bp 
agacaaagtggtggctgagtcccttctacacccaagaaactagagtcccaagaatcccaggcctttctccaggcccagcttctcc 
ccactgtgaagtcatgggcatgaacaggatgatccccccactcttcctttcccaggaccttgcactttatgcccctttgtggtggtccc 
ctcagtgtcttaagagtgagatgtagtgaaggagaggcccctggcccctctgaccgcccatgagaagcgtcattcatggaaagat 
ccta 
>ZIC3274bp 
CCCTAGCTACTTGCTGTTTCCCGGGCTGCATGAGCAGGGCGCTGGGCACCCGTCGCCC 
ACAGGGCACGTGGACAACAACCAGGTCCACCTGGGGCTGCGTGGGGAGCTGTTCGGC 
CGTGCTGACCCATACCGCCCAGTGGCCAGCCCGCGCACGGACCCCTACGCGGCCGGC 
GCTCAGTTTCCTAACTACAGCCCCATGAACATGAACATGGGAGTGAACGTGGCGGCCCA 
CCACGGGCC CGGCGCCTTCTTCCGTTATATGCGGCAGCCTATC 
>43) MYH6 Exon 26 5', 280bp 
tatggttgattggactttgtggttaacttggagaattgcaaaggtatctgattgtttcgaggcatgttgtcacaaatatttgtaaaataca 
agcactcattttcccgtcttatgaatagcgcaacagagcctagtgaatctggggactctgaacttcttgatctcacaggataccagg 
atcccccttcaaccacaggttctcaggatttggggctgcagatgctcacactgggtctgagatgcccttgggagcttcagccaaatt 
cctattgatggccta 
>44) MYH6 Exon 375', 287bp 
gaacctatgtaagtccaggttggagctttatccaccatactggagctggaacagacctggtgcttttatattaccacattagggaatt 
ccattaggttctgagcccctccccctacttctagctttatgacttcagccttcattgctctgtggatccctgactgacaaccttgcattgcc 
cctttgacctacgatagagtcagagaatcttccccaccacctctttgacctggatcattgcagggaggggcagcaaaggcaagg 
ggagaagagtaaaatgatggagg 
>45) MYH6 Exon 34, 293bp . 
ctgctcacacccactctcctgatgctcagGACACCCAGATCCAGCTGGACGA TGCGGTCCGTGCCAAC 
GACGACCTGAAGGAGAACATCGCCATCGTGGAGCGGCGCAACAACCTGCTGCAGGCTG 
AGCTGGAGGAGCTGCGTGCCGTGGTGGAGCAGACAGAGCGGTCCCGGAAGCTGGCGG 
AGCAGGAGCTGATTGAGACCAGCGAGCGGGTGCAGCTGCTGCATTCCCAGgtgagggggtc 
aggagccaccttgtggaaacctactgagtgcagagcccaggacatctag 
>46) MYH6 Exon 2, 299bp 
tctgactccctggtctgtcctgcctgtctgcgctctggggctgcctccatcccogggtggcctgcctctgttgttcttcactctcctcatctg 
ttcttctctctgcccggctctacctctgttgttccttgctccacccaCGGTCCAGA TTCTTCAGGA TTCTCCGTGAA 
GGGA T AACCAGgtgagaactgcccccattttctctgcagagactggggcatgcttctcctgggagccggattgctggacca 
ggggtctgctgtcccaagcactcagcgccaacccttagcatactccag 
>SRY,305bp 
CCATGCACAGAGAGAAATACCCGAATTATAAGTATCGACCTCGTCGGAAGGCGAAGATG 
CTGCCGAAGAATTGCAGTTTGCTTCCCGCAGATCCCGCTTCGGTACTCTGCAGCGAAGT 
GCAACTGGACAACAGGTTGTACAGGGATGACTGTACGAAAGCCACACACTCAAGAATGG 
AGCACCAGCTAGGCCACTTACCGCCCATCAACGCAGCCAGCTCACCGCAGCAACGGGA 
CCGCTACAGCCACTGGACAAAGCTGTAGgacaatcgggtaacattggctacaaagacctacctagatgct 
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Box 4.1 (continued) 
>IRX3,321bp 
ctcctgaatctcacctcttttgctactactgtctctctcttccagGCCCCAGAACCATCTGGACGCCGCCCTGGTCT 
TATCGGCTCTCTCCTCATCCTAGTTCTTTAAAAAAAACAAAAAAACAAAAAAAACIIIIIIIA 
ATCGTTGTAATAATTGTATAAAAAAAATCGCTCTGTATAGTTACAACTTGTAAGCATGTCCG 
TGTATAAATACCTAAAAGCAAAACTAAACAAAGAAAGTAAGAAAAAGAAATAAAACCAGTC 
CTCCTCAGCCCTCCCCAAGTCGCTTCTGTGGCACCCCGCATTCGCTGTGAGGTTTGTT 
>new18) MYH6 Exon 25, 335bp 
acctgtcactcccccacccccacccttctcctgcagGAAGGAGTTTGACA TT AA TCAGCAGAACAGTAAGAT 
TGAGGATGAGCAGGTGCTGGCCCTTCAACTACAGAAGAAACTGAAGGAAAACCAGgtgacttt 
ttttcccagtgcatgaaagtgggagctcaatagccctgaggtaactgaggctgcagcagctgcttagggttctacacaatatctgga 
actccaggcagcctcatagacccaaccatccctgacttacaggcgctcaggaacactagccttcccccatagagcaagaatacat 
tacgttagcaaaactgtttgagaagggg 
>47) MYH6 Exon 373', 366bp 
Ggtgagttcagagctttcttccctttctcatcaacacacctactatttgtgagaaccaatgaatatctcctacagaggggcctggacaa 
agagtttgctataaactttaactctcaaacatttgtttgacacatctggtatgctcagagctgtcaggtgttctgaattaacaaaggcacc 
acctacaagctgcttacaattcagataccataacccaacagaaggcagtgtagatgctagtgcaggacgtggggcagccgaagc 
tgaaggcaggaaggtggcggtggaattgggcctagaaggggacccagctagccacagggcagtggggaagacatctgggtg 
gatgtgagttgctgattagca 
>MEF2C, 374bp 
ttcttcggaaacgtatttgacctagatttcttcctaaatgctttattgttttttgttaacagGGAACGGGTATGGCAATCCCCG 
AAACTCACCAGGTCTGCTGGTCTCACCTGGTAACTTGAACAAGAATATGCAAGCAAAATCT 
CCTCCCCCAATGAATTTAGGAATGAATAACCGTAAACCAGATCTCCGAGTTCTTATTCCAC 
CAGGCAGCAAGAA T ACGA TGCCATCAGTGgtaatacaaaactacattttaaataaatattgataatgttttgtatat 
gttttgctgtttttatatttgtctaacttgatgaattacttaacattctcccagaaaattaacataacagtgccattgacagagccttgct 
>HEY2,391bp 
cattttgctgtggtgatcttaggagaataattattcttatgatttaaaaaagtcattctagtttcttttagtctttaaaagltaaaatggcaaat 
acttgtcattaggtatgacattaattagtgctttcatgtaaagtttggaaagaattcgaagttttctgtgaaaaaataaaagttgggattgt 
ctagtgagagggaaattgaagccataatgctaaattcagtgtataatgtttcagattagtttctgtaggacataggattatttaIttatttatt 
tatttatgaagGGATCTGCAAAGTT AGAAAAAGCTGAAA TA TTGCAAA TGACAGTGGATCA TTTG 
AAGATGCTTCAGGCAACAGGGGGT AAAGgtaagtagatgacttca 
>Lambda Phage, 400bp 
gagagttaatttcgctcacttcgaacctctctgtttactgataagttccagatcctcctggcaacttgcacaagtccgacaaccctgaac 
gaccaggcgtcttcgtlcatctatcggatcgccacactcacaacaatgagtggcagatatagcctggtggttcaggcggcgcattttt 
attgctgtgttgcgctgtaattcttctatttctgatgctgaatcaatgalgtctgccatctttcattaatcoctgaactgttggttaatacgcttg 
agggtgaatgcgaataataaaaaaggagcctgtagctccctgatgattttgcttttcatgttcatcgttccttaaagacgccgtttaacat 
gccgattgccaggcttaaatgagtcggtgtgaatc 
>48) MHY6 Promoter, 408bp 
g a a g g a g a g g c t g g g g a a c a g g g g a g g a a a g c c c a t g g t t g g g a g g c g g a g g a c a g g c a ~ g a a g g t g g
accctcacccatgttttcagttcaccctU:gggttaaaaataactgaggtaagggccatggcagggtgggagaggcggtgtgagaa 
ggtcctgtcttcccactatctgctcatcagccctttgaaggggaggaatgtgcccaaggactaaaaaaaggccgtggagccagag 
aggctggggcagcagacctttcttgggcaaatcagggggccctgctgtcctcctgtcacctccagagccaaaggatcaaaggag 
gaggagccaggaggggagagaggtgggagggagggtccctccggaaggactccaaatttagacagagggtggg 
>49) MYH6 Exon 27-28. 461bp 
ccctctcttccttcctctggtcgactcagcccctcccacactcacccttcctgtcttgcttcctgaagGCAAACCTGGAGAAAG 
TGTCTCGGACGCTGGAGGACCAGGCCAATGAGTACCGCGTGAAGCTAGAAGAGGCCCAA 
CGCTCCCTCAATGATTTCACCACCCAGCGAGCCAAGCTGCAGACCGAGAATGgtgggtgcccc 
taaccaaccccctgcctagggcaggacatgacttgtgaaatggcccacaagcccctcatttcac:ctcca9GAGAGTTGGCC 
CGGCAGCTAGAGGAAAAGGAGGCGCTAATCTCGCAGCTGACCCGGGGGAAGCTCTCTTA 
TACCCAGCAAA TGGAGGACCTCAAAAGGCAGCTGGAGGAGGAGGGCAAGgtgaggcccagtg 
gggagggtgggcaggcttgatggcagccctggggcaattcatctcagtgccag 
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The Klenow digestion reactions were loaded in a 1.5% agarose gel and 
DNA was purified from agarose blocks cut from the gel containing the 
fragments corresponding to each one of the 55 probes and re-dissolved in 
30J-lI of water using the QIAGEN gel purification kit, according to the 
manufacturer's directions. 
5.5J-11 aliquots of the purified DNA solutions were used in 10J-lI ligation 
reactions that included 100ng of pZer02 vector linearized with EcoR V 
(Invitrogen) and 2U of T4 DNA Ligase (New England Biolabs). The ligation 
reactions were incubated overnight at 16°C. 
2J-11 of each ligation reaction were used in CaCI2 competent TOP10 E. coli 
transformation reactions. Two Petri dishes containing 50J-lg/ml Kanamycin 
LB-agar for each one of the 55 transformation reactions plus a negative 
(no insert added) and positive (a known pZero2 recombinant plasmid) 
were inoculated and incubated overnight at 37°C in order to obtain isolated 
bacterial colonies. 
Material from 2-4 colonies per transformation reaction was used to 
inoculate 5ml 50J-lg/ml Kanamycin LB-Broth overnight cultures (37°C in 
orbital incubator at 200rpm). Plasmid DNA was prepared for each 
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Figure 4.3: MAPH probe preparation. A) The desired genomic segment is 
amplified by PCR. Large amounts of DNA are produced by means of a 
secondary PCR reaction. B) The Adenosine residues incorporated by Taq 
polymerase at the 3' of each molecule are removed by Klenow fragment of 
DNA polymerase I digestion in absence of dNTPs. C) The "blunt" PCR 
product is the cloned into the EcoRV site of the pZero-2 vector. The plasmid 
is used as template of a PCR reaction with vector specific primers PZA and 
PZB in order to produce the probes. D) Each probe has a variable segment 
(boxes) that binds the genomic DNA fixed to the filter, and two peripheral 
constant segments derived from the vector used as binding sites for the 
primers used for multiplex amplification. 
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overnight culture using the Qiagen Plasmid Miniprep Kit and sent to 
sequence with M13 primer to our central facility. 
Each sequence was received from the central facility as "seq" (sequence 
in 4-letter code) and "ab1" (electropherogram) via e-mail. Those files were 
used as queries to BLAST comparisons against the sequence of the 
genomic segment spanned by the probe. Those plasmids showing a 
sequence corresponding to the intended segment were selected as 
templates for probe PCR production. For a fraction of transformations, no 
adequate plasmid was identified by sequence. In those cases additional 
colonies were screened and plasmid selected if the sequence data was 
positive. Several probes required a second round of ligation and 
transformation. 
4.3.3 Probe mix preparation 
Once a set of appropriate plasmids was established for the 55 probes, the 
DNA concentration of the corresponding mini-preparations was measured 
using the Nanodrop Spectrophotometer (Nanodrop Technologies). All the 
plasmids were diluted to final concentration of 4ng/,.J1. 1 ",I of this dilution 
was used in a 20 cycles, 20",1 PCR reaction with pZero-2 vector-specific 
primers PZA and PZB (Armour et al. 2000) in order to produce the probes 
(Figure 4.3 C). 
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Amplification was assessed running 51J1 of the peR reaction in a 2% 
agarose gel. 10IJI of each one of the 55 PCR reactions were pooled in a 
single tube, and DNA purified from the mixture using the QIAGEN PCR 
purification kit. 
The concentration of the purified mixture of DNA probes was measured 
and the solution diluted to a final concentration of 110ng/IJI (2ng/lJl for 
each probe). The probe mix was divided in 201J1 aliquots and stored at -
20°C. 
4.3.4 Preparation of the filters 
The samples used for the MAPH analysis consisted in genomic DNA 
solutions at different concentrations from 380 patients affected with 
different variants of congenital heart disease. For samples with a DNA 
concentration <100 ng/lJl the solutions were concentrated using a 
SpeedVac centrifuge. 11J1 of 1 M NaOH was added to every solution 
containing 1IJg of patient genomic DNA. 
For each of the 380 samples a 4mm square filter was cut from a 
hybridization nylon membrane (Osmonics) and numbered with a sharp 
pencil. To the unlabelled surface of the filter, 1IJg of NaOH denaturated 
genomic DNA was applied 11J1 of solution at a time, letting the filter dry 
between applications. 
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Both sides of the filters were irradiated with 50mJ of UV light using a GS 
Gene Linker (Biorad) in order to bind the DNA to the nylon surface. 
Groups of 10-15 filters were introduced to an Eppendorf tube containing 1 
ml of pre-hybridization solution and incubated 2 hours at 65°C. The 
solution was then replaced with a mixture previously boiled for 2 minutes 
of 2001-11 of pre-hybridization and 21-11 of human Cot-1 DNA solution. The 
reaction incubated at 65°C for 30 minutes. 
A mixture of 11-11 of 110 ng/l-ll probe mix, 11-11 of Cot-1 DNA (1mg/ml, 
Invitrogen), 11-11 Herring sperm DNA (10mg/ml, Invitrogen), 21-11 
PhiX174/Haelll (250I-lg/ml. Invitrogen). 11-11 blocker mix (20mM PZAX and 
PZBX primers). and 21-111 M NaOH was incubated at 37°C for 1 minute to 
denature the DNA molecules, the tube with the mixture was then placed 
on ice and 31-11 of 1 M NaH2P04 was added and mixed. The solution was 
transferred to the tube containing the filters and the hybridization reaction 
was incubated at 65°C overnight. 
4.3.5 Post-hybridization washes 
The hybridization solution was removed after the incubation and replaced 
with 1 ml of solution 1 (1 xSSC, 1 % SDS, pre-warmed and equilibrated 
overnight at 65°C). The tube was inverted several times. The solution was 
replaced again repeating the process. The solution was discarded and the 
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filters from 3-4 Eppendorf tubes were transferred to a 50ml Falcon tube 
(no more than 50 in total). The filters were washed 4 times adding and 
replacing solution 1 and inverting the tube repeatedly. After that 4 
successive washes each one with fresh solution 1 were performed in a 
rotating hybridization oven at 65°C for 3 minutes. The solution from the 
final 3 minute wash was discarded and replaced with solution 2 (0.1 xSSC. 
0.1 % SOS. pre-warmed and equilibrated overnight at 65°C) and the tube 
was inverted repeatedly to mix (quick wash) repeating the process once. 
The solution 2 was replaced again and the tube was placed in a rotating 
hybridization oven at 65°C for 5 minutes (long wash). Series of 2 quick 
washes. 1 long wash. 2 quick washed and finally 2 long washes were 
carried out after that (Figure 4.4A). 
4.3.6 Recovery and peR amplification of the specifically bound 
probes 
Most of the solution 2 was discarded after the last long wash. pouring the 
rest along with the filters in to a Petri dish. From there they were 
transferred to 2 0 0 ~ 1 1 PCR tubes containing 5 0 ~ 1 1 of 1 x PCR buffer. The 
tubes were then heated to 95°C for 5 minutes in a thermal cycler to 
release the probes from the genomic DNA fixed to the filter in to the 1 x 
PCR buffer solution. 
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PCRWITH 
FLUORESCENT 
PRIMERS 
1 
STRINGENT 
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TRACE 
Figure 4.4: A) After hybridization the filters are washed several times with 
stringent solutions to remove probes non-specifically bound to the filter. B) 
The probes are recovered by boiling the filter in 1 X PCR buffer. The solution 
is used in a PCR reaction with fluorescent PZA and PZB. C) Electrophoresis 
and fluorescent detection was carried out in an ABI3100 Genetic Analyzer. 
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11J1 of the probe solution was used in a 20lJI peR reaction with 0.8lJl of 
10IJM FAM labelled PZA primer and 21J1 of 10lJM PZB, 95°C 30 seconds, 
60°C 1 minute, 70°C 1 minute for 25 cycles and an extension of 20 
minutes at 72°C (Figure 4.4B). 
4.3.7 Electrophoresis of fluorescent labelled peR products 
1.5lJl of each one of the PCR reactions was added to 10lJI of the mixture of 
1701J1 of HiDi deionized formamide and 21J1 of ROX 500 size standard 
(both from Applied Biosystems) in 96-well plates that were placed In a 
thermal cycler at 95°C for 3 minutes to denature the DNA duplexes and 
then on ice until ready for the electrophoresis. 
Electrophoresis was carried· out using an ABI3100 Genetic Analyzer 
(Applied Biosystems) using the run module Genescan POP4_30 and the 
analysis module GS500Analysis.gsp (Figure 4.4C). 
4.3.8 Production of a size standard file for MYH6 MAPH 
MAPH traces from 40 control individuals were obtained to assess the 
reliability of the MYH6 probe set and washing conditions. One of them was 
selected to produce a .szs standard size file that allowed automated 
recognition and analysis of the electrophoretic pattems of the samples by 
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the GeneScan software (Applied Biosystems). A custom .gta file for the 
analysis of the .fsa files corresponding to a single sample was produced 
using the Genotyper software (Applied Biosystems). 
Through Genotyper, sample data (size and area of the relevant peaks in 
the electrophoresis traces) were extracted from the .fsa files originated by 
the ABI3100 and processed by GeneScan. A MS-DOS tab delimited table 
file was exported from Genotyper and imported in Microsoft Excel format 
.xls. Each row in this initial Excel table corresponded to an Individual peak 
of an individual sample. The first column (labelled "Category") Indicated 
the relevant probe, the second indicated the name of the relevant .fsa files 
and the third "Label", indicated the area of the relevant peak in arbitrary 
units. 
The macro Rearranger (John Armour) was run through the Excel table in 
order to construct, in a separate "sheet" of the file, a new table with 
columns containing the areas of the peaks from each sample and rows 
showing the areas corresponding to each probe in different samples. A 
sex identifier was manually typed at the top of each column according to 
the gender of the individual tested and probes codes located at the left of 
each probe identifier to distinguish control, test, X and Y linked probes so 
the Maphematica macro could process them accordingly (see Figure 4.5). 
143 
Molecular Genetics of Congenital Heart Disease and Holt-Dram Syndrome 
Figure 4.5: Representative example (22 samples) of data in an Excel table constructed 
by the Rearranger macro.The first row was typed manually with identifiers according to 
the sex of the studied subjects (F, female; M, male). The second row indicates the 
sample number in the particular batch. In the first column a probe code was located 
according the type of the probe in each row (1, control probe; 2, test probe; 3, X-linked, 
control probe; 4, V-linked probe). The second column contains the names of the probes. 
The numbers in the cells show the area of the peaks in arbitrary units as they were 
called by GeneScan. 
Figure 4.6: Excel table constructed by the Maphematica macro. The areas of the peak in 
the first table (Figure 4.5) are replaced by the number resulting from the division of the 
area of each peak by the sum of the areas of the 4 nearest peaks in the same sample 
(relative ratios). The last column is constructed by the means of individual values of 
each row. 
Figure 4.7: Second Excel table constructed by the Maphematica macro. The relative 
ratios of the first Maphematica table (Figure 4.6) are replaced by the result from a 
division of these values by the mean of the relevant row in the same table. The last 
column indicate the standard deviation of all the values in each row. 
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The Maphematica macro (John Armour) was the run in the new table. This 
macro made a new table in the same sheet replacing the values of the 
peak areas for a number resulting from the division of the area of each 
peak by the sum of the areas of the 4 nearest peaks in the same sample. 
The last column was the mean of the values in the entire row see Figure 
4.6). A third table was constructed by the macro, this time replacing the 
values in the cells of the second table with the result of its value divided by 
the mean of the relevant row (normalized ratio). The last column in this 
table contained the standard deviations calculated with the values of the 
normalized ratios of each entire row, corresponding to the same probe in 
different samples (see Figure 4.7). 
Idea"y, the values in this last table represented, In the case of the 
autosomal probes, the normal diploid dosage as 1. In the case of the X-
linked probe the normal female dosage was Ideally represented as 1 and 
the normal male dosage as 0.5 whereas for the Y-linked probe the normal 
female value was 0 and the normal male value 1. 
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4.4 Results 
MAPH electrophoresis traces were obtained from the ABI3100 Genetic 
Analyzer corresponding to 40 DNA samples from control subjects. The 
control probe HEY2 showed an extremely low signal in control individuals 
due to its low GC content (30%), for that reason it was ignored during the 
analysis process. The signal from the X and Y chromosome probes 
displayed expected the variation pattern according to the sex of the control 
individuals (see Figure 4.8). The signals corresponding to probes 22 and 
38 had considerable variation between samples from control subjects. 
This variability correlated strongly with the size of the batch of samples 
processed during the same experiment and it was probably due to the 
repetitive nature of those probes. 
The analysis of the 380 samples from our cohort was performed in 
. batches of variable size. The traces were inspected visually for a gross 
assessment of the quality of the data. The .fsa files generated by the 
ABI3700 Genetic Analyzer were processed, obtaining Maphematica Excel 
tables for each batch. 
For autosomal probes with no potential cross hybridization targets, a 
range between 0.7 and 1.3 was established to consider a normalized ratio 
as "normal". For autosomal probes with one potential cross hybridization 
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target the normal range was established as 0.8 to 1.2. When a particular 
sample showed a normalized ratio outside the relevant ranges, a detailed 
inspection of the electrophoresis trace was carried out and the assay 
repeated in order to confirm the potential copy number variation. 
After the first round of hybridizations and analysis, most of the samples 
showed no probe with signal outside the reference intervals while some 
samples showed just one or few normalized ratios outside the reference 
ranges. Few other samples displayed abnormal normalized ratios in most 
of the probes, probably due to a low quality trace, (see Figure 4.9) and 
some produced a trace that did not allowed analysis by Genotyper 
because of the low intensity signal of the whole trace. New filters were 
prepared, hybridized and processed for those samples with at least one 
potential copy number variation and those with signal not strong enough to 
be analyzed on the first round. A third round of MAPH was required for few 
samples that showed a weak trace in the first round and potential 
abnormality in the second. 
The trace from sample x204 showed an X-linked probe peak compatible 
with two copies, whereas the Y-linked probe peak appeared to indicate 
one copy. As this sample corresponds to a male patient, the finding could 
mean a duplication of ZIC3 (the gene to which the X-linked probe binds) or 
a partial or complete disomy of chromosome (Figure 4.10). 
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Figure 4.8: Two of the electrophoresis traces from control DNA used for the 
assessment of the MYH6 MAPH probe set. The expected variation in Y - and X- linked 
(ZIC3) probes according with sex was observed. The peaks from the HEY2 probe 
were too small for analysis and were ignored. The peak from the non-human (.\) probe 
was not observed, as expected. At least one zero DNA filter (bottom panel) was 
included in the hybridization in every batch as a negative control. 
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As the described profile was confirmed with a new hybridization, a new 
filter was processed along with filters with DNA from the parents using the 
XpYp probe set (provided by John Armour) that contains several probes 
that bind the X chromosome in several places distributed across its length 
including including the pseudoautosomal region 1 (PAR1). The analysis of 
the traces from the MAPH experiments with the XpYp probe set revealed 
that the patient carries an extra copy of the targets for probes in Xp21 
(DMD), Xq25 (ZIC3), Xq28 (2d2) and the pseudoautosomal probe PGPL2. 
The rest of the pseudoautosomal probes showed a dosage similar to the 
control samples, indicating a possible incomplete disomy of chromosome 
X, excluding most of PAR1 (Figure 4.11). A karyotype was recommended 
to the cardiologist in charge of the case to define the structural defect. 
None of the samples that showed a trace suggestive of an autosomal copy 
number variation displayed an abnormal trace when their analysis was 
repeated (see Figures 4.12 and 4.13 for representative examples). 
It was concluded that copy number variation of the MYH6 gene segments 
covered by the probes is not a significant contributor factor for Congenital 
Heart Defect in our patient cohort. 
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Figure 4.9: Representative example of data obtained using the Maphematica Excel 
macro. Columns 1 and 4 show a profile compatible with a female sample (signal 
from Y-linked probe close to zero and X-linked probe signal close to 1). Columns 2, 
3 and 5 displayed male profile (an X-linked probe signal close to 0.5 and a Y-linked 
probe signal close to 1). Column 3 and column 4 additionally showed a signal 
reduction from probe 31 and a signal increase from probe 49 respectively 
compatible with copy number variation of the segment spanned by those probes that 
was not observed in SUbsequent analysis of those samples. Column 5 shows 
several numbers outside the reference interval. Detailed analysis revealed low 
quality data for low overall intensity of the relevant trace. 
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x 
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Figure 4.10: Partial MAPH trace of sample x204 sample showing an X-
linked probe profile suggestive of disomy of chromosome X and normal 
male dosage of the Y-linked probe (XXY). This result was confirmed by 
repetition of the analysis with the same probe set and the XpYp probe set. 
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4.5 Discussion 
The MAPH method was used in our congenital heart disease cohort to 
detect copy number variations of the MYH6 gene. Partial duplications of 
this gene have been reported, in the form of a MYH6/MYH7 hybrid gene 
flanked by normal copies of these two genes in cardiomyopathy patients. 
The complementary rearrangement, a MYH71MYH6 hybrid without normal 
flanking cardiac myosin gene is an obligate product of the non-allelic 
homologous recombination event that originated the cardiomyopathy 
hybrid gene, but such a mutation has not been found. 
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Figure 4.12: Representative examples of three MAPH traces suggestive of 
copy number variation. Samples x229 and x291 showed a relative 
increment and sample x195 a relative decrement of the peaks areas from 
probes P42, P33 and P31 respectively in comparison with control DNA 
traces. None of these variations were confirmed in subsequent MAPH 
assays from the same samples (see Figure 4.13). 
157 
Molecular Genetics of Congenital Heart Disease and Holt-Oram Syndrome 
I 
J J I J i J l j J ~ V ~ U U j v v t v u t ~ \ \ . i l l l ~ J ~ U _ _ Control DNA 
~ ~ ' J J l l , '. 
x291 
x195 
II P42 b ~ ~ ~ ~ ! t I J J i U ~ J J ~ J J ~ ~ ~ x229 
~ I I
Figure 4.13: Subsequent MAPH assays of samples x291 , x195 and x229. 
In the first round of MAPH analysis these samples showed traces 
compatible with copy number variation. As the abnormality in the traces 
failed to appear in two further repetitions of the whole process and in new 
secondary PCR and electrophoresis of the first round recovered probe, it 
was concluded that the first result was an electrophoresis artefact. 
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Although the absence of a MAPH result suggestive of deletion or 
duplication in our patients samples indicate that copy number variation of 
the MYH6 gene is not a main contributor to sporadic CHD, it is important 
to notice that the MYH6 MAPH probe set has some limitations. The high 
similarity between several myosin genes across the genome makes the 
task of designing a probe with no more than one potential cross-
hybridization target very difficult in very well conserved segments. 
MYH6 exons showing high similarity with other exons, in other myosin 
genes were not assayed directly. Instead, when possible, probes were 
designed in neighbouring introns (consider exon 15 or 26 of MYH6 in 
Figure 4.2). If a deletion occurs within any of those exons it can not be 
detected with the MYH6 probe set. 
According to the advice of experienced MAPH users, false positive traces 
like those showed in Figure 4.12, are mostly electrophoresis artefacts and 
tend to occur in samples located in the first columns of a 96-well tray. Two 
of the three traces in the Figure were located in the first two columns of 
the tray during electrophoresis. 
4.5.1 Detection of a case XXV 
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The fact that through the use of the MYH6 probe set was possible to 
detect an XXV patient, indicates that the MYH6 MAPH can allow us to 
distinguish real copy number variation. This variation was seen in three 
different MAPH experiments and verified using an entirely different probe 
set, XpYp, which contains multiple X- , Y-linked and pseudoautosomal 
(PAR1 only) probes. As expected, the signals of the Y- and X-linked 
probes were compatible with an XXV diagnosis; however, most of the 
pseudoautosomal probes revealed a normal profile. This suggests that the 
disomy of X in this patient is not complete and that a fraction (if not all) of 
the genes of the PAR1 region exist in normal dosage. If the genes 
escaping X inactivation are in normal dosage, the risk of the child of 
developing Klinefelter stigmata could be considerably reduced. 
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Chapter 5 THE SEARCH FOR A NEW HOLT-
ORAM GENE 
5.1 Introduction 
A high proportion of Mendelian syndromes affecting the limbs include as a 
feature a cardiac defect (Table 5.1). 
The term heart-hand syndrome is reserved to entities where the main 
features occur in heat and upper limb with relatively minor involvement of 
other structures. 
Holt-Oram syndrome is the more common of the heart-hand syndromes. It 
shows an autosomal dominant pattem of inheritance and it is observed in 
1 on 100,000 live births (Elek et al. 1991). This syndrome was first 
recognized in a 4 generation family with atrial septal defect, arrhythmia, 
various ECG alterations and variable degrees of upper limb abnormality, 
ranging from absent and triphalangeal thumb to radial aplasia and clavicle 
malformation (Holt and Oram 1960). Multiple familial cases were reported 
soon after, showing great phenotypic variability (Holmes 1965; Lewis et al. 
1965b; Zeterqvist 1963). 
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TOP= tetralogy of Pallot, PS= pulmonary stenosis, P AD=persistent arterial duct, 
AS= aortic stenosis, A VSD=atrioventricular septal defect 
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5.1.1 Holt-Oram syndrome 
Secundum atrial and ventricular septal defects are the most common 
cardiac abnormalities, followed by mitral valve prolapse, tetralogy of Fallot, 
aortic stenosis, dextrocardia, pUlmo'nary stenosis, patent ductus 
arteriosus, amongst others. (Newbury-Ecob et al. 1996; Smith et al. 
1979). 
The skeletal abnormalities are the most constant feature of the disease, 
they can range from minor thumb defects to phocomelia and tend to be 
bilateral and more severe in the left upper limb. Thumb abnormalities are 
the most common defects. The thumb can be absent, hypoplastic or 
triphalangeal. Fingers are often short, and can sometimes be absent 
(especially the second and third fingers) if the thumb is also absent. The 
carpal bones can be absent fused or irregular or supemumerary bones 
may exist. Radial hypoplasia and aplasia are not uncommon and are 
accompanied by ulnar hypoplasia. The humerus and clavicles can be 
hypoplastic (Basson et al. 1994a; Newbury-Ecob et al. 1996; Poznanski et 
a!. 1970; Smith et a!. 1979) (Figures 5.1 and 5.2). 
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Figure 5.1: Limb abnormalities in a Holt-Oram 
syndrome patient. Hypoplastic radius and ulna, 
absence of thumb and first metacarpal bone. Figure 
taken from emedecine.com. 
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Figure 5.2: Radiograph of the hands of a patient with Holt-Oram 
syndrome. The distal phalanx of the left thumb is hypoplastic. Ca rpal 
abnormalities are more pronounced in left side and consist of 
deformity with enlargement of scaphoid and trapezium. Source: 
Craig T Sasson, Deborah A McDermott. Cardiovascular Research, 
Greenberg Division of Cardiology, Department of Medicine, Weill 
Medical College of Cornell University. 
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5.1.2 Identification of TBX5 with HOS1 
Linkage studies were conducted in large Holt-Oram families by several 
groups in order to identify the genomic location of the gene responsible for 
Holt-Oram syndrome (HOS1) (Basson et al. 1994b; Bonnet et al. 1994; 
Terrett et al. 1994). They located a critical interval in the long arm of 
chromosome 12q21.3-12q22. 
An affected patient carrying a complex rearrangement of chromosome 12 
was identified (Terrett et al. 1996), with two of the breakpoints within the 
critical interval defined by linkage. This allowed the gene Identification 
efforts to focus in a shorter segment. 
By means of exon trapping, database searching of EST sequences and 
cDNA library screening, two groups independently located the human 
orthologues of mouse Tbx5 and Tbx3 and identified mutations by SSCP in 
the human TBX5 in Holt-Oram patients (Basson et al. 1997; Li et al. 1997). 
5.1.3 Mutations of TBX5 
Several additional mutations (Table 5.2) have been reported by other 
groups (Akrami et al. 2001; Basson et al. 1999; Brassington et al. 2003; 
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Cross et al. 2000a; Fan et al. 2003; Gruenauer-Kloevekorn and Froster 
2003; Heinritz et al. 2005; Reamon-Buettner and Borlak 2004; Yang et al. 
2000). 
It was observed that in a family with a mutation in the N-terminal end of 
the T-Box domain of TBX5 (G80R) the cardiac abnormalities predominate 
over the limb defects and that murine Tbx5 with this mutation failed to 
interact with Nkx2.5 and activate the cardiac specific Nppa gene in COS-7 
transfection experiments. 
In subjects with the R237Q and R237W mutations (C-terminal end of the 
T-box) it was noticed that severe limb defects coexisted with relatively mild 
cardiac abnormalities. The mutant Tbx5 with the former mutation was 
capable to activate Nppa in a level comparable to the wild-type protein in 
the same transfection experiments (Basson et al. 1999; Hirol et al. 2001). 
These observations suggested a genotype-phenotype correlation; 
however, a study taking in to account fourteen different mutations in 17 
families failed to confirm a clear tendency (Brassington et al. 2003). 
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Table 5.2: Mutations of TBX5 
Mutation Type Predicted amino acid change Reference 
100deiG FS A34P-+65X 7 
100-1011nsG FS A34G-+60X 7 
145 C-+A MS Q49K 5 
161 T-+C MS 154T 5 
161 T -+C (somatic) MS 154T 10 
192 G-+A NS W64X 8 
205 G-+T NS E69X 1 
236 C-+ T (somatic) MS A79V 10 
238 G-+A MS G80R 3 
246delGinsM FS R82R-+95X 3 
280deiC FS L94L-+123X 11 
287 C-+ T (somatic) MS P96L 10 
299 A-+G (somatic) MS P96L 10 
305 T -+C (somatic) MS L102P 10 
361 T-+G MS W121G 7 
376-402de127bp IFD del146 (KAEPAMPGR) 8 
400-401insC FS R134P-+182X 7 
400 C-+ T(somatic) MS R134C 10 
408C-+A NS Y136X 9 
416deiC FS P139Q-+149X 5 
420-432de113bp FS D140E-+145X 3 
426-427insC FS D.A143fsX182 7 
431 C-+T(somatic) MS T1441 10 
456deiC FS L 152L-+173X 7 
467-468insA FS Q156Q-+182X 11 
(439-484dup) FS ins162(HWMRQL VSFQKLKL T)-+ 197X 11 
505 G-+A MS G169R 4 
568 G-+T NS E190X 4 
584 G-+C MS G195A 7 
587 C-+A NS S196X 2 
593-5941nsA FS N198K-+208X 2 
668C-+T MS T223M 7 
709C-+T MS R237W 3 
710 G-+A MS R237Q 1 
727deiG FS E243S-+263X 3 
755G-+T MS S2521 4 
781 A-T MS S261C 7 
797 A-+G(somatic) MS K266R 10 
798de1A FS K266K-+393X 7 
805deiT FS S269P-+393X 4 
835 C-+T NS R279X 2 
875 A-+G(somatic) MS Q292R 10 
946G-T NS E316X 4 
1084 C-+T NS Q362X 11 
1159-1160insA FS S387K-486X 2 
del Exons 3-9 LD del(Exon3-9) 6 
In the first column the numbers Indicate the position In sequence Accasslon number U8953. In the third column, 
for frameshift deletions the element to the left of the arrow refers to the first modified residue; the element to the 
right refers to the amino acid position were the aberrant slop codon occurs. Numbers Indicate the position of the 
change In sequence Accession number AAC04619. Ins, Insertion; del, deletion; dup, duplication; FS, frameshift; 
MS, missense; NS, nonsense; IFD, In-frame deletion; LD, large deletion. References: 1 )Basson, Bachlnsky el 
a!. 1997; 2) LI, Newbury-Ecob et al. 1997; 3) Basson, Huang el a!. 1999; Cross, Ching et al. 2000; 5) Yang, Hu 
et al. 2000; 6) Akraml, Winter et al. 2001; 7) Brassington, Sung et a!. 2003; 8) Fan, Duhagon et al. 2003; 9) 
Gruenauer-Kloevekom and Froster 2003; 10) Reamon-Buettner and Borlak 2004; 11) Helnrltz, Moschik et al. 
2005 
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Traditionally, the sensitivity of the molecular testing for TBX5 mutations in 
Holt-Dram patients ranged from 22% to 35% (Brassington et al. 2003; 
Cross et al. 2000b; Heinritz et al. 2005). However, when only patients 
complying with the minimal criteria (Newbury-Ecob et al. 1996), I.e. at least 
one family member with radial ray defect and septal defects (atrial or 
ventricular) or atrioventricular block, are screened, the sensitivity of the 
test exceeds 70% (McDermott et al. 2005; Mori and Bruneau 2004). 
5.1.4 Other loci involved 
The finding of a Holt-Dram patient with a pericentric inversion with a 
breakpoint at chromosome 20q13 (Yang et al. 1990) led two groups to 
find, in Holt-Dram cases, mutations in SALL4, a gene located In that 
region and previously known to cause Dkihiro syndrome, a phenotype that 
can overlap with Holt-Dram syndrome (Brassington et a!. 2003; Kohlhase 
et al. 2003). 
Two deletions of chromosome 14q (Le Meur et a,l. 2005; Turleau et al. 
1984), a large deletion of chromosome 4q (Dckey et al. 1967), and 
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chromosome 5 (Rybak et al. 1971) have been reported in patients with 
heart-hand syndromes resembling Holt-Oram syndrome in variable 
degrees, but no mutations have been found in those intervals. 
5.1.5 Previous analysis of chromosome 12q non-linked families 
When the initial linkage analysis to locate HOS1 (TBX5) was carried out, 
two Holt-Oram, families (HOS15 and HOS32, Figures 5.3 and 5.4) that did 
not show linkage to markers in chromosome 12q, were identified (Terrett 
et al. 1994). DNA samples from individuals of family HOS15 were used to 
perform a genome-wide linkage analysis, in order to locate a second gene 
responsible for Holt-Oram syndrome (HOS2). After an initial, low resolution 
analysis of 400 microsatellites, fine mapping was carried out in five 
candidate regions (Figure 5.5) that showed the highest LOD scores in 
chromosomes 4, 8, 11, 16 and 17 (Ching 2001; Cross 2003). 
The analysis of the haplotypes obtained by genotyplng the microsatellites 
within the candidate intervals revealed that for the regions In 
chromosomes 8, 11, 16 and 17 more than one unaffected Individual In the 
family shared the alleles present In all the affected subjects and therefore 
they needed to be considered as "non-penetrant" cases if each Interval is 
considered to include HOS2. The same happened for just one individual 
for the region in chromosome 4 (Figure 5.3). The mapping efforts were 
focused In the 4q interval, that showed the highest LOD score 1.75. A 
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minimum (from marker 048413 to 0482962) and maximum (0482962 to 
0481595) linkage intervals were defined (Cross 2003). 
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HOS32 
HOS31 
HOS1 
HOS3 
HOS13 
HOS9 
Figure 5.4: Pedigrees of other HOS families not linked to 
chromosome 12q. 
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Figure 5.5: Microsatellite markers used by S. Cross for fine mapping 
of regions with the highest LOD sore obtained during his genome-wide 
linkage analysis . Taken from Cross 2003. 
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Analysis by SSCP was carried out in three genes within or close the 4q 
interval, MADH1, TLL 1 and HAND2, but no mutation was found (Cross 
2003). 
5.2 Aim of the project 
The aims of the project described in this chapter were: a) to reduce the 
maximum linkage interval in the 4q candidate region, b) to systematically 
screen the expression pattern of the genes in the new maximum interval to 
prioritize targets for mutational analysis and c) to find a new Holt-Oram 
syndrome causing gene. 
5.3 Methods 
5.3.1 Physical annotation of the linkage Intervals 
The sequence of the microsatellites used to define the maximum and 
minimum linkage intervals were retrieved from GeneBank at the NCBI 
website. These sequences were used as BLAST queries for comparisons 
against the sequenced human genome (Build 36).The chromosomal 
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localization of the BLAST hits and surrounding genomic features was 
established using the Genome View interface of the BLAST output. 
Microsatellite 04S2952 defines the centromeric limit of the maximum 
linkage interval and its sequence (Accession: Z53372) maps 
approximately to 150,580kb of chromosome 4 (pter-qter) and is located 
within the second last intron of the LOC285423, a genomic alignment 
match to IMAGE clone 5295442. 
04S413 (Accession: Z16837) defines the centromeric end of the minimum 
interval and maps to 158,570kb. It is located between the ionotropic 
glutamate receptor gene (GRIA2) and LOC729937, a computational 
prediction of a transcript by the program GNOMON that resembles and is 
possibly related to the MAST2 gene (microtubule associated 
serine/threonine kinase 2) located in 1 p34.1. 
04S2952 (Accession: Z51120), at the, telomeric end of the minimum 
interval is located between the carboxipeptidase E gene (CPE) and a 
GNOMON prediction (LOC402191), possibly a pseudogene similar to 
nucleolar protein 8. It is approximately located at 166,675kb. 
At the telomeric limit of the maximum interval, 0481595 (Accession: 
Z24146) is located in the second intron of SCRG1 (scrapie responsive 
protein 1) and maps to approximately 174,554kb from the pter end of 
chromosome 4. 
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Knowing the physical location of these microsatellites, it was possible to 
calculate the length of the minimum (8.1 05Mb) and maximum (23.97 4Mb) 
linkage intervals. A list of "gene-related" genomic features in the whole 
maximum interval was made using the Map Viewer interface at the NCBI 
website (Table 5.3), incorporating known genes, alignments of well 
characterized cONA clones, mRNAs and ESTs as well as GNOMON 
predictions. A total of 126 gene related elements were located within the 
maximum interval and 43 within the minimum interval. 
Additional microsatellites were located between the limits of the minimum 
and the maximum interval in order to define a smaller maximum interval to 
reduce the number of candidate genes for expression and eventually 
mutational analysis. 
By the time the analysis of the 4q region was stopped (Section 5.3.5.1), 
one microsatellite (04S1646) had been typed (Figure 5.6). 
Typing of the four microsatellites defining both intervals, plus those to be 
used for reduction of the maximum interval, was planned on subjects 
belonging to families presumably not linked to chromosome 12q but too 
small to be used in a genome-wide analysis. The purpose was to test 
them for consistency with a possible linkage with chromosome 4q. By the 
time the analysis of the 4q region was abandoned (see Section 5.3.5.1), 
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Table 5.3 
Symbol 
D4S2962 
LOC285423 
OCAMKL2 
LRBA 
LOC729558 
MAB21L2 
LOC729566 
LOC649288 
RPS3A 
SNORD73B 
SNOR073A 
SH3D19 
~ ~
LOC729830 
PET112L 
FBXW7 
OKFZP43410714 
LOC391706 
LOC646737 
TMEM154 
TIG04 
ARFIP1 
LOC152667 
LOC729870 
KIM1727 
TRIM2 
ANXA2P1 
MN01 
KlAA0922 
WDR45p 
TLR2 
RNF175 
SFRP2 
DCHS2 
PLRG1 
.Bill 
.BZ8 
.Lilll 
L0C729651 
LRAT 
MGC2701 6 
04S2976 
LOC729902 
~ ~
~ ~
GUCY1A3 
GUCY1B3 
~ ~
.-lIm 
CTSO 
FTHP2 
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Description 
Microsateillte: centromeric end of maximum linkage interval 
hypothetical gene supported by BC031092 
doublecortin and CaM kinase-like 2 
LPS-responsive vesicle trafficking, beach and anchor containing 
hypothetical protein LOC729558 
mab-21-like 2 (C . elegans) 
continues in next page .... 
simi lar to zinc finger and BTB domain containing 8 oPPOsite strand 
similar to Adenylate kinase isoenzyme 4, mitochondrial (ATP-AMP transphosphorytasc) 
ribosomal protein S3A 
small nucleolar RNA, CID box U73B pseudogene 
small nucleolar RNA, C/O box 73A 
SH3 domain protein 01 9 
epidermis-specific serine protease-like protein 
similar to CG3558-PA, isoform A 
PETl12·like (yeast) 
F-box and WD-40 domain protein 7 (archipelago homolog, Drosophi la) 
hypothetical protein OKFZP43410714 
similar to 40S ribosomat protein S3a (V-fos transfonmation effector protein) 
similar to ribosomal protein S14 
transmembrane protein 154 
tigger transposable element derived 4 
ADP-ribosylation factor interacting protein 1 (arfaptin 1) 
NIP30-like 
hypothetical protein LOC729870 
KIM 1727 protein 
tripartite motif-containing 2 
annexin A2 pseudogene 1 
meiotic nuctear divisions 1 homolog (S. cerevisiae) 
KlAA0922 
WDR45 psuedogene 
toll-like receptor 2 
ring finger protein 175 
secreted frizzled·related protein 2 
dachsous 2 (Drosophila) 
pleiotropic regulator 1 (PRL 1 homolog, Arabidopsis) 
fibrinogen beta chain 
fibrinogen alpha chain 
fibrinogen gamma chain 
similar to leci thin retinol acyttransferase (phosphatidylcholine- retlnol O-acyltransrerase) 
lecithin retinol acyltransferase (phosphalidylcholine- retinol O-acyttransrerase) 
hypothetical protein MGC27016 
Microsateliite 
hypothetical protein LOC729902 
neuropeptide Y receptor Y2 
microtubule-associated protein 9 
guanytate cyclase 1, soluble, alpha 3 
guanylate cyclase 1, sotuble, beta 3 
amiloride-sensitive cation channel 5, intestinal 
tryptophan 2,3-dioxygenase 
cathepsin 0 
ferritin , heavy polypeptide pseudogene 2 
simitar to solute carrier family 22 (organic cation transporter), member 4 
hypothetical protein LOC646865 
platetet derived growth factor C 
glycine receptor, beta 
similar to Chromatin accessibility comptex protein 1 (CHRAC-1) 
glutamate receptor, ionotropic, AMPA 2 
Mlcrosatellite centromeric end of minimum linkage Interval 
similar to micrOtubule associated serinelthreonlne kinase 2 
ChromOSOme 4 open reading frame 18 
transmernbrane protein 144 
hypothellcal protein LOCs..S890 
~ 1 ~ i t l 1 i n s u l i n - l i k e e famllv peptlde r ~ p t O r r 1 
hypothetical protein LOC201725 
e i e c t r o n - ~ n s f e r r f n g - n a v o p r o t e l n n dehydrogenase 
peptidylprolyllsomerase 0 (cyclophllin 0) 
hyppthetlcai protein LOC729951 
h thellcal p'roteln FW25371 
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, lOC338095 
RAPGEF2 
~ ~
, LOC729725 
lOC72997l 
lOC92345 
lOC133332 
~ ~
lOC729743 
~ ~
~ ~
FUll184' 
MARCH 1 
lOC646954 
ANP32C 
lOC653794 
LOC646966 
LOC391Z10 
LOC389240 
LOC391711 
~ ' i 1 3 3
lOC646989 
~ ~
I 7 
FLJ38482I 
.JSJJjJ.l 
~ ~
I ~ ~ O O . .
I 
b t t A P H A A ~ ~
~ ~
lOC402191 
LOC646995 
...Iill 
5POCK3 
.AtlMlQ 
FLJ20035 
FLJ31033 
PALLO 
LOC727835 
~ ~
~ ~
.1fill 
~ ~
~ ~
LOC441050 
LOC402192 
MFAP3L 
..MJJAI 
lOC642544 
LOC727891 
~ ~
LOC441052 
GALNT17 
FLJ46681 
~ ~
LOC727929 
~ ~
~ ~
ZRQl 
04S1595 
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proteasome activator subunit 2 pseudogene 
Rap guanine nucleotide exchange factor (GEF) 2 
follistatin-Iike 5 
hypothetical protein LOC729725 
hypothetical protein LOC729971 
hypothetical protein BC008207 
mitochondrial ribosomal protein 55 pseudogene 
neuropeptide Y receptor Yl 
similar to neuropeptide Y receptor Y1 
neuropeptide Y receptor Y5 
transketolase-like 2 
hypothetical protein FLJ 11184 
• membrane-associated ring finger (C3HC4) 1 
similar to 14-3-3 protein theta (14·3·3 protein tau) (14-3·3 protein T-cell) (HSl protein) 
acidic (Ieucine-rich)'nuclear phosphoproteln 32 family, member C 
similar to ring finger protein 129 
similar to 60S ribosomal protein L26 
• similar to ring finger protein 129 
. similar-to nascent polypeptlde·associated complex alpha polypeptide 
hYpOthetlCaI L()C391711 
tripartite motlf-containing 61 
hypothetical protein FLJ31659 
similar to ring finger protein 129 
similar to ring finger protein 129 
tripartite mOtif-contalnlng 60 
tripartite motif-containlng 75 
hypothetical protein FW38482 
kelch·like 2, Mayven (Drosophila) 
glycerol kinase pseudogene 3 
sterol·C4·methyl oxidase-like 
carboxypeptidase E 
microRNA578 
{pseudogene) hydroxyacyl-Coenzyme A dehydrogenase 
Mlcrosatelhte telomenc end of minimum entlcal Interval 
simi lar to nucleolar protein 8 
similar to Tripartite motif protein 38 (RING finger protein 15) (Zinc finger protein RoRet) 
tolloid-like 1 
sparclosteonectin , CoNev and kazal·like domains proteoglycan (tastican) 3 
annexin Al0 
hypothetical protein FLJ20035 
hypothetical protein FLJ31 033 
palladin, cyloskeletal associated protein 
similar to 60S ribosomal protein L9 
carbonyl reductase 4 
SH3 domain containing ring finger 1 
NIMA (never in mitosis gene a)-related kinase 1 
chloride channel 3 
chromosome 4 open reading frame 27 
similar to unactive progesterone receptor, 23 kD 
similar to Methylosome subunit plCln 
microfibrillar-associated protein 3-like 
aminoadipate aminotransferase 
hypothetical protein LOC642544 
similar to Heat shock protein HSP 90-alpha (HSP 86) (NY-REN-38 antigen) 
Mlcrosatelhte 
hypothetical gene supported by AF131741 
polypeptide N-acetylgalactosaminyltransferase 17 
hypothetical protein LOC642586 
UOP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosamlnyltransferase 7 
hypothetical protein LOC727929 
high·mobility group box 2 
Sin3A-associated protein, 30kDa 
scrapie responsive protein 1 
Mlcrosatelhte telomenc end of maximum linkage Interval 
Table 5.3: Gene-related features in the maximum and minimum 
linkage interval of chromosome 4q. The minimum Interval Is hlghlated 
in grey and the microsatellites in black. 
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-
-(D)4,4 2,3 2,4 3,4 3,4 1,3 1,4 1,4 3,4 2,3 2.4 4,4 3,4 2,4 2,4 3,4 
Figure 5.6: Fluorescent gel electrophoresis used for genotyping of the 
0451646 marker in subjects from family HOS15 in an attempt to reduce 
the length of the maximum linkage interval defined for chromosome 4q . 
Most of the meioses are uninformative for this marker as the deduced 
genotype of the affected founder (deceased) is 4,4. 
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typing of marker 04S2962 was done in those subjects and it is shown in 
Figure 5.7. 
5.3.2 Identification of cDNA clones for expression analysis. 
In order to assess if the expression pattern of the elements in the linkage 
interval resemble the expression pattern of Tbx5 during embryonic 
development, BLAST comparisons were made between each of the gene-
related features in the minimum interval against mouse ESTs using the 
known or predicted sequence of the relevant transcript as a query. The 
ESTs with the longest BLAST hit were selected. Expression analysis of 
the elements in the maximum interval would depend on its reduction by 
means of further micro satellite typing. Until the efforts in the 4q region 
were suspended (see Section 5.3.5.1), the idea was to use the mouse 
eDNA clones corresponding to the identified ESTs to make radioactive 
probes to be employed in Northern blot experiments. 
The relevant IMAGE clones were requested to the MRC Geneservice 
(Cambridge, UK). On arrival, agar Petri dishes with the appropriate 
antibiotic were inoculated with material from the culture received, to obtain 
isolated colonies after overnight incubation at 37°C. Overnight broth 
antibiotic supplemented cultures were inoculated with material of the 
single colonies and located in an orbital incubator at 37°C, 200rpm. 
Minipreparations of plasmid DNA were made from the broth culture using 
the Qiagen Miniprep kit according to manufacturer's indications. Purified 
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HOS1 T HOS3 HOS9 HOS13 ~ ~ ~ ~~ ~ ~ ~ ~
3 3 3 3 4 1 1 4 3 4 3 4 3 3 1 3 4 ) 1 10 1 4 4 5 5 ) I 
44455444444 55 45 444 4 4444 1 444 
Figure 5.7: Radioactive polyacrilamyde gel electrophoresis used for 
genotyping of the 04S2962 marker in subjects from five families that showed 
no linkage with chromosome 12q in order to test for consistency with linkage 
to chromosome 4q. The allele calling is shown in the inferior two rows of 
numbers. Families HOS13 and HOS31are consistent with linkage between 
the disease and the marker. HOS1, HOS9 and HOS32 appear to be non-
consistent with linkage and HOS3 is not informative for this marker. 
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plasmid DNA was used in double or single endonuclease restriction 
digestions with the appropriate enzymes (Table 5.4) in order to release the 
insert from the plasmid. A representative selection of agarose gel 
electrophoresis of the restriction digestion reactions is shown in Figure 
5.B. 
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Table 5.4. cDNA clones for gene expression analysis 
ELEMENT IMAGE 10 DIGESTION WITH 
AD021 3026048 Notl EcoRI 
GRIA2 6516365 Not! EcoRV 
FLJ35882 1550743 Not! EcoRI 
LOC285505 3664790 Xholl EcoRI 
KLHL2 3987559 Notl Sail 
LOC285504 6056308 Notl Sail 
FLJ34659 752523 Notl EcoRI 
FLJ11155 3593194 Sail Notl 
LGR7 6051251 Not! Sail 
LOC201725 6309627 Notl EcoRV 
ETFDH 6442431 Notl Sail 
PPID 6507446 Notl EcoRV 
KlAA1450 555113 Sail Notl 
LOC152940 6369005 Xholl EcoRI 
LOC152941 3025655 Notl EcoRI 
PDZ-GEF1 5699825 Notl EcoRI 
DKFZp566D234 6390044 Notl EcoRV 
LOC92345 6489898 Sail Notl 
LOC133332 5146817 Notl EcoRI 
NPY1R 6490858 Notl Sail 
NPY5R 461223 Sfil sm 
DKFZP434L 1717 5165431 PCR used to produce Insert DNA 
FLJ11184 5120919 Notl EcoRI 
FLJ20668 3812896 Sail Not! 
LOC132689 2398278 Not! EcoRI 
LOC152682 4936600 Not! Sail 
LOC166655 777988 Sail Mlul 
LOC201931 5328056 Sail Not! 
SC4MOL 6336341 Not I EcoRV 
CPE 5707928 Notl EcoRI 
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A 
B 
Figure 5.8: Representative agarose gel electrophoresis of IMAGE 
clones endonuclease restriction digestions performed to release the 
inserts. Each pair of contiguous lanes shows, to the left, undigested 
miniprep; to the right, a superior band of linearized vector and an 
inferior band, the released insert. Insert DNA was purified from excised 
agarose blocks containing the inferior bands. 
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5.3.3 RNA preparation 
RNA to be used in the Northern blot experiments was prepared as follows: 
Total RNA was purified from forelimb, hindlimb and heart from 11.5dpc 
mouse embryos. The concentration and purity of the RNA was assessed 
in a Nanodrop spectrophotometer and agarose gel electrophoresis (Figure 
5.9A). As an internal control for RNA quality, RT-PCR was carried out 
using oligo-dT for cDNA synthesis and mouse Tbx5 specific PCR primers 
(provided by Liz Packham). Amplification occurred as expected in RNA 
samples of all three tissues (Figure 5.9B). 
5.3.4 Northern blot 
The conditions and reagents to be used in the Northern blot were tested to 
ensure a rational use of the RNA extracted from mouse embryos. For that 
purpose, a riboprobe (provided by Thelma Robinson) produced using T7 
RNA polymerase and a cDNA Tbx5 clone with the T7 phage promoter, 
was loaded in different concentrations in an agarose gel. The RNA was 
transferred and fixed to a nylon membrane and a Northern hybridization 
using probes generated with the same cDNA clone by the random priming 
method was carried out (Figure 5.10). 
5.3.5 Study in 16q region 
186 
Molecular Genetics of Congenital Heart Disease and Holt-Oram Syndrome 
1 2 3 4 
A 
1 2 345 
B 
Figure 5.9: Agarose gel electrophoresis of A) RNA preparations 
from 11.5 dpc mouse embryo 1 )heart, 2)whole, 3)forelimb 
4)hindlimb; B) RT-PCR using mouse Tbx5 primers on RNA from 
1 )heart, 2)hindlimb, 3)negative control and 5)Plasmid DNA used 
as a positive control. 
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A 
Figure 5.10: Northern blot hybridization experiment designed to test 
the conditions and reagents to be used in the expression analysis 
with RNA extracted from heart and limb mouse tissue in order to 
ensure its rational use. A) Agarose gel electrophoresis of different 
amounts of riboprobe synthesized with a mouse Tbx5 cDNA clone. 
A RNA size marker was loaded in the leftmost lane. B) 
Autoradiography of the filter after the hybridization. The radioactive 
probe was produced by random priming of the same clone used to 
synthesize the riboprobe. 
188 
Molecular Genetics of Congenital Heart Disease and Holt-Oram Syndrome 
5.3.5.1 Clinical re-classification of patient 9/318 
The work in region 4q was suspended when we learned that a member of 
the HOS15 family that was previously classified as not affected (9/318) 
showed minimal manifestations of the disease and was re-classified as 
affected. 
As this patient showed two haplotypes in the 4q region not shared by any 
other affected subject, the assumption that the H052 locus is located 
within that interval is not compatible with the modification of the clinical 
data (see Figure 5.3). 
As subject 9/318 was one of the cases labelled as "non-penetrant" 
assuming that the interval on chromosome 16 contains H052, the change 
in the clinical status classification reduced the number of non-penetrant 
cases to two, and according with an alternative interpretation (see below) 
to one (Figure 5.11). For that reason, further efforts were directed towards 
the region on chromosome 16. 
5.3.5.2 Linkage intervals in the 16q region 
The maximum interval was established using the method employed for the 
4q region. Its centromeric limit was defined by the marker 01653136, 
located at 49,260Kb from 16pter, centromeric to the selectin ligand 
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Figure 5.11 : Haplotypes of markers in the HOS2 candidate reg ion 16q. The haplotypes of the 
affected founder are derived. The "affected haplotype" is shown in blue. The arrow points to 
subject 9/318. Modified from Cross 2003. 
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interactor cytoplasmic-1 gene (SLlC1). The telomeric end of the maximum 
interval was defined by 01653049, at 77,480kb, between LOC645957 and 
LOC729251. 
The minimum interval was defined at the centromeric end by 01653057, 
located at 56,087kb between the gene of the docking protein 4 (DOK4) 
and the coiled-coil domain containing 102A protein gene (CCDC102A). 
The telomeric limit was defined by 0165515, located in the intron 12 of the 
contactin associated protein-like 4 gene (CNTNAP4), at 75,070kb. 
The length of the maximum interval was calculated as 28.220Mb, 
spanning most of the long arm of chromosome 16 and containing 297 
gene related elements. The length of the minimum interval was calculated 
as 18.989Mb and comprises 214 elements. 
Given the number of candidate genes in the minimum interval, it was 
considered impractical to adopt a screening strategy similar to that 
planned for the interval in chromosome 4q. 
However, according to an alternative interpretation of the microsatellite 
typing data, a smaller candidate region could be defined between markers 
01653136 and 01653057. Non-affected subject KP showed, in the 
chromosome inherited from her affected father an "affected haplotype" 
(shared by all affected subjects), corresponding to 01653136 and the two 
markers centromeric to it, whereas the equally unaffected subject 9/297 
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. showed in the paternal chromosome the affected haplotype in 01653057 
and seven markers telomeric to it (Figure 5.11). This suggests that a 
segment between 01653136 and 01653057 was the only part of the 
original affected paternal chromosome that was not transmitted to any of 
the two unaffected children and therefore liable to contain a hypothetical 
HOS2locus. 
This interpretation could also account for the unaffected status of subjects 
9/296, 9/303, 9/297, 9/298, and 9/300 and the reclassification of 9/318 as 
affected, but not for subject 9/299, who being unaffected shows 016S3136 
and D1653057 alleles shared by all affected subjects. This patient could 
be considered as an example of non-penetrance if this interpretation is 
assumed as correct. 
The chromosomal segment between 01653136 and 016S3057 is 
6.827Mb long and contains 74 gene-related elements. Amongst them, four 
were considered as good H052 candidates: IRX3, IRX5, IRX6 and SALL 1 
(Table 5.5). 
5.3.5.3 The Iroquois B cluster 
The Iroquois (Irx) genes were first discovered in Drosophila (araucan, 
caupolican and mirror), within a cluster In chromosome 3L (Gomez-
5karmeta et al. 1996). In mammals, an ancestral duplication event 
produced two very similar IRX clusters. In humans, the IrxA cluster is 
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Table 5.5 continues in next page .. 
016S3136 Mlcrosatelhte 
SLlC1 
CARD1 5 
CYLD 
LOC727992 
LOC643533 
LOC728654 
LOC643560 
~ L L L > >
UNGP1 
LOC642659 
LOC388276 
TNRC9 
LOC643714 
LOC146253 
LOC390730 
CHD9 
LOC643802 
RBL2 
FTS 
KlAA1005 
FTO 
selectin ligand interactor cytoplasmic-1 
caspase recruitment domain family, member 15 
cylindromatosis (turban tumor syndrome) 
hypothetical protein LOC727992 
hypothetical protein LOC643533 
hypothetical protein LOC728654 
similar to Superoxide dismutase 
uracil-DNA glycosylase pseudogene 1 
heterogeneous nuclear ribonucleoprotein A 1 pseudogene 
hypothetical LOC388276 
trinucleotide repeat containing 9 
hypothetical protein LOC643714 
tropomyosin-like 
similar to prohibitin 
chromodomain helicase DNA binding protein 9 
similar to M-phase phosphoprotein 10 
retinoblastoma-like 2 (p130) 
fused toes homolog (mouse) 
KlAA1005 protein 
........ - . , ~ . , - -
MMP2 
AYTL1 
CAPNS2 
SLC6A2 
LOC390732 
CES4 
~ ~
CES7 
GNA01 
AMFR 
NUDT21 
OGF001 
BBS2 
MT4 
hypothetical gene supported by AF275804 
u' uols homeobox r1roteln 5 
similar to Iroquois homeobox protein 6 
Ir uols homeobox J)rotein 6 
matrix metallopeptidase 2 (gelatinase A, 72kOa gelaUnase, 72kDa type IV collagenase ) 
acyltransferase like 1 
calpain, small subunit 2 
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 
similar to carboxylesterase 1 Isoform c precursor 
carboxylesterase 4-like 
carboxylesterase 1 (monocyte/macrophage serine esterase 1) 
carboxylesterase 7 
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide 0 
autocrlne motility factor receptor 
nudix (nucleoside diphosphate linked moiety Xl-type motif 21 
2-oxoglutarate and iron-dependent oxygenase domain containing 1 
Bardet-Biedl syndrome 2 
metallothloneln IV 
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MT3 
MT2A 
MT1L 
MT1E 
MT1M 
MT1JP 
MT1A 
MTM 
MT1B 
MT1F 
MT1G 
LOC727730 
MT1H 
MT1X 
NUP93 
MIRN138-2 
SLC12A3 
HERPUD1 
CETP 
NOD27 
CPNE2 
NIP3Q 
RSPRY1 
ARL2BP 
PLLP 
CCL22 
CX3CL1 
CCL17 
CIAPIN1 
C009 
POLR2C 
DOK4 
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metailothionein 3 (growth inhibitory factor (neurotrophic» 
metallothionein 2A 
metallothionein 1 L (pseudogene) 
metaliothionein 1 E (functional) 
metaliothionein 1 M 
metaliothionein 1 J (pseudogene) 
metaliothionein 1 A (functional) 
metaliothionein M 
metaliothionein 1 B (functional) 
metaliothionein 1 F (functional) 
metaliothionein 1 G 
similar to metaliothionein 1 H-like protein 
metaliothionein 1 H 
metaliothionein 1X 
nucleoporin 93kDa 
microRNA 138-2 
solute carrier family 12 (sodium/chloride transporters), member 3 
homocysteine-inducible, endoplasmic reticulum stress-Inducible, ublquitin-Iike domain member 1 
cholesteryl ester transfer protein, plasma 
nucleotide-binding oligomerization domains 27 
copine II 
NEFA-interacting nuclear protein NIP30 
ring finger and SPRY domain containing 1 
ADP-ribosylalion factor-like 2 binding protein 
plasma membrane proteolipid (plasmolipin ) 
chemokine (C-C motif) ligand 22 
chemokine (C-X3-C motif) ligand 1 
chemokine (C-C motif) ligand 17 
cytokine induced apoptosis inhibitor 1 
coenzyme 09 homolog (S. cerevisiae) 
polymerase (RNA) II (DNA directed) polypeptide C, 33kDa 
docking protein 4 
D16S3057 Mlcrosatelhte 
Table 5.5: Gene-related features In the region of chromosome 16Q, 
between microsatelites 016S3136 and 01653057. Genes screened 
for mutations in Family HOS15 are highlighted In grey. 
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located in chromosome 5p15 and includes the genes IRX1, IRX2 and 
IRX4, whereas cluster B in chromosome 16q12 comprises IRX3, IRX6 and 
IRX6 (Ogura et al. 2001), all three included in the mutational analysis. 
Additionally, the developmentally expressed mohawk homeobox gene 
(MKX) highly related to IRX3, has been mapped to 1 Op12 (Anderson et al. 
2006). 
Interest in the genes of the Iroquois cluster B as potential HOS2 
candidates was based in several observations. First, all three genes are 
highly expressed in the developing heart (Christoffels et al. 2000b; 
Mummenhoff et al. 2001). Second, a mouse deletion of the entire Iroquois 
B and the genes Fto and Fta, the mutation Fused toes (Ft), generated by 
transgenic insertional mutagenesis (van der Hoeven et al. 1994) produces, 
in the heterozygous animal, alterations of forelimb but not of the hindlimb, 
whereas the null embryos show other defects and die owing to heart 
malformations (Peters et al. 2002). Third, In a comparative gene 
expression analysis between mouse forelimb and hindlimb mouse tissues 
using serial analysis of gene expression (SAGE), expression of Irx3 was 
observed in forelimb but not in hindlimb (Margulies et al. 2001). Fourth, a 
case of a human deletion 16q11.2-16q21, spanning, amongst other genes, 
SALL 1 (the gene mutated in lownes-Brocks syndrome, rrBS]) and the 
whole Iroquois B cluster, showed abnormalities typically associated with 
lBS plus radial aplasia (never found in patients with SALL 1 mutation), 
complex congenital heart defect and other malformations (Knoblauch et al. 
2000). 
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5.3.5.4 SALL1 
As mentioned above, mutations in SALL 1 cause Townes-Brocks 
syndrome (Kohlhase et al. 1998). This is an autosomal dominant disorder, 
typically characterized by malformations of the anus, hands, ears, 
sensorineural deafness, renal and genitourinary anomalies (Reid and 
Turner 1976; Townes and Brocks 1972). Foot defects, scolioSiS, extra ribs, 
palsy of sixth and seventh cranial nerves and mental retardation have 
been also reported (Surka et al. 2001) and congenital heart defects are 
relatively rare (Monteiro de Pina-Neto 1984; Walpole and Hockey 1982). 
There is some phenotypic overlap with VATER (vertebral defects, anal 
atresia, tracheoesophageal fistula with esophageal atresia, and radial 
dysplasia) and VACTERL (with the addition of cardiac and limb 
abnormalities), two mostly sporadic associations that can be distinguished 
from TBS by the tracheal and oesophageal findings (Khoury et al. 1983). 
SALL 1 was included in the mutational analysis as phenotypic overlap 
occurs between Townes-Brocks and Holt-Oram syndromes. A sporadic 
case of a patient thought to have Holt-Oram syndrome showed absence of 
right thumb, aplasia of right radius, angulation of the right ulna, a lower 
dorsal hemivertebra, ventricular septal defect, duodenal atresia and 
rectovaginal fistula (Silver et al. 1972). The visceral abnormalities are not 
compatible with Holt-Oram syndrome and the right upper limb is more 
affected than the left; radial aplasia Is not a feature of Townes-Brocks, and 
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the absence of tracheal or esophageal abnormalities is not compatible 
with VATER or VACTERL associations. 
5.3.6 Mutational analysis 
Four genes were screened in DNA samples of subjects from the HOS 15 
family: IRX3 (four exons), IRX5 (three exons), IRX6 (six exons) and SALL 1 
(three exons). In order to cover the all the coding regions of the genes, 26 
amplicons were designed as described in Chapter 3 for the MYH6 gene. 
In most cases each exon and adjacent splicing regulatory regions were 
spanned by one amplicon. In the case of large exons (exons 1 and 2 In 
IRX3, exons 2 in IRX5, exons 1 and 5 in IRX6, and exon 3 in SALL 1) two 
or more overlapping amplicons were designed to cover it completely. An 
exceptionally large exon (SALL 1, exon 2) of 3.4kb was amplified In a long-
PCR assay (amplicon 3.8kb) and subsequently sequenced using primers 
located approximately each 500 base pairs, as its size Is not suitable for 
dHPLC analysis (Figures 5.12-5.15). 
A pair of PCR primers was designed per amplicon (see Tables 5.6-5.9). 
The amplicons were screened for mutations either by direct sequence or 
dHPLC as described in Chapter 3. Because of their unusual GC content 
percentages (up to 80% for some regions exonic regions of IRX3, IRX5, 
and SALL 1), several amplicons were impossible to amplify using 
conventional peR methods. In these cases, amplification was achieved by 
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Figure 5.12: Scaled schematic representation of IRX3 in 16q12.2. The orientation of 
the gene is telomeric to centromeric as indicated by the black arrow and here Is 
drawn in its actual direction in the chromosome. The solid blue boxes represent the 
coding sequence of the exons. while empty blue boxes represent untranslated 
regions of the exons. The red lines indicate peR amplicons used for the mutational 
analysis of the gene. The ruler indicate the distance in base-pairs from the telomere 
of the short arm of the chromosome. 
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Figure 5.13: Scaled schematic representation of IRX5 in 16q12.2. The orientation 
of the gene is centromeric to telomeric as indicated by the black arrow and here is 
drawn in its actual direction in the chromosome. The solid blue boxes represent the 
coding sequence of the exons, while empty blue boxes represent untranslated 
regions of the exons. The red lines indicate peR amplicons used for the mutational 
analysis of the gene. The ruler indicate the distance in base-pairs from the 
telomere of the short arm of the chromosome. 
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53915K 
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t-----IRX6E6 
IRX6 ' 
Figure 5.14: Scaled schematic representation of IRX6 in 16q12.2. The orientation of the 
gene is centromeric to telomeric as indicated by the black arrow and here is drawn In Its 
actual direction in the chromosome. The solid blue boxes represent the coding sequence 
of the exons, while empty blue boxes represent untranslated regions of the exons. The red 
lines indicate peR amplicons used for the mutational analysis of the gene. The ruler 
indicate the distance in kilobases from the telomere of the short arm of the chromosome. 
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SALL 1E3b 4<i1728K I } EXON 3 SALL 1E3a I 4<i172<i1K 
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4'373SK 
4 '3736K 
. <a737K 
SALL1 
41l738K 
4 1l739K 
4<a74 OK 
4 '3741K 
4 <i1742K 
SALL 1E1 ==-- EXON 1 4 <a74 3K 
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Figure 5.15: Scaled schematic representation of SALL 1 in 16q12.1. The orientation of tho 
gene is telomeric to centromeric as indicated by the black arrow and here is drawn in its 
actual direction in the chromosome. The solid blue boxes represent the coding sequence 
of the exons, while empty blue boxes represent untranslated regions of the exons. The red 
lines indicate peR amplicons used for the mutational analysis of the gene. The ruler 
indicate the distance in kilo bases from the telomere of the short arm of the chromosome. 
The large exon 2 was analyzed as a single long-PeR, and sequenced using six Intemal 
primers and a smaller, nested peR amplification. 
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addition of DMSO as well as the proprietary reagent GC-melt (SO 
Biosciences) to the PCR reaction. PCR products obtained by this method 
could not be processed by dHPLC as proper absorption and elution of the 
mixture by the chromatography column is prevented by these compounds. 
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Table 5.6: Primers used for mutational analysis 
of IRX3 
Primer Sequence 
E1AF tggaaaggtcgcggggagtatcg 
E1AR cggggcacggacggagagg 
E1BF ccgccgcggagcagatcaatagg 
E1BR tcctggcctgcacccctctagtcc 
Exon2-1F atcttcccgcagctggtaagagccc 
Exon2-1R cgctcccataagcgtttccctcctc 
Exon2-2F agcaccgcaagaacccctaccccacc 
Exon2-2R cctctaagccctcagagctatcttc 
IRX3short2-3F cggccaccgagcctgagctgtcc 
I RX3short2-3R gaccgctgcccccggtggagacc 
X1F atctggtccctcgcggagactg 
X1R gcagaaagcaggagtggagagg 
IRX3E3F tctccactcctgctttctgc 
IRX3E3R ctcggcgtcctctccttt 
I RX3E4F cgatcggccccaatccaagtagg 
IRX3E4R actcggtcccgattcgtctctcg 
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Table 5.7: Primers used for mutational analysis 
of/RX5 
Primer Sequence 
IRX5EOF gcaaaggcaaaagcagagc 
IRX5EOR aatcgcccaagtttgaagg 
IRX51F cccgtaggaagctggagtg 
IRX5E2F ggcgggagtaaaaaggaaaa 
IRX51R ctccaggcctctcttttcct 
IRX5E2BF ggccctcggttatccatt 
IRX5E2AR atggagagccctcdttcc 
IRX5UTR2F cctatgaattgaagaaaggtatgtcc 
IRX52R ctgccaaggccatgttttta 
IRX5UTR2R tctgtggaacctttcaatcc 
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Table 5.8: Primers used for mutational analysis 
of IRX6 
Primer Sequence 
IRX6PromoF aaattggaggttccatgtctcg 
IRX6E1aF agagaagctccaaggtcaagg 
IRX6PromoR gtaaagtttgttcacgccacagg 
IRX6E1bF gaggcgtttctcctacttctcc 
IRX6E1aR ctcacccacactcacacttgc 
IRX6E1bR acaagaggaggatgatcagagg 
IRX6E2F ggtctctaaggccaccttctagc 
IRX6E2R ctggatttcacctgtctctactgc 
IRX6E3F ttgaaccagacccttagctacca 
IRX6E4F gactggcactgtgagtctttcc 
IRX63R ccttgagtgtactggtggtctcc 
IRX6E4R ggaccttccagaaaatctaccc 
IRX6E5aF agaaattctttcccaaggacagg 
IRX6E5bF ctgaagacgaggaggtagtgg 
IRX6E5aR gaagggtcattgaaggagaagc 
IRX6E5bR gagcgctgtaaagcaatctcc 
IRX6E6F cttgccttcagaagagcatgg 
IRX6E6R ccagctactaaaggaactgagg 
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Table 5.9: Primers used for mutational analysis 
ofSALL1 
Primer Sequence 
SALL1E1F caaatcacgaactaattgattaagg 
SALL1E1R attacgccgagtggaagaagc 
SALL1E2F catcatgcaccaatgtctcc 
SALL1EgapF gttcacgaacgctgtggtc 
SALL1EgapR gccacaaatgtcacaagcag 
SALL1E2R atctgggctgatgactctgg 
SALL1E3aF gaatagacatttaggccacttgc 
SALL1E3bF ctatggtggcctcctactcc 
SALL1E3aR tttgcaaagcaaggttatatcg 
SALL1E3bR tgttacgtctcagtttcaactacc 
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In the case of amplicons that did not required extra reagents, the 
sequence of each individual amplicon was analyzed using the Navigator 
program, part of the dHPLC Wave system software (Transgenomic) in 
order to calculate the optimum temperatures for mutation detection. 
dHPLC was carried out using the WAVE System (Transgenomlc), as 
described in Chapter 3. 
5.3.7 Results of mutational analysis 
Good quality dHPLC traces were obtained for all the amplicons that did 
not require the addition of DMSO or GC-Melt for PCR amplification. No 
sequence variants segregating with the disease were detected. Some 
representative traces are shown in Figures 5.16 and 5.17. 
Good quality sequence data were obtained for all GC-rich ampllcons and 
the 3.8Kb SALL 1 exon 2 PCR amplicon. 
A three base pair deletion was detected with exon 2 of the SALL 1 gene 
(Figure 5.18). This was an in-frame deletion of a serine codon in the 164 
position. This variant was not considered relevant for the phenotype as it 
has been reported as a polymorphism (Kohlhase 2000) and does not 
segregate with the disease in the HOS15 family. 
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Figure 5.16: Two representative examples of dHPLC traces obtained 
during the mutational analysis of the selected candidate genes in the 
16q region . A) IRX3 exon 4; 8) IRX5 exon 1. 
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Figure 5.17: Two representative examples of dHPLC traces obtained 
during the mutational analysis of the selected candidate genes in the 
16q region. A) IRX 6 exon 4; 8) SALL 1 exon 3, amplicon a. 
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TGTCCTGGCC CCTTTTCTAA TCCTGCACCT TTTTGACATT TGTAGCAGAC ACAGAAAAGC 
~ ~
G D T E K 
GTCAACCGAG TCGCCCTACT AAGAGCAAGG ATGCCCACGT CTGTCCCCGC TGCTGTCCCC 
~ ~
G Q P S R P T K S K D A H V C G R C C A 
AGTTCTTTGA ATTATCAGAT CTTCTGCTCC ACAAGAAGAA CTGTACTAAA AATCAATTnc 
~ ~
E F F E L S D L L L H K K H C T K N Q L 
TTTTAATCGT AAATGAAAAT CCAGCCTCCC CACCCCAAAC CTTCTCCCCC ACCCCCCCTf 
V L I V N E N P C S P PET F S P S P P 
CTGATAATCC TGATGAACAA ATGAATGACA CAGTTAACAA AACAGATCAA CTCCACTCCr 
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GCCACCTTTC AGAACACAAC CCACTTGACA GCGAAGACTC CATGGACCTC CACCCCCCGG 
S D L S E H N G L D R E E S M EV E A P 
• 
; 
TTCCTAACAA AAGCCGCAGC CGCACTTCCA CCCGCACCCA CACCACTACC eCCCCA eCA ; 
v A H K S C S C T s S C S H SST A P S 
GCAGCAGCAG CAGCAGCAGC AGe ACc GeG GCGGCCGCAG CTCCTCCACA CCTACCTCOP 
-S S S S S S S S ...§... C C C C S S S T e T s 
CGATCACAAC CTCTCTACCT CAACTCGGGG ACCTCACAAC ACTCGGCAAC TTCTCCCTAf 
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----..... AFe21116 Un ISTS:53632 
TCAACAGCAA CGTCATCATC GAGAACCTCC AGAGCACCAA GGTGCcceTG GC C TTCT ; 
V I E N L Q S T K V A V A Q F 
Figure 5.18: In-frame three base pair deletion found in subjects from the 
HOS15 family corresponding the exon 2 of SALL1. The product of this 
variant allele lacks of one of a long tract of serine residues. This variant 
has been described as a benign polymorphism and does not segregate 
with the disease. A) Electropherogram showing the position of the 
deletion (reverse and complement trace); 8)The deletion in its annotated 
sequence context. 
". 
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No other coding variant was identified in the remaining direct sequence 
screened peR amplicons. 
A control probe included in the MYH6 MAPH probe set (Chapter 4) is 
specific for a short segment of the IRX3 gene. The second objective of this 
probe was to detect complete deletions of IRX3 when DNA samples from 
family HOS15 individuals were processed with the MYH6 MAPH probe 
set. This of course was not intended as a comprehensive IRX3 deletion 
detection strategy but if positive it could provide important information. The 
HOS 15 samples showed a normal MAPH trace. 
5.4 Discussion 
Holt-Oram syndrome is a genetically heterogeneous entity. Mutations in 
TBX5 and SALL4 have been found in sporadic and familial cases. Some 
affected families do not show linkage to any of them. In one such family 
(HOS 15). a previous genome-wide linked analysis identified a candidate 
region in chromosome 4q. 
It has been estimated that a LOD score higher than 3 can be used as 
evidence of linkage it two point mapping with a 5% chance of error 
(Morton 1955). whereas a threshold of 3.3 can be used for genome-wide 
linkage analysis (Lander and Schork 1994). 
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Although according to simulations with the program SLINK (Ott 1976), was 
estimated that, given the size of family HOS 15, the maximum LOO score 
obtainable by linkage would be of 2.25, and that the highest actual LOD 
score obtained during the fine mapping stage was 1.75 for the 04S3046 
marker (Cross 2003), it was considered that the available data should at 
least allow meaningful haplotype analysis to define candidate regions 
(probably large) with an acceptable degree of confidence. It was as well 
considered that the complexities of a large number of candidate genes 
could be overcome with an efficient gene expression screening as we are 
dealing with a purely developmental trait. 
This chapter summarizes further efforts done to screen the genes located 
within the 4q linkage interval and subsequently another interval in 16q, 
once modifications in the clinical classification of a family member 
rendered the former incompatible with the new data. 
The second region considered in 16q, however, contains a much larger 
number of candidates and the expression screening was considered 
impractical. 
Mutational analysis was carried out in IRX3, IRX5, IRX6, and SALL 1, all 
four located in the 16q interval. No sequence variant compatible with a 
disease causing mutation was found. 
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5.4.1 Conserved non-coding sequences in the Iroquois B cluster 
The analysis of the sequences provided by the Human Genome Project 
has highlighted, besides coding sequences, certain elements that are not 
likely to produce a functional transcript and that have been conserved 
during evolution. This "conserved non-genic sequences" or "conserved 
non-coding sequences" (CNS) are thought to have an important role In 
regulation of gene expression and some times they cluster in regions with 
very little gene content or "gene deserts" (Dermitzakis et aJ. 2005). 
The 5Mb gene-poor region that contains the SALL 1, and the Iroquois 
cluster 8 is located within the largest block of unbroken synteny across 
human/mouse/dog/chicken found in chromosome 16, where approximately 
59% of all chromosome 16 human/mouse/fugu CNSs are clustered (Martin 
et al. 2004) 
In transgenesis experiments using Zebrafish and Xenopus tropicalis it has 
been noticed that the intergenic regions between the Iroquois cluster B 
genes function as modular tissue or organ specific enhancers, where 
specific segments control the expression of a reporter gene in specific 
tissues and developmental stages (de la CaIJe-Mustienes et al. 2005). 
Even though no heterozygous potentially pathogenic sequence variation 
was found In the coding regions of the Iroquois B, mutations in the non-
coding regions of the cluster could be relevant to the phenotype. 
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5.4.2 Limitations of the HOS15 family for linkage 
The main problem facing the identification of the mutation responsible for 
the phenotype in family HOS15 is the great length of the linkage intervals 
which is a direct consequence of the small size of the family. If more 
informative meioses are studied, should new members of the youngest 
generation or members of a new generation be born, higher LOD scores 
could be obtained. 
5.4.3 Phenotypic variability and future mapping efforts 
A striking phenotypic variability has been observed between Tbx5 knock-
out mice. Heterozygous Black-Swiss mice showed mild skeletal 
abnormalities and mild cardiac malformations whereas 129SvEv mice 
displayed complex cardiac malformations and died in utero. This points to 
an important role of modifier genes in the establishment of heart 
abnormalities in the phenotype associated wlth Tbx5 mutation (Bruneau et 
al. 2001). If the effect of modifier genes is even greater when other 
hypothetical Holt-Cram causing genes are mutated, incomplete 
penetrance could pose further difficulties to their identification. 
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Chapter 6 FINAL DISCUSSION 
Congenital heart defects (CHD) belong to a heterogeneous group of 
diseases of complex aetiology. Most of them appear sporadically in the 
population. probably because of the interaction between an unknown 
number of genetic determinants and environmental factors. 
Even though the discovery of a new gene responsible for a Mendelian 
form of a particular type of CHD has little immediate impact over the way 
this kind of diseases can be prevented or treated. the knowledge gained in 
that way is a useful tool in the dissection of the mechanisms of cardiac 
development. an extremely complex process. 
The discovery of a mutation of the gene MYH6 as a cause of a Mendelian 
form of atrial septal defect (Ching 2005). the first gene encoding a 
structural protein to be related to this particular phenotype, inspired the 
first main topic of this thesis: The search for point mutations and copy 
number variations in the MYH6 gene in subjects with apparently sporadic 
CHDs. 
No de novo mutations were discovered in our CHD cohort. Several 
inherited mutations were identified. In particular a nonsense mutation and 
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a splicing acceptor site mutation inherited from healthy parents are a 
striking feature of these findings that deserve further investigation. 
Possible explanations were developed in the discussion of Chapter 3. 
No copy number variations were discovered. Recurrent deletions are a 
cause of several Mendelian diseases mostly due to non-allelic 
homologous recombination events between very similar genes or 
repetitive elements. 
MYH6 and MYH7 are remarkably similar and are located in tandem in the 
long arm of chromosome 14. A previously reported non-allelic homologous 
recombination event made the prospect of a similar event being 
responsible for a small number of CHD cases seemed very interesting. 
The second main topic in this work is related to a purely Mendelian 
condition: Holt-Oram syndrome. 
The main Holt-Oram gene (TBX5 in chromosome 12) was identified a 
decade ago and numerous advances in developmental biology a 
molecular pathology have been achieved as a direct consequence. The 
identification of a new gene (SALL4 in chromosome 20) capable of 
producing a phenotype clinically indistinguishable from Holt-Oram 
syndrome and of families without linkage with either TBX5 or SALL4 was 
very encouraging. Nevertheless, the size of the biggest family in this case 
is not large enough to provide a chromosomal interval small enough to 
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conduct a comprehensive and efficient mutational screening. The growing 
of this family and the identification of new families not linked to 
chromosomes 12 or 20 should bring new hope. 
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